<SEC-DOCUMENT>0001493152-24-039093.txt : 20241002
<SEC-HEADER>0001493152-24-039093.hdr.sgml : 20241002
<ACCEPTANCE-DATETIME>20241002061535
ACCESSION NUMBER:		0001493152-24-039093
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		19
CONFORMED PERIOD OF REPORT:	20240930
ITEM INFORMATION:		Entry into a Material Definitive Agreement
ITEM INFORMATION:		Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
ITEM INFORMATION:		Unregistered Sales of Equity Securities
ITEM INFORMATION:		Other Events
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20241002
DATE AS OF CHANGE:		20241002

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			AgEagle Aerial Systems Inc.
		CENTRAL INDEX KEY:			0000008504
		STANDARD INDUSTRIAL CLASSIFICATION:	AIRCRAFT [3721]
		ORGANIZATION NAME:           	04 Manufacturing
		IRS NUMBER:				880422242
		STATE OF INCORPORATION:			NV
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-36492
		FILM NUMBER:		241345120

	BUSINESS ADDRESS:	
		STREET 1:		8201 E. 34TH CIR N
		CITY:			WICHITA
		STATE:			KS
		ZIP:			67226
		BUSINESS PHONE:		(620) 325-6363

	MAIL ADDRESS:	
		STREET 1:		8201 E. 34TH CIR N
		CITY:			WICHITA
		STATE:			KS
		ZIP:			67226

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	EnerJex Resources, Inc.
		DATE OF NAME CHANGE:	20060926

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	MILLENNIUM PLASTICS CORP
		DATE OF NAME CHANGE:	20000525

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	AURORA CORP
		DATE OF NAME CHANGE:	19990825
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>form8-k.htm
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:xs="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:dei="http://xbrl.sec.gov/dei/2024" xmlns:us-gaap="http://fasb.org/us-gaap/2024" xmlns:us-roles="http://fasb.org/us-roles/2024" xmlns:country="http://xbrl.sec.gov/country/2024" xmlns:srt="http://fasb.org/srt/2024" xmlns:UAVS="http://ageagle.com/20240930">
<head>
     <title></title>
<meta http-equiv="Content-Type" content="text/html"/>
</head>
<!-- Field: Set; Name: xdx; ID: xdx_02D_US%2DGAAP%2D2024 -->
<!-- Field: Set; Name: xdx; ID: xdx_036_UAVS_ageagle.com_20240930 -->
<!-- Field: Set; Name: xdx; ID: xdx_04A_20240930_20240930 -->
<!-- Field: Set; Name: xdx; ID: xdx_059_edei%2D%2DAmendmentFlag_false -->
<!-- Field: Set; Name: xdx; ID: xdx_05B_edei%2D%2DEntityCentralIndexKey_0000008504 -->
<!-- Field: Set; Name: xdx; ID: xdx_06B_USD_1_iso4217%2D%2DUSD -->
<!-- Field: Set; Name: xdx; ID: xdx_062_Shares_2_xbrli%2D%2Dshares -->
<!-- Field: Set; Name: xdx; ID: xdx_06D_USDPShares_3_iso4217%2D%2DUSD_xbrli%2D%2Dshares -->
<body style="font: 10pt Times New Roman, Times, Serif">
<div style="display: none">
<ix:header>
 <ix:hidden>
  <ix:nonNumeric contextRef="AsOf2024-09-30" id="Fact000003" name="dei:AmendmentFlag">false</ix:nonNumeric>
  <ix:nonNumeric contextRef="AsOf2024-09-30" id="Fact000004" name="dei:EntityCentralIndexKey">0000008504</ix:nonNumeric>
  </ix:hidden>
 <ix:references>
  <link:schemaRef xlink:href="uavs-20240930.xsd" xlink:type="simple"/>
  </ix:references>
 <ix:resources>
    <xbrli:context id="AsOf2024-09-30">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000008504</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-09-30</xbrli:startDate>
        <xbrli:endDate>2024-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:unit id="USD">
      <xbrli:measure>iso4217:USD</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="Shares">
      <xbrli:measure>xbrli:shares</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="USDPShares">
      <xbrli:divide>
        <xbrli:unitNumerator>
          <xbrli:measure>iso4217:USD</xbrli:measure>
        </xbrli:unitNumerator>
        <xbrli:unitDenominator>
          <xbrli:measure>xbrli:shares</xbrli:measure>
        </xbrli:unitDenominator>
      </xbrli:divide>
    </xbrli:unit>
  </ix:resources>
 </ix:header>
</div>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<!-- Field: Rule-Page --><div style="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><div style="border-top: Black 4pt solid; border-bottom: Black 1.5pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 18pt"><b>UNITED
STATES</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 18pt"><b>SECURITIES
AND EXCHANGE COMMISSION</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 12pt"><b>WASHINGTON,
D.C. 20549</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<!-- Field: Rule-Page --><div style="margin: 0pt auto; width: 100%"><div style="border-top: Black 1pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 18pt"><b>FORM
<span id="xdx_90C_edei--DocumentType_c20240930__20240930_zWnX2ZcAHfCf"><ix:nonNumeric contextRef="AsOf2024-09-30" id="Fact000009" name="dei:DocumentType">8-K</ix:nonNumeric></span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>CURRENT
REPORT</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>PURSUANT
TO SECTION 13 OR 15(d) OF THE</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>SECURITIES
EXCHANGE ACT OF 1934</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date
of Report (Date of earliest event reported): <b><span id="xdx_90E_edei--DocumentPeriodEndDate_c20240930__20240930_z1vk6I4rSZn7"><ix:nonNumeric contextRef="AsOf2024-09-30" format="ixt:datemonthdayyearen" id="Fact000010" name="dei:DocumentPeriodEndDate">September 30, 2024</ix:nonNumeric></span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 18pt"><b><span id="xdx_904_edei--EntityRegistrantName_c20240930__20240930_z4fxjYGgQVk5"><ix:nonNumeric contextRef="AsOf2024-09-30" id="Fact000011" name="dei:EntityRegistrantName">AGEAGLE
AERIAL SYSTEMS INC.</ix:nonNumeric></span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Exact
Name of Registrant as Specified in Charter)</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center; width: 32%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_902_edei--EntityIncorporationStateCountryCode_c20240930__20240930_z8OiXFV7q2j7"><ix:nonNumeric contextRef="AsOf2024-09-30" format="ixt-sec:stateprovnameen" id="Fact000012" name="dei:EntityIncorporationStateCountryCode">Nevada</ix:nonNumeric></span></b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center; width: 32%"><span id="xdx_90B_edei--EntityFileNumber_c20240930__20240930_zFRpdGg9zexe" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_908_edei--EntityFileNumber_c20240930__20240930_z0FDM5OFkQFi"><ix:nonNumeric contextRef="AsOf2024-09-30" id="Fact000013" name="dei:EntityFileNumber"><ix:nonNumeric contextRef="AsOf2024-09-30" id="Fact000014" name="dei:EntityFileNumber">001-36492</ix:nonNumeric></ix:nonNumeric></span></b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center; width: 32%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_902_edei--EntityTaxIdentificationNumber_c20240930__20240930_zdKyWLeSG6A7"><ix:nonNumeric contextRef="AsOf2024-09-30" id="Fact000015" name="dei:EntityTaxIdentificationNumber">88-0422242</ix:nonNumeric></span></b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(State
                                            or other jurisdiction</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">of
    incorporation)</span></p></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Commission</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">File
    Number)</span></p></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(IRS
                                            Employer</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Identification
    No.)</span></p></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center; width: 66%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_90B_edei--EntityAddressAddressLine1_c20240930__20240930_zrhdjKjAZhAc"><ix:nonNumeric contextRef="AsOf2024-09-30" id="Fact000016" name="dei:EntityAddressAddressLine1">8201
    E. 34th Cir N</ix:nonNumeric></span>, <span id="xdx_90F_edei--EntityAddressAddressLine2_c20240930__20240930_zAMwxoS66fS3"><ix:nonNumeric contextRef="AsOf2024-09-30" id="Fact000017" name="dei:EntityAddressAddressLine2">Suite 1307</ix:nonNumeric></span>, <span id="xdx_90B_edei--EntityAddressCityOrTown_c20240930__20240930_zIp8L8MB1Xz"><ix:nonNumeric contextRef="AsOf2024-09-30" id="Fact000018" name="dei:EntityAddressCityOrTown">Wichita</ix:nonNumeric></span>, <span id="xdx_903_edei--EntityAddressStateOrProvince_c20240930__20240930_zh6XThCxWvZf"><ix:nonNumeric contextRef="AsOf2024-09-30" format="ixt-sec:stateprovnameen" id="Fact000019" name="dei:EntityAddressStateOrProvince">Kansas</ix:nonNumeric></span></b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center; width: 32%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_90E_edei--EntityAddressPostalZipCode_c20240930__20240930_z6Eqd76A8lB"><ix:nonNumeric contextRef="AsOf2024-09-30" id="Fact000020" name="dei:EntityAddressPostalZipCode">67226</ix:nonNumeric></span></b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Address
    of principal executive offices)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Zip
    Code)</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Registrant&#8217;s
telephone number, including area code: <span id="xdx_904_edei--CityAreaCode_c20240930__20240930_zNFjyCocz6W1"><b><ix:nonNumeric contextRef="AsOf2024-09-30" id="Fact000021" name="dei:CityAreaCode">(620)</ix:nonNumeric> </b></span></span><b><span id="xdx_903_edei--LocalPhoneNumber_c20240930__20240930_zMihNEYfooa7" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonNumeric contextRef="AsOf2024-09-30" id="Fact000022" name="dei:LocalPhoneNumber">325-6363</ix:nonNumeric></span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Former
name or former address, if changed since last report)</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Check
the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under
any of the following provisions:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_906_edei--WrittenCommunications_c20240930__20240930_z7XRyzJgP7J4"><ix:nonNumeric contextRef="AsOf2024-09-30" format="ixt:booleanfalse" id="Fact000023" name="dei:WrittenCommunications">&#9744;</ix:nonNumeric></span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Written
    communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_902_edei--SolicitingMaterial_c20240930__20240930_zjBTmEKgmCv8"><ix:nonNumeric contextRef="AsOf2024-09-30" format="ixt:booleanfalse" id="Fact000024" name="dei:SolicitingMaterial">&#9744;</ix:nonNumeric></span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Soliciting
    material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_901_edei--PreCommencementTenderOffer_c20240930__20240930_zoM5qcLEHpX6"><ix:nonNumeric contextRef="AsOf2024-09-30" format="ixt:booleanfalse" id="Fact000025" name="dei:PreCommencementTenderOffer">&#9744;</ix:nonNumeric></span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pre-commencement
    communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90A_edei--PreCommencementIssuerTenderOffer_c20240930__20240930_zDeJOf6jLnMd"><ix:nonNumeric contextRef="AsOf2024-09-30" format="ixt:booleanfalse" id="Fact000026" name="dei:PreCommencementIssuerTenderOffer">&#9744;</ix:nonNumeric></span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pre-commencement
    communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 45pt; text-align: justify; text-indent: -45pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Securities
registered pursuant to Section 12(b) of the Act:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center; width: 38%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Title
    of each class</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: center; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center; width: 20%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Trading
    Symbol(s)</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: center; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center; width: 38%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Name
    of each exchange on which registered</b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_901_edei--Security12bTitle_c20240930__20240930_zVfWiqGJWXg3"><ix:nonNumeric contextRef="AsOf2024-09-30" id="Fact000027" name="dei:Security12bTitle">Common
    Stock</ix:nonNumeric></span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90A_edei--TradingSymbol_c20240930__20240930_zQhhyKRATjG6"><ix:nonNumeric contextRef="AsOf2024-09-30" id="Fact000028" name="dei:TradingSymbol">UAVS</ix:nonNumeric></span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_904_edei--SecurityExchangeName_c20240930__20240930_zJt1yYxXahGl"><ix:nonNumeric contextRef="AsOf2024-09-30" format="ixt-sec:exchnameen" id="Fact000029" name="dei:SecurityExchangeName">NYSE
    American</ix:nonNumeric></span></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Indicate
by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&#167;230.405
of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (&#167;240.12b-2 of this chapter). <b><span id="xdx_908_edei--EntityEmergingGrowthCompany_c20240930__20240930_zeKSodhO9np8"><ix:nonNumeric contextRef="AsOf2024-09-30" format="ixt:booleanfalse" id="Fact000030" name="dei:EntityEmergingGrowthCompany">&#9744;</ix:nonNumeric></span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying
with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. <b>&#9744;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<!-- Field: Rule-Page --><div style="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><div style="border-top: Black 1.5pt solid; border-bottom: Black 4pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<!-- Field: Page; Sequence: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Item
1.01. Entry into a Material Definitive Agreement.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Unit
Offering</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.45in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
September 30, 2024, AgEagle Aerial Systems Inc. (the &#8220;Company&#8221;) entered into a placement agency agreement (the &#8220;Placement
Agency Agreement&#8221;) with Spartan Capital Securities, LLC (the &#8220;Placement Agent&#8221;) in connection with the issuance and
sale by the Company in a public offering (the &#8220;Offering&#8221;) of 26,899,996 units (the &#8220;Units&#8221;), consisting
of common units (&#8220;Common Units&#8221;), each consisting of one share of common stock of the Company, $0.001 par value per share,
one Series A warrant (&#8220;Series A Warrant&#8221;) to purchase one share of common stock and one Series B warrant (&#8220;Series B
Warrant&#8221;) to purchase one share of common stock and pre-funded Units (the &#8220;Pre-Funded Units&#8221; and together with the
Common Units, the &#8220;Units&#8221;), with each Pre-Funded Unit consisting of one pre-funded warrant (the &#8220;Pre-Funded Warrants&#8221;)
to purchase one share of common stock, one Series A Warrant to purchase one share of common stock and one Series B Warrant to purchase
one share of common stock.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.45in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.45in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
purchase price of each Common Unit was $0.24, and the purchase price of each Pre-Funded Unit was $0.239, less Placement Agent fees and
commissions.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.45in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Units have no stand-alone rights and will not be certificated or issued as stand-alone securities. Each Series A Warrant is immediately
exercisable on the date of issuance at an exercise price of the public offering price of the Units, or pursuant to an alternate cashless
exercise option, and expires five years from the closing date of the offering. Each Series B Warrant is immediately exercisable
on the date of issuance at an exercise price equal to one hundred percent (100%) of the public offering price of the Units, and expires
five years from the closing date of the offering.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.45in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.45in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under
the alternate cashless exercise option of the Series A Warrants, a holder of the Series A Warrant, has the right to receive an
aggregate number of shares equal to the product of (x) the aggregate number of shares of common stock that would be issuable upon a cash
exercise of the Series A Warrant and (y) 2.0. In addition, the Series A Warrants and Series B Warrants contain a reset of the exercise
price to a price equal to the lesser of (i) the then exercise price and (ii) the lowest volume weighted average price for the five trading
days immediately preceding and immediately following the date the Company effects a reverse stock split in the future with a proportionate
adjustment to the number of shares underlying the Series A Warrants and Series B Warrants. Finally, with certain exceptions, the Series
B Warrants provide for an adjustment to the exercise price and number of shares underlying the Series B Warrants upon the Company&#8217;s
issuance of its common stock or common stock equivalents at a price per share that is less than the exercise price of the
Series B Warrant.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.45in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.45in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under
NYSE American listing rules, the alternative cashless exercise option in the Series A Warrants and certain anti-dilution provisions in
the Series B Warrants described above, will not be effective until, and unless, the Company obtains the approval of its
shareholders. If the Company is  unable to obtain the shareholder approval, the foregoing provisions will not become effective
and the Series A Warrants and Series B Warrants will have substantially less value.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.45in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.45in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Each
Pre-Funded Warrant is exercisable for one share of common stock. Subject to limited exceptions, a holder of Pre-Funded Warrants
does not have the right to exercise any portion of its Pre-Funded Warrants if the holder, together with its affiliates, would
beneficially own in excess of 4.99% (or, at the election of the holder, such limit may be increased to up to 9.99%) of the number of
shares of common stock outstanding immediately after giving effect to such exercise. The purchase price of each Pre-Funded Unit is equal
to the price per Common Unit minus $0.001, and the remaining exercise price of each Pre-Funded Warrant equals $0.001 per share.
The Pre-Funded Warrants are immediately exercisable (subject to the beneficial ownership cap) and may be exercised at any time
until all of the Pre-Funded Warrants are exercised in full.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.45in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.45in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
shares of common stock, the Pre-Funded Warrants, the Series A Warrants and the Series B Warrants and the shares of common stock issuable
upon exercise of the Pre-Funded Warrants, the Series A Warrants and the Series B Warrants described above, were offered by the Company
pursuant to a Registration Statement on Form S-1 (File No. 333-281897), filed with the Securities and Exchange Commission (the &#8220;SEC&#8221;)
under the Securities Act of 1933, as amended (the &#8220;Securities Act&#8221;) and declared effective by the SEC on September 30, 2024.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.45in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.45in"></p>

<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 2 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.45in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.45in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
closing of the Offering occurred on October 1, 2024.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.45in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.45in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company engaged the Placement Agent as the Company&#8217;s sole placement agent for the Offering pursuant to the Placement Agency Agreement.
Pursuant to the Placement Agency Agreement, the Company agreed to pay the Placement Agent a cash placement fee equal to 8.0% of the gross
proceeds of the Offering. The Company also agreed to pay the Placement Agent 0.5% of the gross proceeds received by the Company
in the Offering, plus reimbursement of certain expenses and legal fees up to $215,000. The Placement Agency Agreement contains customary
representations, warranties and agreements by the Company, customary conditions to closing, indemnification obligations of the Company
and the Placement Agent, including for liabilities under the Securities Act of 1933, as amended, other obligations of the parties and
termination provisions. The representations, warranties and covenants contained in the Placement Agency Agreement were made only for
purposes of such agreements and as of a specific date, were solely for the benefit of the parties to such agreements, and may be subject
to limitations agreed upon by the contracting parties.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
foregoing descriptions of the terms and conditions of the Placement Agency Agreement, the Pre-Funded Warrants, the Series A Warrants
and the Series B Warrants do not purport to be complete and are qualified in their entirety by the full text of the Placement Agency
Agreement, the form of the Pre-Funded Warrants, the form of the Series A Warrants and the form of the Series B Warrants, which are attached
hereto as Exhibits 1.1, 4.1, 4.2, and 4.3, respectively, and are incorporated by reference herein.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Omnibus
Agreement</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
previously reported on a Current Report on Form 8-K filed on February 8, 2024, the Company issued to Alpha Capital Anstalt (&#8220;Alpha&#8221;)
a Convertible Note due January 8, 2024, as amended on July 25, 2024, in the principal amount of $4,849,491 (the &#8220;Convertible Note&#8221;)
and pursuant to that certain Securities Purchase Agreement dated June 26, 2022 (the &#8220;SPA&#8221;), the Company issued to Alpha shares
of Series F 5% Convertible Preferred Stock (&#8220;Series F 5% Convertible Preferred Stock&#8221;) described in the Certificate of Designation
of Preferences, Rights and Limitations of Series F 5% Convertible Preferred Stock (&#8220;Series F CoD&#8221;) and warrants to purchase
shares of the Company&#8217;s Common Stock (the &#8220;Warrants,&#8221; and together with the Convertible Note, SPA, and Series F 5%
Convertible Preferred Stock being the &#8220;Holder Securities&#8221;). The Offering in part constitutes a Variable Rate Transaction
as defined in the Holder Securities that requires the consent of Alpha.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to the Omnibus Agreement, among other things, (i) Alpha consented to the Offering, (ii) Alpha agreed to purchase $3,000,000 of the
units in the offering and the Company agreed to apply said $3,000,000 towards the repayment of the Convertible Note
balance, (iii) upon such repayment, $2,000,000.00 in principal will remain outstanding on the Convertible Note which will be paid
in six monthly installments consisting of $333,333.33 in principal plus all accrued commencing on October 15, 2024 and continuing on
the 15th day of each calendar month until the Convertible Note is paid in full, and (iv) in consideration of Alpha&#8217;s consent,
the Company will issue to Alpha 1,500 shares of Series F 5% Convertible Preferred Stock with an aggregate stated value of $1,500,000.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
foregoing description of the Omnibus Agreement does not purport to be complete and is qualified in its entirety by reference to the Omnibus
Agreement, which is filed as Exhibit 10.1 to this Current Report and incorporated by reference herein.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Item
2.03. Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
information set forth in Item 1.01 is incorporated herein by reference.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"></p>

<!-- Field: Page; Sequence: 3; Value: 2 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Item
3.02. Unregistered Sale of Equity Securities.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
information set forth in Item 1.01 is incorporated herein by reference.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Item
8.01. Other Events.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
October 1, 2024, the Company issued a press release announcing the closing of the Offering. A copy of the press release is attached hereto
as Exhibit 99.1 to this Current Report on Form 8-K.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Item
9.01. Financial Statements and Exhibits.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exhibits.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 0.75in"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Exhibit</b></span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Number</b></span></p></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; width: 0.1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; padding-bottom: 1pt"><p style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Description</b></span></p></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.1</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline"><a href="ex1-1.htm">Placement Agency Agreement, dated as of September 30, 2024, between AgEagle Aerial Systems Inc. and Spartan Capital Securities, LLC</a></span></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.1</span></p></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><a href="ex4-1.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Form of Pre-Funded Warrant</span></a></p></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4,2</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"><a href="ex4-2.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Form of Series A Warrant</span></a></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.3</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"><a href="ex4-3.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Form of Series B Warrant</span></a></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.1</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline"><a href="ex10-1.htm">Omnibus Agreement, dated September 30, 2024</a></span></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">99.1</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="ex99-1.htm">Press Release, dated October 1, 2024</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">104</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cover
    Page Interactive Data File (embedded within the Inline XBRL document).</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 4; Value: 2 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>SIGNATURES</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by
the undersigned hereunto duly authorized.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dated:
    October 1, 2024</span></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>AGEAGLE
    AERIAL SYSTEMS INC.</b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 50%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 5%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 45%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>/s/
    Mark DiSiena</i></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mark
    DiSiena</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief
    Financial Officer</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"></p>

<!-- Field: Page; Sequence: 5; Options: Last -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center">&#160;</p>

<!-- Field: Set; Name: xdx; ID: xdx_08B_extensions -->
<!-- eJxFjdEKgkAQRb/Afxj2OVLXevExqYgsRCJ6XXKKJd2R2c30k/rLNiUaBobh3nOvEDOxpY2ukeGyKnM4YdPWyiGUeENGc0XvyHb7FPwt8a6tY2Xc+P7AjDyDnlnO5UJ5YbR22mKVQhyFURzKBcQyTRIoDiL46hmZm67QOK1qUKaCgqlljU7xMCWcVE+GmmGsOiNbTcbHzaNJfoOMYglH6tSL+GEhzzMRzMYJxJbp2XrXundoviSsa2x8nZ3o/wYfAhVKhQ== -->
</body>
</html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-1.1
<SEQUENCE>2
<FILENAME>ex1-1.htm
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exhibit
1.1</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">PLACEMENT
AGENCY AGREEMENT</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: right">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">September
30, 2024</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">AgEagle
Aerial Systems Inc.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8201
E. 34<SUP>th</SUP> Cir N, Suite 1307</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Wichita,
Kansas 67226</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Attention</U>:
William Irby, Chief Executive Officer</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dear
Mr. Irby:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
agreement (the &ldquo;<B>Agreement</B>&rdquo;) constitutes the agreement between Spartan Capital Securities, LLC (the &ldquo;<B>Placement
Agent</B>&rdquo;) and <FONT STYLE="background-color: white">AgEagle Aerial Systems, Inc.</FONT>, a Nevada corporation (the &ldquo;<B>Company</B>&rdquo;),
pursuant to which the Placement Agent shall serve as the exclusive placement agent for the Company, on a &ldquo;reasonable best efforts&rdquo;
basis, in connection with the proposed public offering (the &ldquo;<B>Placement</B>&rdquo;) of up to an aggregate of $12.0 million of
(a) shares (the &ldquo;<B>Shares</B>&rdquo;) of the Company&rsquo;s common stock, par value $0.001 per share (the &ldquo;<B>Common Shares</B>&rdquo;)
and/or pre-funded warrants to subscribe for Common Shares (the &ldquo;<B>Prefunded Warrants</B>&rdquo;), (b) five year Class A Warrants
to purchase shares of the Company&rsquo;s common stock (the &ldquo;<B>Class A Warrants</B>&rdquo;) and (c) five year Class B Warrants
to purchase shares of the Company&rsquo;s common stock (the &ldquo;<B>Class B Warrants</B>&rdquo; and together with the Class A Warrants
the &ldquo;<B>Warrants</B>&rdquo;). The Common Shares underlying the Prefunded Warrants shall hereinafter be referred to as the &ldquo;<B>Prefunded
Warrant Shares</B>&rdquo;, the Common Shares underlying the Warrants shall hereinafter be referred to as the &ldquo;<B>Warrant Shares</B>&rdquo;,
and the Shares, the Prefunded Warrants, the Prefunded Warrant Shares, the Warrants and the Warrant Shares shall hereinafter be referred
to collectively as the &ldquo;<B>Securities</B>.&rdquo; The terms of the Placement and the Securities shall be mutually agreed upon by
the Company and the purchasers (each, a &ldquo;<B>Purchaser</B>&rdquo; and collectively, the &ldquo;<B>Purchasers</B>&rdquo;) and nothing
herein constitutes that the Placement Agent would have the power or authority to bind the Company or any Purchaser or an obligation for
the Company to issue any Securities or complete the Placement. The Placement Agent shall act solely as the Company&rsquo;s agent and
not as principal. The Company shall have the sole right to accept offers to purchase Securities and may reject any such offer, in whole
or in part. The purchase price to the Purchasers for each Common Share is $0.24, the purchase price to the Purchasers for each Pre-Funded
Warrant is $0.239, the exercise price to the Purchasers for each Prefunded Warrant Share issuable upon exercise of the Pre-Funded Warrants
is $0.001, the exercise price to the Purchasers for each Warrant Share issuable upon exercise of the Class A Warrants is $0.24, and the
exercise price to the Purchasers for each Warrant Share issuable upon exercise of the Class B Warrants is $0.50. This Agreement and the
documents executed and delivered by the Company and the Purchasers in connection with the Placement, including but not limited to the
Purchase Agreement (as defined below), and the forms of the Prefunded Warrants and Warrants shall be collectively referred to herein
as the &ldquo;<B>Transaction Documents</B>.&rdquo; The date of the closing of the Placement shall be referred to herein as the &ldquo;<B>Closing
Date</B>.&rdquo; The Company expressly acknowledges and agrees that the Placement Agent&rsquo;s obligations hereunder are on a reasonable
best-efforts basis only and that the execution of this Agreement does not constitute a commitment by the Placement Agent to purchase
the Securities and does not ensure the successful placement of the Securities or any portion thereof or the success of the Placement
Agent with respect to securing any other financing on behalf of the Company. With the prior written consent of the Company, the Placement
Agent may retain other brokers or dealers to act as sub-agents or selected-dealers on its behalf in connection with the Placement. The
sale of the Securities to any Purchaser will be evidenced by a securities purchase agreement (the &ldquo;<B>Purchase Agreement</B>&rdquo;)
between the Company and such Purchaser in a form reasonably acceptable to the Company and the Placement Agent. Capitalized terms that
are not otherwise defined herein have the meanings given to such terms in the Purchase Agreement. Prior to the signing of any Purchase
Agreement, officers of the Company will be available to answer inquiries from prospective Purchasers.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 1; Options: NewSection -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT>&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>SECTION
1. REPRESENTATIONS AND WARRANTIES OF THE COMPANY; COVENANTS OF THE COMPANY</U>.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">A.
<U>Representations of the Company</U>. Each of the representations and warranties (together with any related disclosure schedules thereto)
and covenants made by the Company to the Purchasers in the Purchase Agreement in connection with the Placement is hereby incorporated
herein by reference into this Agreement (as though fully restated herein) and is, as of the date of this Agreement and as of the Closing
Date, hereby made to, and in favor of, the Placement Agent. In addition to the foregoing, the Company represents and warrants that:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.
The Company has prepared and filed with the U.S. Securities and Exchange Commission (the &ldquo;<B>Commission</B>&rdquo;) a registration
statement on Form S-1, as amended (Registration No. 333-281897), and amendments thereto, for the registration under the Securities Act
of 1933, as amended (the &ldquo;<B>Securities Act</B>&rdquo;), of the Securities, which registration statement, as so amended (including
post-effective amendments, if any) became effective on September 30, 2024. Such registration statement, including the exhibits thereto,
as of the date of this Agreement, is hereinafter called the &ldquo;<B>Registration Statement</B>.&rdquo; Any reference in this Agreement
to the Registration Statement shall each be deemed to refer to and include the documents incorporated by reference therein (the &ldquo;<B>Incorporated
Documents</B>&rdquo;) on or before the date of this Agreement; and any reference in this Agreement to the terms &ldquo;amend,&rdquo;
&ldquo;amendment&rdquo; or &ldquo;supplement&rdquo; with respect to the Registration Statement shall be deemed to refer to and include
the filing of any document under the Securities Exchange Act of 1934, as amended (the &ldquo;<B>Exchange Act</B>&rdquo;), after the date
of this Agreement, deemed to be incorporated therein by reference. All references in this Agreement to financial statements and schedules
and other information which is &ldquo;contained,&rdquo; &ldquo;included,&rdquo; &ldquo;described,&rdquo; &ldquo;referenced,&rdquo; &ldquo;set
forth&rdquo; or &ldquo;stated&rdquo; in the Registration Statement (and all other references of like import) shall be deemed to mean
and include all such financial statements and schedules and other information which is or is deemed to be incorporated by reference in
the Registration Statement. No stop order suspending the effectiveness of the Registration Statement has been issued, and no proceeding
for any such purpose is pending or has been initiated or, to the Company&rsquo;s knowledge, is threatened by the Commission. For purposes
of this Agreement, the &ldquo;<B>Time of Sale Prospectus</B>&rdquo; means the preliminary prospectus, if any, together with the free
writing prospectuses, if any, used in connection with the Placement, including any documents incorporated by reference therein.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.
The Registration Statement (and any further documents to be filed with the Commission) contains all exhibits and schedules as required
by the Securities Act. Each of the Registration Statement and any post-effective amendment thereto, at the time it became effective,
complied in all material respects with the Securities Act and the Exchange Act and the rules and regulations (the &ldquo;<B>Rules and
Regulations</B>&rdquo;) of the Commission promulgated thereunder and did not and, as amended or supplemented, if applicable, will not,
contain any untrue statement of a material fact or omit to state a material fact required to be stated therein or necessary to make the
statements therein not misleading. The Incorporated Documents, when they were filed with the Commission, conformed in all material respects
to the requirements of the Exchange Act and the applicable Rules and Regulations, and none of such documents, when they were filed with
the Commission, contained any untrue statement of a material fact or omitted to state a material fact necessary to make the statements
therein (with respect to Incorporated Documents incorporated by reference in the Registration Statement), in the light of the circumstances
under which they were made not misleading; and any further documents so filed and incorporated by reference in the Registration Statement,
when such documents are filed with the Commission, will conform in all material respects to the requirements of the Exchange Act and
the applicable Rules and Regulations, as applicable, and will not contain any untrue statement of a material fact or omit to state a
material fact necessary to make the statements therein, in the light of the circumstances under which they were made, not misleading.
No post-effective amendment to the Registration Statement reflecting any facts or events arising after the date thereof which represent,
individually or in the aggregate, a fundamental change in the information set forth therein is required to be filed with the Commission.
There are no documents required to be filed with the Commission in connection with the transaction contemplated hereby that (x) have
not been filed as required pursuant to the Securities Act or (y) will not be filed within the requisite time period. There are no contracts
or other documents required to be described in the Time of Sale Prospectus or to be filed as exhibits or schedules to the Registration
Statement, which (x) have not been described or filed as required or (y) will not be filed within the requisite time period.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.
Neither the Company nor any of its directors and officers has distributed, and none of them will distribute, prior to the Closing Date,
any offering material in connection with the offering and sale of the Securities other than the Time of Sale Prospectus.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.
The Company has the requisite corporate power and authority to enter into and to consummate the transactions contemplated by this Agreement
and the Time of Sale Prospectus and otherwise to carry out its obligations hereunder and thereunder. The execution and delivery of each
of this Agreement by the Company and the consummation by it of the transactions contemplated hereby and thereby have been duly authorized
by all necessary action on the part of the Company and no further action is required by the Company, the Company&rsquo;s Board of Directors
(the &ldquo;<B>Board of Directors</B>&rdquo;) or the Company&rsquo;s shareholders in connection therewith other than in connection with
the Required Approvals (as defined in the Purchase Agreement). This Agreement has been duly executed by the Company and, when duly execute
by the Placement Agent and delivered in accordance with the terms hereof, will constitute the valid and binding obligation of the Company
enforceable against the Company in accordance with its terms, except (i) as limited by general equitable principles and applicable bankruptcy,
insolvency, reorganization, moratorium and other laws of general application affecting enforcement of creditors&rsquo; rights generally,
(ii) as limited by laws relating to the availability of specific performance, injunctive relief or other equitable remedies and (iii)
insofar as indemnification and contribution provisions may be limited by applicable law.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.
The execution, delivery and performance by the Company of this Agreement and the transactions contemplated pursuant to the Time of Sale
Prospectus, the issuance and sale of the Securities and the consummation by it of the transactions contemplated hereby and thereby to
which it is a party do not and will not (i) conflict with or violate any provision of the Company&rsquo;s or any subsidiary&rsquo;s certificate
or articles of incorporation, bylaws or other organizational or charter documents, or (ii) conflict with, or constitute a default (or
an event that with notice or lapse of time or both would become a default) under, result in the creation of any Lien upon any of the
properties or assets of the Company or any subsidiary, or give to others any rights of termination, amendment, acceleration or cancellation
(with or without notice, lapse of time or both) of, any agreement, credit facility, debt or other instrument (evidencing a Company or
subsidiary debt or otherwise) or other understanding to which the Company or any subsidiary is a party or by which any property or asset
of the Company or any subsidiary is bound or affected, or (iii) subject to the Required Approvals, conflict with or result in a violation
of any law, rule, regulation, order, judgment, injunction, decree or other restriction of any court or governmental authority to which
the Company or a subsidiary is subject (including federal and state securities laws and regulations), or by which any property or asset
of the Company or a subsidiary is bound or affected; except in the case of each of clauses (ii) and (iii), such as could not have or
reasonably be expected to result in a Material Adverse Effect (as defined in the Purchase Agreement).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.
Any certificate signed by an officer of the Company and delivered to the Placement Agent or to counsel for the Placement Agent shall
be deemed to be a representation and warranty by the Company to the Placement Agent as to the matters set forth therein.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">7.
The Company acknowledges that the Placement Agent will rely upon the accuracy and truthfulness of the foregoing representations and warranties
and hereby consents to such reliance.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8.
No forward-looking statements (within the meaning of Section 27A of the Securities Act and Section 21E of the Exchange Act) contained
in the Time of Sale Prospectus has been made or reaffirmed without a reasonable basis or has been disclosed other than in good faith.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">9.
Any statistical, industry-related and market-related data included or incorporated by reference in the Time of Sale Prospectus, are based
on or derived from sources that the Company reasonably and in good faith believes to be reliable and accurate, and such data agree with
the sources from which they are derived.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.
Except as set forth in the Registration Statement and the Time of Sale Prospectus, no brokerage or finder&rsquo;s fees or commissions
are or will be payable by the Company, any subsidiary or affiliate of the Company to any broker, financial advisor or consultant, finder,
placement agent, investment banker, bank or other person with respect to the transactions contemplated by the Purchase Agreement. There
are no other arrangements, agreements or understandings of the Company or, to the Company&rsquo;s knowledge, any of its shareholders
that may affect the Placement Agent&rsquo;s compensation, as determined by the Financial Industry Regulatory Authority (&ldquo;<B>FINRA</B>&rdquo;).
Other than payments to the Placement Agent for this Placement, the Company has not made and has no agreements, arrangements or understanding
to make any direct or indirect payments (in cash, securities or otherwise) to: (i) any person, as a finder&rsquo;s fee, consulting fee
or otherwise, in consideration of such person raising capital for the Company or introducing to the Company persons who raised or provided
capital to the Company; (ii) any FINRA member participating in the offering as defined in FINRA Rule 5110 (a &ldquo;<B>Participating
Member</B>&rdquo;); or (iii) any person or entity that has any direct or indirect affiliation or association with any Participating Member,
within the 180-day period preceding the initial filing of the Registration Statement through the 60-day period after the effective date
of the Registration Statement. None of the net proceeds of the Placement will be paid by the Company to any Participating Member or its
affiliates, except as specifically authorized herein. To the Company&rsquo;s knowledge, no officer, director or any beneficial owner
of 10% or more of the Company&rsquo;s Common Shares or Common Share equivalents has any direct or indirect affiliation or association
with any Participating Member in the Placement. Except for securities purchased on the open market, no Company affiliate is an owner
of stock or other securities of any Participating Member. No Company affiliate has made a subordinated loan to any Participating Member.
No proceeds from the sale of the Securities (excluding placement agent compensation as disclosed in the Registration Statement and the
Time of Sale Prospectus) will be paid to any Participating Member, any persons associated with a Participating Member or an affiliate
of a Participating Member. Except as disclosed in the Registration Statement or the Time of Sale Prospectus, the Company has not issued
any warrants or other securities or granted any options, directly or indirectly, to the Placement Agent within the 180-day period prior
to the initial filing date of the Registration Statement. Except for securities issued to the Placement Agent as disclosed in the Registration
Statement, no person to whom securities of the Company have been privately issued within the 180-day period prior to the initial filing
date of the Time of Sale Prospectus is a Participating Member, is a person associated with a Participating Member or is an affiliate
of a Participating Member. No Participating Member in the Placement has a conflict of interest with the Company. For this purpose, a
&ldquo;conflict of interest&rdquo; exists when a Participating Member, the parent or affiliate of a Participating Member or any person
associated with a Participating Member in the aggregate beneficially own 5% or more of the Company&rsquo;s outstanding subordinated debt
or common equity, or 5% or more of the Company&rsquo;s preferred equity. &ldquo;FINRA member participating in the Placement&rdquo; includes
any associated person of a Participating Member in the Placement, any member of such associated person&rsquo;s immediate family and any
affiliate of a Participating Member in the Placement. When used in this <U>Section 1.A.10</U> the term &ldquo;affiliate of a FINRA member&rdquo;
or &ldquo;affiliated with a FINRA member&rdquo; means an entity that controls, is controlled by or is under common control with a FINRA
member. The Company will advise the Placement Agent and its counsel if it learns that any officer, director or owner of 10% or more of
the Company&rsquo;s outstanding Common Shares or Common Share equivalents is or becomes an affiliate or associated person of a Participating
Member.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 4 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">11.
The Board of Directors is comprised of the persons set forth under the heading of the Registration Statement captioned &ldquo;Management.&rdquo;
The qualifications of the persons serving as board members and the overall composition of the Board of Directors comply with the Sarbanes-Oxley
Act of 2002 and the rules promulgated thereunder applicable to the Company and the rules of the Trading Market (as defined below). In
addition, at least a majority of the persons serving on the Board of Directors qualify as &ldquo;independent&rdquo; as defined under
the rules of the Trading Market.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">12.
To the Company&rsquo;s knowledge, all information contained in the questionnaires most recently completed by each of the Company&rsquo;s
directors and officers is true and correct in all respects and the Company has not become aware of any information which would cause
the information disclosed in such questionnaires become inaccurate and incorrect.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">B.
<U>Covenants of the Company</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.
The Company has delivered, or will as promptly as practicable deliver, to the Placement Agent materially complete conformed copies of
the Registration Statement and of each consent and certificate of experts, as applicable, filed as a part thereof, and conformed copies
of the Registration Statement (without exhibits), the Time of Sale Prospectus, as amended or supplemented, in such quantities and at
such places as the Placement Agent reasonably requests. Neither the Company nor any of its directors and officers has distributed and
none of them will distribute, prior to the Closing Date, any offering material in connection with the offering and sale of the Securities
pursuant to the Placement other than the Time of Sale Prospectus, the Registration Statement, copies of the documents incorporated by
reference therein and any other materials permitted by the Securities Act.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.
Section 4.15 of the Purchase Agreement as in effect on the date hereof may not be amended or waived without the prior written consent
of the Placement Agent.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.
The Company covenants that it will not, unless it obtains the prior written consent of the Placement Agent, make any offer relating to
the Securities that would constitute a Company Free Writing Prospectus or that would otherwise constitute a &ldquo;free writing prospectus&rdquo;
(as defined in Rule 405 of the Securities Act) required to be filed by the Company with the Commission or retained by the Company under
Rule 433 of the Securities Act. In the event that the Placement Agent expressly consents in writing to any such free writing prospectus
(a &ldquo;<B>Permitted Free Writing Prospectus</B>&rdquo;), the Company covenants that it shall (i) treat each Permitted Free Writing
Prospectus as a Company Free Writing Prospectus, and (ii) comply with the requirements of Rule 164 and 433 of the Securities Act applicable
to such Permitted Free Writing Prospectus, including in respect of timely filing with the Commission, legending and record keeping.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.
The Company will maintain, at its expense, a registrar and transfer agent for the Common Shares.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 5 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.
The Company shall (a) hold a special meeting of stockholders (which may also be at the annual meeting of stockholders) at the earliest
practicable date after the date hereof, or (b) obtain by written consent the Stockholder Approval, but in no event later than twenty
(20) business days (which time period, for the avoidance of doubt, does not include the time required to file and mail an information
statement on Schedule 14C with respect to such written consent as required under the Exchange Act), after the Closing Date for the purpose
of obtaining Stockholder Approval (as defined below), if required to effect the purpose thereof, with the recommendation of the Board
that such proposal be approved, and the Company shall, if applicable, solicit proxies from its stockholders in connection therewith in
the same manner as all other management proposals in such proxy statement and all management-appointed proxyholders shall vote their
proxies in favor of such proposal. The Company shall use its reasonable best efforts to obtain such Stockholder Approval, and officers,
directors and stockholders subject to Lock-Up Agreement pursuant to Section 7Q shall, if applicable, cast their proxies in favor of such
proposal. If the Company does not obtain Stockholder Approval at the first meeting or by written consent, the Company shall call a meeting
every twenty (20) days thereafter to seek Stockholder Approval until the earlier of the date Stockholder Approval is obtained or the
Warrants are no longer outstanding. &ldquo;<B>Stockholder Approval</B>&rdquo; has the meaning set forth in the Warrants.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.
The Company shall effect a reverse stock split within seven (7) business days after the date that is the earlier of the date on which
(x) the first meeting of stockholders to obtain Stockholder Approval is held or (y) the items to be approved under the Stockholder Approval
have been approved in accordance with the applicable laws and corporate governing documents of the Company (including, if applicable
and without limitation, the filing and mailing of an information statement on Schedule 14C (the &ldquo;<B>First Reverse Split Date</B>&rdquo;).
No reverse stock split shall be effectuated before the First Reverse Split Date, except if the consent has been obtained from a purchasers
of a majority of the Shares.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>SECTION
2. REPRESENTATIONS OF THE PLACEMENT AGENT</U>.</B> The Placement Agent represents and warrants that it (i) is a member in good standing
of FINRA, (ii) is registered as a broker/dealer under the Exchange Act, (iii) is licensed as a broker/dealer under the laws of the states
applicable to the offers and sales of the Securities by such Placement Agent, (iv) is and will be a body corporate validly existing under
the laws of its place of incorporation, and (v) has full power and authority to enter into and perform its obligations under this Agreement.
The Placement Agent will immediately notify the Company in writing of any change in its status as such. The Placement Agent covenants
that it will use its reasonable best efforts to conduct the Placement hereunder in compliance with the provisions of this Agreement and
the requirements of applicable law.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>SECTION
3. COMPENSATION</U>.</B> In consideration of the services to be provided for hereunder, the Company shall pay to the Placement Agent
or their respective designees their pro rata portion (based on the Securities placed) of the following compensation with respect to the
Securities which they are placing:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">A.
A cash fee (the &ldquo;<B>Cash Fee</B>&rdquo;) equal to 8.0% of the aggregate gross proceeds raised in the Placement. The Company also
agrees to pay the Placement Agent a non-accountable expense allowance of 0.5% of the aggregate gross proceeds raised in the Placement
(the &ldquo;<B>Non-Accountable Expense Allowance</B>&rdquo;). Each of the Cash Fee and the Non-Accountable Expense Allowance shall be
paid at the closing of the Placement (the &ldquo;<B>Closing</B>&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">B.
Subject to compliance with FINRA Rule 5110(g), out of the aggregate gross proceeds of raised in the Placement, the Company also agrees
to pay Spartan up to $215,000for fees and expenses of legal counsel and other out-of-pocket expenses, roadshow expenses and cost of background
checks, escrow agent or clearing agent fees; plus the additional amount payable by the Company pursuant to Paragraph A hereunder and,
if applicable, the costs associated with the use of a third-party electronic road show service The Company will reimburse the Placement
Agent directly out of the gross proceeds of the Closing. Notwithstanding the foregoing, any amounts paid or payable under this Section
3(B) in no way limits or impairs the indemnification and contribution obligations set forth in Section 4 hereof and any advance received
by the Placement Agent will be reimbursed to the Company to the extent not actually incurred in compliance with FINRA Rule 5110(g)(4)(A).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 6 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">C.
The Placement Agent will be entitled to the cash compensation set forth above, with respect to any public or private offering or other
financing or capital-raising transaction of any kind (&ldquo;<B>Tail Financing</B>&rdquo;) to the extent that such financing or capital
is provided to the Company by investors whom Placement Agent had contacted during the 12-month term of that Engagement Agreement dated
June 28, 2024 by and between the Company and the Placement Agent (the &ldquo;<B>Engagement Agreement</B>&rdquo;) or introduced to the
Company during such term, if such Tail Financing is consummated at any time within the 12-month period following the expiration or termination
of the Engagement Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">D.
The Placement Agent reserves the right to reduce any item of its compensation or adjust the terms thereof as specified herein in the
event that a determination shall be made by FINRA to the effect that such Placement Agent&rsquo;s aggregate compensation is in excess
of FINRA rules or that the terms thereof require adjustment.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>SECTION
4. INDEMNIFICATION</U>.</B> The Company agrees to the indemnification and other agreements set forth in the indemnification provisions
(the &ldquo;<B>Indemnification Provisions</B>&rdquo;) attached hereto as <U>Addendum A</U>, the provisions of which are incorporated
herein by reference and shall survive the termination or expiration of this Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>SECTION
5. PLACEMENT AGENT INFORMATION</U></B>. The Company agrees that any information or advice rendered by the Placement Agent in connection
with this engagement is for the confidential use of the Company only in their evaluation of the Placement and, except as otherwise required
by law, the Company will not disclose or otherwise refer to the advice or information in any manner without the Placement Agent&rsquo;s
prior written consent.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>SECTION
6. NO FIDUCIARY RELATIONSHIP</U></B>. This Agreement does not create, and shall not be construed as creating rights enforceable by any
person or entity not a party hereto, except those entitled hereto by virtue of the Indemnification Provisions hereof. The Company acknowledges
and agrees that the Placement Agent is not and shall not be construed as a fiduciary of the Company and shall have no duties or liabilities
to the equity holders or the creditors of the Company or any other person by virtue of this Agreement or the retention of the Placement
Agent hereunder, all of which are hereby expressly waived.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>SECTION
7. CLOSING</U></B>. The obligations of the Placement Agent, and the closing of the sale of the Securities hereunder, are subject to the
accuracy, when made and on the Closing Date, of the representations and warranties on the part of the Company and its subsidiaries contained
herein and in the Purchase Agreement, to the accuracy of the statements of the Company and its subsidiaries made in any certificates
pursuant to the provisions hereof, to the performance by the Company and its subsidiaries of their obligations hereunder, and to each
of the following additional terms and conditions, except as otherwise disclosed to and acknowledged and waived by the Placement Agent
to the Company:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">A.
No stop order suspending the effectiveness of the Registration Statement shall have been issued and no proceedings for that purpose shall
have been initiated or threatened by the Commission, and any request for additional information on the part of the Commission (to be
included in the Registration Statement or otherwise) shall have been complied with to the reasonable satisfaction of the Placement Agent.
Any filings required to be made by the Company in connection with the Placement shall have been timely filed with the Commission.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">B.
The Placement Agent shall not have discovered and disclosed to the Company on or prior to the Closing Date that the Registration Statement
or any amendment or supplement thereto contains an untrue statement of a fact which, in the reasonable opinion of counsel for the Placement
Agent, is material or omits to state any fact which, in the reasonable opinion of such counsel, is material and is required to be stated
therein or is necessary to make the statements therein not misleading and was not remedied prior to the Closing Date by the filing of
an amendment to the Registration Statement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 7 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">C.
All corporate proceedings and other legal matters incident to the authorization, form, execution, delivery and validity of each of this
Agreement, the Securities, the Registration Statement and all other legal matters relating to this Agreement and the transactions contemplated
hereby shall be reasonably satisfactory in all material respects to counsel for the Placement Agent, and the Company shall have furnished
to such counsel all documents and information that they may reasonably request to enable them to pass upon such matters.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">D.
The Placement Agent shall have received on the Closing Date the favorable opinion of Duane Morris, LLP, counsel to the Company, dated
as of such Closing Date, including, without limitation, a negative assurance letter addressed to the Placement Agent and in form and
substance satisfactory to the Placement Agent.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">E.
The Placement Agent shall have received &ldquo;comfort&rdquo; letters from WithumSmith+Brown, PC <FONT STYLE="background-color: white">(the
Company&rsquo;s independent registered accounting firm)</FONT> (&ldquo;<B>Auditor</B>&rdquo;) as of the date of this Agreement and as
of the Closing Date, addressed to the Placement Agent and in form and substance satisfactory in all respects to the Placement Agent and
Placement Agent&rsquo;s counsel.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">F.
On the Closing Date, the Placement Agent shall have received a certificate duly executed by an executive officer of the Company, dated
as of the Closing Date, certifying (i) the resolutions with respect to the transactions contemplated hereby as adopted by the Company&rsquo;s
board of directors, (ii) the certificate of incorporation of the Company and (iii) the bylaws of the Company, each as in effect at the
Closing.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">G.
On the Closing Date, the Placement Agent shall have received a certificate duly executed by an executive officer of the Company, dated
as of the Closing Date, certifying that each and every representation and warranty of the Company shall be true and correct in all material
respects (or, to the extent representations or warranties are qualified by materiality or Material Adverse Effect (as defined in the
Purchase Agreement), in all respects) as of the date when made and as of the Closing Date as though originally made at that time (except
for representations and warranties that speak as of a specific date, which shall be true and correct as of such specific date) and the
Company shall have performed, satisfied and complied in all respects with the covenants, agreements and conditions required to be performed,
satisfied or complied with by the Company at or prior to the Closing Date;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">H.
On the Closing Date, the Placement Agent shall have received a certificate of the Chief Financial Officer of the Company, dated the Closing
Date, providing a customary certification as to such accounting or financial matters that are included or incorporated by reference in
the Registration Statement that the Auditor is unable to provide assurances on in the letter contemplated by <U>Section 7.E</U> above.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">I.
On the Closing Date, the Placement Agent shall have received a letter from the Transfer Agent certifying the number of shares of Common
Stock outstanding on the Closing Date immediately prior to the Closing.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">J.
The Placement Agent shall have received evidence of the good standing of the Company as of the date of the Agreement and at the Closing
Date, in its jurisdictions of organization (to the extent the concept of &ldquo;good standing&rdquo; or such equivalent concept exists
under the laws of the applicable jurisdictions) and its good standing as foreign entities in such other jurisdictions as the Placement
Agent may reasonably request, in each case in writing or any standard form of telecommunication from the appropriate governmental authorities
of such jurisdictions. If the applicable jurisdiction does not have a concept of &ldquo;good standing,&rdquo; the Company will furnish
evidence in writing or any standard form of telecommunication from the appropriate governmental authorities that the relevant company
was duly incorporated and remains duly registered in the jurisdiction of its incorporation.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 8 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">K.
Neither the Company nor any of its subsidiaries, as applicable, (i) shall have sustained since the date of the latest audited financial
statements included or incorporated by reference in the Registration Statement any loss or interference with its business from fire,
explosion, flood, terrorist act or other calamity, whether or not covered by insurance, or from any labor dispute or court or governmental
action, order or decree, otherwise than as set forth in or contemplated by the Registration Statement, or (ii) since such date there
shall not have been any change in the capital stock or long-term debt of the Company or any of its subsidiaries or any material change,
or any development involving a prospective material change, in or affecting the business, general affairs, management, financial position,
shareholders&rsquo; equity, results of operations or prospects of the Company and its subsidiaries, otherwise than as set forth in or
contemplated by the Registration Statement, and (iii) since such date there shall not have been any new or renewed inquiries by the Commission,
FINRA or any other regulatory body regarding the Company, the effect of which, in any such case described in clause (i), (ii) or (iii),
is, in the judgment of the Placement Agent, so material and adverse as to make it impracticable or inadvisable to proceed with the sale
or delivery of the Securities on the terms and in the manner contemplated by the Time of Sale Prospectus and the Registration Statement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">L.
The Common Shares are registered under the Exchange Act and, as of the Closing Date, the Shares and the Common Shares underlying the
Prefunded Warrants shall be listed and admitted and authorized for trading on the Nasdaq Capital Market (the &ldquo;<B>Trading Market</B>&rdquo;)
or other applicable U.S. national exchange, or an application for such listing shall have been submitted to the Trading Market, and satisfactory
evidence of such action shall have been provided to the Placement Agent. The Company shall have taken no action designed to, or likely
to have the effect of, terminating the registration of the Common Shares under the Exchange Act or delisting or suspending from trading
the Common Shares from the Trading Market or other applicable U.S. national exchange, nor, except as disclosed in the Time of Sale Prospectus
and Registration Statement, has the Company received any information suggesting that the Commission or the Trading Market or other U.S.
applicable national exchange is contemplating terminating such registration or listing.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">M.
No action shall have been taken and no statute, rule, regulation or order shall have been enacted, adopted or issued by any governmental
agency or body which would, as of the Closing Date, prevent the issuance or sale of the Securities or materially and adversely affect
or potentially and adversely affect the business or operations of the Company; and no injunction, restraining order or order of any other
nature by any federal or state court of competent jurisdiction shall have been issued as of the Closing Date which would prevent the
issuance or sale of the Securities or materially and adversely affect or potentially and adversely affect the business or operations
of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">N.
The Company shall have prepared and filed with the Commission a Form 8-K with respect to the Placement, including as an exhibit thereto
this Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">O.
The Company shall have entered into a Purchase Agreement with each of the Purchasers and such agreements shall be in full force and effect
and shall contain representations, warranties and covenants of the Company as agreed between the Company and the Purchasers.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">P.
FINRA shall have raised no objection to the fairness and reasonableness of the terms and arrangements of this Agreement. In addition,
the Company shall, if requested by the Placement Agent, make or authorize Placement Agent&rsquo;s counsel to make on the Company&rsquo;s
behalf, any filing with the FINRA Corporate Financing Department pursuant to FINRA Rule 5110 with respect to the Placement and pay all
filing fees required in connection therewith.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 9 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Q.
On the Closing Date, Placement Agent shall have received signed lock-up agreements, in the form attached hereto as <U>Exhibit A</U>,
addressed to the Placement Agent by each of the Company, the Company&rsquo;s directors, officers and any other holder(s) of five percent
(5.0%) or more of the outstanding shares of Common Shares of the Company as of the effective date of the Registration Statement. The
Company shall not amend, modify, waive or terminate any provision of any of the lock-up agreements without the prior written consent
of the Placement Agent, except to extend the term of the lock-up period, and shall enforce the provisions of each lock-up agreement in
accordance with its terms. If any party to a lock-up agreement breaches any provision of a lock-up agreement, the Company shall promptly
use its best efforts to seek specific performance of the terms of such lock-up agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">R.
Prior to the Closing Date, the Company shall have furnished to the Placement Agent such further information, certificates and documents
as the Placement Agent may reasonably request.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
any of the conditions specified in this <U>Section 7</U> shall not have been fulfilled when and as required by this Agreement, or if
any of the certificates, opinions, written statements or letters furnished to the Placement Agent or to the Placement Agent&rsquo;s counsel
pursuant to this <U>Section 7</U> shall not be reasonably satisfactory in form and substance to the Placement Agent and to the Placement
Agent&rsquo;s counsel, all obligations of the Placement Agent hereunder may be cancelled by the Placement Agent at, or at any time prior
to, the consummation of the Closing. Notice of such cancellation shall be given to the Company in writing or orally. Any such oral notice
shall be confirmed promptly thereafter in writing.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>SECTION
8. </U></B><U>Governing Law; Jurisdiction and Venue Arbitration</U>. This Agreement will be governed by and construed in accordance with
the laws of the State of New York, without regard to principles of conflicts of law. Any controversy between the parties to this Agreement,
or arising out of the Agreement, shall be resolved by arbitration before the American Arbitration Association (&ldquo;AAA&rdquo;) or
FINRA Arbitration (FINRA&rdquo;) in New York, New York. The following arbitration agreement should be read in conjunction with these
disclosures:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ARBITRATION
    IS FINAL AND BINDING ON THE PARTIES.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">THE
    PARTIES ARE WAIVING THEIR RIGHT TO SEEK REMEDIES IN COURT, INCLUDING THE RIGHT TO JURY TRIAL.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">PRE-ARBITRATION
    DISCOVERY IS GENERALLY MORE LIMITED THAN AND DIFFERENT FROM COURT PROCEEDING; AND</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">THE
    ARBITRATORS&rsquo; AWARD IS NOT REQUIRED TO INCLUDE FACTUAL FINDING OR LEGAL REASONING AND ANY PARTY&rsquo;S RIGHT TO APPEAL OR TO
    SEEK MODIFICATION OF RULINGS BY THE ARBITRATORS IS STRICTLY LIMITED.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>ARBITRATION
    AGREEMENT</U>. ANY AND ALL CONTROVERSIES, DISPUTES OR CLAIMS BETWEEN SPARTAN AND YOU OR YOUR AGENTS, REPRESENTATIVES, EMPLOYEES,
    DIRECTORS, OFFICERS OR CONTROL PERSONS, ARISING OUT OF, IN CONNECTION WITH, OR WITH RESPECT TO (i) ANY PROVISIONS OF OR THE VALIDITY
    OF THIS AGREEMENT OR ANY RELATED AGREEMENTS, (ii) THE RELATIONSHIP OF THE PARTIES HERETO, OR (iii) ANY CONTROVERSY ARISING OUT OF
    YOUR BUSINESS SHALL BE CONDUCTED BY THE AMERICAN ARBITRATION ASSOCIATION UNDER ITS COMMERCIAL ARBITRATION RULES OR FINRA ARBITRATION
    RULES. ARBITRATION MUST BE COMMENCED BY SERVICE OF A WRITTEN DEMAND FOR ARBITRATION OR A WRITTEN NOTICE OF INTENTION TO ARBITRATE.
    IF YOU ARE A PARTY TO SUCH ARBITRATION, TO THE EXTENT PERMITTED BY THE RULES OF THE APPLICABLE ARBITRATION TRIBUNAL, THE ARBITRATION
    SHALL BE CONDUCTED IN NEW YORK, NEW YORK. THE DECISION AND AWARD OF THE ARBITRATORS(S) SHALL BE CONCLUSIVE AND BINDING UPON ALL PARTIES,
    AND ANY JUDGMENT UPON ANY AWARD RENDERED MAY BE ENTERED IN THE STATE OR FEDERAL COURTS LOCATED IN NEW YORK, NEW YORK, OR ANY OTHER
    COURT HAVING JURISDICTION THEREOF, AND NEITHER PARTY SHALL OPPOSE SUCH ENTRY.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>SECTION
9. ENTIRE AGREEMENT/MISC</U>.</B> This Agreement (including the attached Indemnification Provisions) embodies the entire agreement and
understanding between the parties hereto, and supersedes all prior agreements and understandings, relating to the subject matter hereof
except the Engagement Letter, as amended, by and between the Company and the Placement Agent, dated , 2024. If any provision of this
Agreement is determined to be invalid or unenforceable in any respect, such determination will not affect such provision in any other
respect or any other provision of this Agreement, which will remain in full force and effect. This Agreement may not be amended or otherwise
modified or waived except by an instrument in writing signed by the Placement Agent and the Company. The representations, warranties,
agreements and covenants contained herein shall survive the closing of the Placement and delivery of the Securities. This Agreement may
be executed in two or more counterparts, all of which when taken together shall be considered one and the same agreement and shall become
effective when counterparts have been signed by each party and delivered to the other party, it being understood that both parties need
not sign the same counterpart. In the event that any signature is delivered by facsimile transmission or a .pdf format file, such signature
shall create a valid and binding obligation of the party executing (or on whose behalf such signature is executed) with the same force
and effect as if such facsimile or .pdf signature page were an original thereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>SECTION
10. NOTICES</U>.</B> Any and all notices or other communications or deliveries required or permitted to be provided hereunder shall be
in writing and shall be deemed given and effective on the earliest of (a) the date of transmission, if such notice or communication is
sent to the email address specified on the signature pages attached hereto prior to 5:30 p.m. (New York City time) on a business day,
(b) the next business day after the date of transmission, if such notice or communication is sent to the email address on the signature
pages attached hereto on a day that is not a business day or later than 5:30 p.m. (New York City time) on any business day, (c) the third
business day following the date of mailing, if sent by U.S. internationally recognized air courier service, or (d) upon actual receipt
by the party to whom such notice is required to be given. The address for such notices and communications shall be as set forth on the
signature pages hereto.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>[The
remainder of this page has been intentionally left blank.]</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 11 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0pt 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Please
confirm that the foregoing correctly sets forth our agreement by signing and returning to the Placement Agent the enclosed copy of this
Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Very
    truly yours,</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 5%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 45%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>SPARTAN
    CAPITAL SECURITIES, LLC</B></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:
    </FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>/s/
    Kim Monchik</I></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:
    </FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Kim
    Monchik</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:
    </FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">CAO</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Address
    for notice:</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">45
    Broadway, 19<SUP>th</SUP> Floor </FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">New
    York, NY 10006</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accepted
    and Agreed to as of</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    date first written above:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 5%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 45%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>AGEAGLE
    AERIAL SYSTEMS, INC.</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">By:
    </FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>/s/
    William Irby</I></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">Name:
    </FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">William
    Irby</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">Title:
    </FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief
    Executive Officer</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Address
    for notice:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8201
    E. 34<SUP>th</SUP> Cir N, Suite 1307</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Wichita,
    Kansas 67226</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 12; Options: Last -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;</FONT></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-4.1
<SEQUENCE>3
<FILENAME>ex4-1.htm
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-transform: uppercase; text-align: center"></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-transform: uppercase; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: none">Exhibit
4.1</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-transform: uppercase; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-transform: uppercase; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">PRE-FUNDED
WARRANT TO PURCHASE COMMON STOCK</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-transform: uppercase; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">AgEagle
Aerial Systems Inc.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 3in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Initial
Exercise Date: [&#9679;], 2024</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 3in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Issue
Date: [&#9679;], 2024</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 3in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>THIS
PRE-FUNDED WARRANT TO PURCHASE COMMON STOCK</B> (the &ldquo;<B><U>Warrant</U></B>&rdquo;) certifies that, for value received, [&#9679;]
or its assigns (the &ldquo;<B><U>Holder</U></B>&rdquo;) is entitled, upon the terms and subject to the limitations on exercise and the
conditions hereinafter set forth, at any time until this Warrant is exercised in full (the &ldquo;<B><U>Termination Date</U></B>&rdquo;)
but not thereafter, to subscribe for and purchase from AgEagle Aerial Systems Inc., a Nevada corporation (the &ldquo;<B><U>Company</U></B>&rdquo;),
up to [&#9679;] shares (as subject to adjustment hereunder, the &ldquo;<B><U>Warrant Shares</U></B>&rdquo;) of Common Stock. The purchase
price of one (1) share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2.2. This Warrant
shall initially be issued and maintained in the form of a security held in book-entry form and the Depository Trust Company or its nominee
(&ldquo;<B><U>DTC</U></B>&rdquo;) shall initially be the sole registered holder of this Warrant, subject to a Holder&rsquo;s right to
elect to receive a Warrant in certificated form pursuant to the terms of the Warrant Agent Agreement, in which case this sentence shall
not apply.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.
<B><U>Definitions</U></B>. In addition to the terms defined elsewhere in this Warrant or in the Placement Agency Agreement dated [&#9679;],
2024, the following terms have the meanings indicated in this Section 1:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.1
&ldquo;<B><U>Affiliate</U></B>&rdquo; means any Person that, directly or indirectly through one or more intermediaries, controls or is
controlled by or is under common control with a Person, as such terms are used in and construed under Rule 405 under the Securities Act.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.2
&ldquo;<B><U>Bid Price</U></B>&rdquo; means, for any date, the price determined by the first of the following clauses that applies: (a)
if the Common Stock is then listed or quoted on a Trading Market, the bid price of the Common Stock for the time in question (or the
nearest preceding date) on the Trading Market on which the Common Stock is then listed or quoted as reported by Bloomberg L.P. (based
on a Trading Day from 9:30 a.m. (New York City time) to 4:02 p.m. (New York City time)), (b) if OTCQB or OTCQX is not a Trading Market,
the volume weighted average price of the Common Stock for such date (or the nearest preceding date) on OTCQB or OTCQX as applicable,
(c) if the Common Stock is not then listed or quoted for trading on OTCQB or OTCQX and if prices for the Common Stock are then reported
on the Pink Open Market (or a similar organization or agency succeeding to its functions of reporting prices), the most recent bid price
per share of Common Stock so reported, or (d) in all other cases, the fair market value of a share of Common Stock as determined by an
independent appraiser selected in good faith by the Holders of a majority in interest of the Warrants then outstanding and reasonably
acceptable to the Company, the fees and expenses of which shall be paid by the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.3
&ldquo;<B><U>Board of Directors</U></B>&rdquo; means the board of directors of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 1; Options: NewSection; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.4
&ldquo;<B><U>Business Day</U></B>&rdquo; means any day other than Saturday, Sunday or other day on which commercial banks in The City
of New York are authorized or required by law to remain closed; <U>provided</U>, <U>however</U>, for clarification, commercial banks
shall not be deemed to be authorized or required by law to remain closed due to &ldquo;stay at home&rdquo;, &ldquo;shelter-in-place&rdquo;,
&ldquo;non-essential employee&rdquo; or any other similar orders or restrictions or the closure of any physical branch locations at the
direction of any governmental authority so long as the electronic funds transfer systems (including for wire transfers) of commercial
banks in The City of New York generally are open for use by customers on such day.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.5
&ldquo;<B><U>Commission</U></B>&rdquo; means the United States Securities and Exchange Commission.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.6
&ldquo;<B><U>Common Stock</U></B>&rdquo; means the common stock of the Company, $0.001 par value per share, and any other class of securities
into which such securities may hereafter be reclassified or changed.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.7
&ldquo;<B><U>Common Stock Equivalents</U></B>&rdquo; means any securities of the Company or the Subsidiaries which would entitle the
holder thereof to acquire at any time Common Stock, including, without limitation, any debt, preferred stock, right, option, warrant
or other instrument that is at any time convertible into or exercisable or exchangeable for, or otherwise entitles the holder thereof
to receive, Common Stock.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.8
&ldquo;<B><U>Exchange Act</U></B>&rdquo; means the Securities Exchange Act of 1934, as amended, and the rules and regulations promulgated
thereunder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.9
&ldquo;<B><U>Person</U></B>&rdquo; means an individual or corporation, partnership, trust, incorporated or unincorporated association,
joint venture, limited liability company, joint stock company, government (or an agency or subdivision thereof) or other entity of any
kind.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.10
&ldquo;<B><U>Placement Agency Agreement</U></B>&rdquo; means the placement agency agreement, dated as of [&#9679;], 2024, between the
Company and Spartan Capital Securities, LLC as amended, modified or supplemented from time to time in accordance with its terms.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.11&rdquo;<B><U>Registration
Statement</U></B>&rdquo; means the Company&rsquo;s registration statement on Form S-1 (File No. 333-281897).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.12
&ldquo;<B><U>Securities Act</U></B>&rdquo; means the Securities Act of 1933, as amended, and the rules and regulations promulgated thereunder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.13
&ldquo;<B><U>Subsidiary</U></B>&rdquo; means any subsidiary of the Company and shall, where applicable, also include any direct or indirect
subsidiary of the Company formed or acquired after the date hereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.14
&ldquo;<B><U>Trading Day</U></B>&rdquo; means a day on which the Common Stock is traded on a Trading Market.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.15
&ldquo;<B><U>Trading Market</U></B>&rdquo; means any of the following markets or exchanges on which the Common Stock is listed or quoted
for trading on the date in question: the NYSE American, the Nasdaq Capital Market, the Nasdaq Global Market, the Nasdaq Global Select
Market, the New York Stock Exchange, OTCQB or OTCQX (or any successors to any of the foregoing).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 2; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.16
&ldquo;<B><U>Transfer Agent</U></B>&rdquo; means Equiniti, the current transfer agent of the Company, with a mailing address of 1110
Centre Pointe Curve, Suite 101, Mendota Heights, Minnesota 55120 and an email address of, and any successor transfer agent of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.17
&ldquo;<B><U>VWAP</U></B>&rdquo; means, for any date, the price determined by the first of the following clauses that applies: (a) if
the Common Stock is then listed or quoted on a Trading Market, the daily volume weighted average price of the Common Stock for such date
(or the nearest preceding date) on the Trading Market on which the Common Stock is then listed or quoted as reported by Bloomberg L.P.
(based on a Trading Day from 9:30 a.m. (New York City time) to 4:02 p.m. (New York City time)), (b) if OTCQB or OTCQX is not a Trading
Market, the volume weighted average price of the Common Stock for such date (or the nearest preceding date) on OTCQB or OTCQX as applicable,
(c) if the Common Stock is not then listed or quoted for trading on OTCQB or OTCQX and if prices for the Common Stock are then reported
on the Pink Open Market (or a similar organization or agency succeeding to its functions of reporting prices), the most recent bid price
per share of Common Stock so reported, or (d) in all other cases, the fair market value of a share of Common Stock as determined by an
independent appraiser selected in good faith by the holders of a majority in interest of the Warrants then outstanding and reasonably
acceptable to the Company, the fees and expenses of which shall be paid by the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.18
&ldquo;<B><U>Warrant Agent Agreement</U></B>&rdquo; means that certain Warrant Agent agreement, dated on or about the Initial Exercise
Date, between the Company and the Warrant Agent.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.19
&ldquo;<B><U>Warrant Agent</U></B>&rdquo; means the Transfer Agent and any successor warrant agent of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.20
&ldquo;<B><U>Warrants</U></B>&rdquo; means this Warrant and other Common Stock purchase warrants issued by the Company pursuant to the
Registration Statement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.
<B><U>Exercise</U></B>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.1
<B><U>Exercise of Warrant</U></B>. Exercise of the purchase rights represented by this Warrant may be made, in whole or in part, at any
time or times on or after the Initial Exercise Date and on or before the Termination Date by delivery to the Company of a duly executed
PDF copy submitted by e-mail (or e-mail attachment) of the Notice of Exercise substantially in the form attached hereto as Exhibit <U>2.1
</U>(the &ldquo;<B><U>Notice of Exercise</U></B>&rdquo;). Within the earlier of (i) two (2) Trading Days and (ii) the number of Trading
Days comprising the Standard Settlement Period (as defined in Section 2.4.1 herein) following the date of exercise as aforesaid, the
Holder shall deliver the aggregate Exercise Price for the Warrant Shares specified in the applicable Notice of Exercise by wire transfer
or cashier&rsquo;s check drawn on a United States bank unless the cashless exercise procedure specified in Section 2.3 below is specified
in the applicable Notice of Exercise. No ink-original Notice of Exercise shall be required, nor shall any medallion guarantee (or other
type of guarantee or notarization) of any Notice of Exercise be required. Notwithstanding anything herein to the contrary, the Holder
shall not be required to physically surrender this Warrant to the Company until the Holder has purchased all of the Warrant Shares available
hereunder and the Warrant has been exercised in full, in which case, the Holder shall surrender this Warrant to the Company for cancellation
within three (3) Trading Days of the date on which the final Notice of Exercise is delivered to the Company. Partial exercises of this
Warrant resulting in purchases of a portion of the total number of Warrant Shares available hereunder shall have the effect of lowering
the outstanding number of Warrant Shares purchasable hereunder in an amount equal to the applicable number of Warrant Shares purchased.
The Holder and the Company shall maintain records showing the number of Warrant Shares purchased and the date of such purchases. The
Company shall deliver any objection to any Notice of Exercise within one (1) Trading Day of receipt of such notice. <B>The Holder and
any assignee, by acceptance of this Warrant, acknowledge and agree that, by reason of the provisions of this paragraph, following the
purchase of a portion of the Warrant Shares hereunder, the number of Warrant Shares available for purchase hereunder at any given time
may be less than the amount stated on the face hereof.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 3; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Notwithstanding
the foregoing in this Section 2.1, a holder whose interest in this Warrant is a beneficial interest in certificate(s) representing this
Warrant held in book-entry form through DTC (or another established clearing corporation performing similar functions), shall effect
exercises made pursuant to this Section 2.1 by delivering to DTC (or such other clearing corporation, as applicable) the appropriate
instruction form for exercise, complying with the procedures to effect exercise that are required by DTC (or such other clearing corporation,
as applicable), subject to a Holder&rsquo;s right to elect to receive a Warrant in certificated form pursuant to the terms of the Warrant
Agent Agreement, in which case this sentence shall not apply.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.2
<B><U>Exercise Price</U></B>. The aggregate exercise price of this Warrant, except for a nominal exercise price of $0.001 per Warrant
Share, was pre-funded to the Company on or prior to the Initial Exercise Date and, consequently, no additional consideration (other than
the nominal exercise price of $0.001 per Warrant Share) shall be required to be paid by the Holder to any Person to effect any exercise
of this Warrant. The Holder shall not be entitled to the return or refund of all, or any portion, of such pre-paid aggregate exercise
price under any circumstance or for any reason whatsoever, including in the event this Warrant shall not have been exercised prior to
the Termination Date. The remaining unpaid exercise price per share of Common Stock under this Warrant shall be $0.001, subject to adjustment
hereunder (the &ldquo;Exercise Price&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.3
<B><U>Cashless Exercise</U></B>. If at the time of exercise hereof there is no effective registration statement registering, or the prospectus
contained therein is not available for the issuance of, the Warrant Shares to the Holder, the this Warrant may also be exercised, in
whole or in part, at such time by means of a &ldquo;cashless exercise&rdquo; in which the Holder shall be entitled to receive a number
of Warrant Shares equal to the quotient obtained by dividing [(A-B) (X)] by (A), where:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; width: 0.25in; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(A)</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; width: 0.25in; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">=</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">as
                                            applicable: (i) the VWAP on the Trading Day immediately preceding the date of the applicable
                                            Notice of Exercise if such Notice of Exercise is (1) both executed and delivered pursuant
                                            to Section 2.1 hereof on a day that is not a Trading Day or (2) both executed and delivered
                                            pursuant to Section 2.1 hereof on a Trading Day prior to the opening of &ldquo;regular trading
                                            hours&rdquo; (as defined in Rule 600(b) of Regulation NMS promulgated under the federal securities
                                            laws) on such Trading Day, (ii) at the option of the Holder, either (y) the VWAP on the Trading
                                            Day immediately preceding the date of the applicable Notice of Exercise or (z) the Bid Price
                                            of the Common Stock on the principal Trading Market as reported by Bloomberg L.P. as of the
                                            time of the Holder&rsquo;s execution of the applicable Notice of Exercise if such Notice
                                            of Exercise is executed during &ldquo;regular trading hours&rdquo; on a Trading Day and is
                                            delivered within two (2) hours thereafter (including until two (2) hours after the close
                                            of &ldquo;regular trading hours&rdquo; on a Trading Day) pursuant to Section 2.1 hereof or
                                            (iii) the VWAP on the date of the applicable Notice of Exercise if the date of such Notice
                                            of Exercise is a Trading Day and such Notice of Exercise is both executed and delivered pursuant
                                            to Section 2.1 hereof after the close of &ldquo;regular trading hours&rdquo; on such Trading
                                            Day;</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(B)</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">=</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            Exercise Price of this Warrant, as adjusted hereunder; and</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(X)</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">=</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    number of Warrant Shares that would be issuable upon exercise of this Warrant in accordance with the terms of this Warrant if such
    exercise were by means of a cash exercise rather than a cashless exercise.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 4; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
Warrant Shares are issued in such a cashless exercise, the parties acknowledge and agree that in accordance with Section 3(a)(9) of the
Securities Act, the Warrant Shares shall take on the registered characteristics of the Warrants being exercised, and the holding period
of the Warrant Shares being issued may be tacked on to the holding period of this Warrant. Assuming (i) the Holder is not an Affiliate
of the Company, and (ii) all of the applicable conditions of Rule 144 promulgated under the Securities Act with respect to Holder and
the Warrant Shares are met in the case of such a cashless exercise, the Company agrees that the Company will cause the removal of the
legend from such Warrant Shares (including by delivering an opinion of the Company&rsquo;s counsel to the Company&rsquo;s transfer agent
at its own expense to ensure the foregoing), and the Company agrees that the Holder is under no obligation to sell the Warrant Shares
issuable upon the exercise of the Warrant prior to removing the legend. The Company agrees not to take any position contrary to this
Section 2.3.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.4
<B><U>Mechanics of Exercise</U></B>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.4.1.
<B><U>Delivery of Warrant Shares upon Exercise</U></B>. The Company shall cause the Warrant Shares purchased hereunder to be transmitted
by the Transfer Agent to the Holder by crediting the account of the Holder&rsquo;s or its designee&rsquo;s balance account with The Depository
Trust Company through its Deposit or Withdrawal at Custodian system (&ldquo;<B><U>DWAC</U></B>&rdquo;) if the Company is then a participant
in such system and either (A) there is an effective registration statement permitting the issuance of the Warrant Shares to or resale
of the Warrant Shares by Holder or (B) the Warrant Shares are eligible for resale by the Holder without volume or manner-of-sale limitations
pursuant to Rule 144 (assuming cashless exercise of the Warrants), and otherwise by physical delivery of a certificate, for the number
of Warrant Shares to which the Holder is entitled pursuant to such exercise to the address specified by the Holder in the Notice of Exercise
by the date that is the earliest of (i) two (2) Trading Days after the delivery to the Company of the Notice of Exercise, (ii) one (1)
Trading Day after delivery of the aggregate Exercise Price to the Company and (iii) the number of Trading Days comprising the Standard
Settlement Period after the delivery to the Company of the Notice of Exercise (such date, the &ldquo;<B><U>Warrant Share Delivery Date</U></B>&rdquo;).
Upon delivery of the Notice of Exercise, the Holder shall be deemed for all corporate purposes to have become the holder of record of
the Warrant Shares with respect to which this Warrant has been exercised, irrespective of the date of delivery of the Warrant Shares,
provided that payment of the aggregate Exercise Price (other than in the case of a cashless exercise) is received within the earlier
of (i) two (2) Trading Days and (ii) the number of Trading Days comprising the Standard Settlement Period following delivery of the Notice
of Exercise. Notwithstanding anything herein to the contrary, upon delivery of the Notice of Exercise, the Holder shall be deemed for
purposes of Regulation SHO under the Exchange Act to have become the holder of the Warrant Shares irrespective of the date of delivery
of the Warrant Shares. If the Company fails for any reason to deliver to the Holder the Warrant Shares subject to a Notice of Exercise
by the Warrant Share Delivery Date, the Company shall pay to the Holder, in cash, as liquidated damages and not as a penalty, for each
$1,000 of Warrant Shares subject to such exercise (based on the VWAP of the Common Stock on the date of the applicable Notice of Exercise),
$10 per Trading Day (increasing to $20 per Trading Day on the third (3rd) Trading Day after the Warrant Share Delivery Date) for each
Trading Day after such Warrant Share Delivery Date until such Warrant Shares are delivered or Holder rescinds such exercise. The Company
agrees to maintain a Transfer Agent that is a participant in the FAST program so long as this Warrant remains outstanding and exercisable.
As used herein, &ldquo;<B><U>Standard Settlement Period</U></B>&rdquo; means the standard settlement period, expressed in a number of
Trading Days, on the Company&rsquo;s primary Trading Market with respect to the Common Stock as in effect on the date of delivery of
the Notice of Exercise. Notwithstanding the foregoing, with respect to any Notice(s) of Exercise delivered on or prior to 12:00 p.m.
(New York City time) on the Initial Exercise Date, which may be delivered at any time after the time of execution of the Placement Agency
Agreement, the Company agrees to deliver the Warrant Shares subject to such notice(s) by 4:00 p.m. (New York City time) on the Initial
Exercise Date and the Initial Exercise Date shall be the Warrant Share Delivery Date for purposes hereunder, provided that payment of
the aggregate Exercise Price (other than in the case of a cashless exercise) is received by such Warrant Share Delivery Date.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 5; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.4.2.
<B><U>Delivery of New Warrants Upon Exercise</U></B>. If this Warrant shall have been exercised in part, the Company shall, at the request
of a Holder and upon surrender of this Warrant certificate, at the time of delivery of the Warrant Shares, deliver to the Holder a new
Warrant evidencing the rights of the Holder to purchase the unpurchased Warrant Shares called for by this Warrant, which new Warrant
shall in all other respects be identical with this Warrant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.4.3.
<B><U>Rescission Rights</U></B>. If the Company fails to cause the Transfer Agent to transmit to the Holder the Warrant Shares pursuant
to Section 2.4.1 by the Warrant Share Delivery Date, then the Holder will have the right to rescind such exercise.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.4.4.
<B><U>Compensation for Buy-In on Failure to Timely Deliver Warrant Shares upon Exercise</U></B>. In addition to any other rights available
to the Holder, if the Company fails to cause the Transfer Agent to transmit to the Holder the Warrant Shares in accordance with the provisions
of Section 2.4.1 above pursuant to an exercise on or before the Warrant Share Delivery Date, and if after such date the Holder is required
by its broker to purchase (in an open market transaction or otherwise) or the Holder&rsquo;s brokerage firm otherwise purchases, shares
of Common Stock to deliver in satisfaction of a sale by the Holder of the Warrant Shares which the Holder anticipated receiving upon
such exercise (a &ldquo;<B><U>Buy-In</U></B>&rdquo;), then the Company shall (A) pay in cash to the Holder the amount, if any, by which
(x) the Holder&rsquo;s total purchase price (including brokerage commissions, if any) for the shares of Common Stock so purchased exceeds
(y) the amount obtained by multiplying (1) the number of Warrant Shares that the Company was required to deliver to the Holder in connection
with the exercise at issue times (2) the price at which the sell order giving rise to such purchase obligation was executed, and (B)
at the option of the Holder, either reinstate the portion of the Warrant and equivalent number of Warrant Shares for which such exercise
was not honored and return any amount received by the Company in respect of the Exercise Price for those Warrant Shares (in which case
such exercise shall be deemed rescinded) or deliver to the Holder the number of shares of Common Stock that would have been issued had
the Company timely complied with its exercise and delivery obligations hereunder. For example, if the Holder purchases Common Stock having
a total purchase price of $11,000 to cover a Buy-In with respect to an attempted exercise of this Warrant to purchase shares of Common
Stock with an aggregate sale price giving rise to such purchase obligation of $10,000, under clause (A) of the immediately preceding
sentence the Company shall be required to pay the Holder $1,000. The Holder shall provide the Company written notice indicating the amounts
payable to the Holder in respect of the Buy-In and, upon request of the Company, evidence of the amount of such loss. Nothing herein
shall limit a Holder&rsquo;s right to pursue any other remedies available to it hereunder, at law or in equity including, without limitation,
a decree of specific performance and/or injunctive relief with respect to the Company&rsquo;s failure to timely deliver shares of Common
Stock upon exercise of the Warrant as required pursuant to the terms hereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 6; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.4.5.
<B><U>No Fractional Shares or Scrip</U></B>. No fractional shares or scrip representing fractional shares shall be issued upon the exercise
of this Warrant. As to any fraction of a share which the Holder would otherwise be entitled to purchase upon such exercise, the Company
shall, at its election, either pay a cash adjustment in respect of such final fraction in an amount equal to such fraction multiplied
by the Exercise Price or round up to the next whole share.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.4.6.
<B><U>Charges, Taxes and Expenses</U></B>. Issuance of Warrant Shares shall be made without charge to the Holder for any issue or transfer
tax or other incidental expense in respect of the issuance of such Warrant Shares, all of which taxes and expenses shall be paid by the
Company, and such Warrant Shares shall be issued in the name of the Holder or in such name or names as may be directed by the Holder;
<U>provided</U>, <U>however</U>, that, in the event that Warrant Shares are to be issued in a name other than the name of the Holder,
this Warrant when surrendered for exercise shall be accompanied by the Assignment Form attached hereto as <U>Exhibit 2.4.6</U> duly executed
by the Holder and the Company may require, as a condition thereto, the payment of a sum sufficient to reimburse it for any transfer tax
incidental thereto. The Company shall pay all Transfer Agent fees required for same-day processing of any Notice of Exercise and all
fees to the Depository Trust Company (or another established clearing corporation performing similar functions) required for same-day
electronic delivery of the Warrant Shares.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.4.7.
<B><U>Closing of Books</U></B>. The Company will not close its stockholder books or records in any manner which prevents the timely exercise
of this Warrant, pursuant to the terms hereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 7; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.5
<B><U>Holder&rsquo;s Exercise Limitations</U></B>. The Company shall not effect any exercise of this Warrant, and a Holder shall not
have the right to exercise any portion of this Warrant, pursuant to Section 2 or otherwise, to the extent that after giving effect to
such issuance after exercise as set forth on the applicable Notice of Exercise, the Holder (together with the Holder&rsquo;s Affiliates,
and any other Persons acting as a group together with the Holder or any of the Holder&rsquo;s Affiliates (such Persons, &ldquo;<B><U>Attribution
Parties</U></B>&rdquo;)), would beneficially own in excess of the Beneficial Ownership Limitation (as defined below). For purposes of
the foregoing sentence, the number of shares of Common Stock beneficially owned by the Holder and its Affiliates and Attribution Parties
shall include the number of shares of Common Stock issuable upon exercise of this Warrant with respect to which such determination is
being made, but shall exclude the number of shares of Common Stock which would be issuable upon (i) exercise of the remaining, unexercised
portion of this Warrant beneficially owned by the Holder or any of its Affiliates or Attribution Parties and (ii) exercise or conversion
of the unexercised or unconverted portion of any other securities of the Company (including, without limitation, any other Common Stock
Equivalents) subject to a limitation on conversion or exercise analogous to the limitation contained herein beneficially owned by the
Holder or any of its Affiliates or Attribution Parties. Except as set forth in the preceding sentence, for purposes of this Section 2.5,
beneficial ownership shall be calculated in accordance with Section 13(d) of the Exchange Act and the rules and regulations promulgated
thereunder, it being acknowledged by the Holder that the Company is not representing to the Holder that such calculation is in compliance
with Section 13(d) of the Exchange Act and the Holder is solely responsible for any schedules required to be filed in accordance therewith.
To the extent that the limitation contained in this Section 2.5 applies, the determination of whether this Warrant is exercisable (in
relation to other securities owned by the Holder together with any Affiliates and Attribution Parties) and of which portion of this Warrant
is exercisable shall be in the sole discretion of the Holder, and the submission of a Notice of Exercise shall be deemed to be the Holder&rsquo;s
determination of whether this Warrant is exercisable (in relation to other securities owned by the Holder together with any Affiliates
and Attribution Parties) and of which portion of this Warrant is exercisable, in each case subject to the Beneficial Ownership Limitation,
and the Company shall have no obligation to verify or confirm the accuracy of such determination. In addition, a determination as to
any group status as contemplated above shall be determined in accordance with Section 13(d) of the Exchange Act and the rules and regulations
promulgated thereunder. For purposes of this Section 2.5, in determining the number of outstanding shares of Common Stock, a Holder may
rely on the number of outstanding shares of Common Stock as reflected in (A) the Company&rsquo;s most recent periodic or annual report
filed with the Commission, as the case may be, (B) a more recent public announcement by the Company or (C) a more recent written notice
by the Company or the Transfer Agent setting forth the number of shares of Common Stock outstanding. Upon the written or oral request
of a Holder, the Company shall within one (1) Trading Day confirm orally and in writing to the Holder the number of shares of Common
Stock then outstanding. In any case, the number of outstanding shares of Common Stock shall be determined after giving effect to the
conversion or exercise of securities of the Company, including this Warrant, by the Holder or its Affiliates or Attribution Parties since
the date as of which such number of outstanding shares of Common Stock was reported. The &ldquo;<B><U>Beneficial Ownership Limitation</U></B>&rdquo;
shall be 4.99% (or, upon election by a Holder prior to the issuance of any Warrants, 9.99%) of the number of shares of Common Stock outstanding
immediately after giving effect to the issuance of shares of Common Stock issuable upon exercise of this Warrant. The Holder, upon notice
to the Company, may increase or decrease the Beneficial Ownership Limitation provisions of this Section 2.5, provided that the Beneficial
Ownership Limitation in no event exceeds 9.99% of the number of shares of Common Stock outstanding immediately after giving effect to
the issuance of shares of Common Stock upon exercise of this Warrant held by the Holder and the provisions of this Section 2.5 shall
continue to apply. Any increase in the Beneficial Ownership Limitation will not be effective until the 61st day after such notice is
delivered to the Company. The provisions of this paragraph shall be construed and implemented in a manner otherwise than in strict conformity
with the terms of this Section 2.5 to correct this paragraph (or any portion hereof) which may be defective or inconsistent with the
intended Beneficial Ownership Limitation herein contained or to make changes or supplements necessary or desirable to properly give effect
to such limitation. The limitations contained in this paragraph shall apply to a successor holder of this Warrant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 8; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.
<B><U>Certain Adjustments</U></B>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.1
<B><U>Stock Dividends and Splits</U></B>. If the Company, at any time while this Warrant is outstanding: (i) pays a stock dividend or
otherwise makes a distribution or distributions on shares of Common Stock or any other equity or equity equivalent securities payable
in shares of Common Stock (which, for avoidance of doubt, shall not include any shares of Common Stock issued by the Company upon exercise
of this Warrant), (ii) subdivides outstanding shares of Common Stock into a larger number of shares, (iii) combines (including by way
of reverse stock split) outstanding shares of Common Stock into a smaller number of shares, or (iv) issues by reclassification of shares
of Common Stock any shares of capital stock of the Company, then in each case the Exercise Price shall be multiplied by a fraction of
which the numerator shall be the number of shares of Common Stock (excluding treasury shares, if any) outstanding immediately before
such event and of which the denominator shall be the number of shares of Common Stock outstanding immediately after such event, and the
number of Shares issuable upon exercise of this Warrant shall be proportionately adjusted such that the aggregate Exercise Price of this
Warrant shall remain unchanged. Any adjustment made pursuant to this Section 3.1 shall become effective immediately after the record
date for the determination of stockholders entitled to receive such dividend or distribution and shall become effective immediately after
the effective date in the case of a subdivision, combination or re-classification.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.2
<B><U>Subsequent Rights Offerings</U></B>. In addition to any adjustments pursuant to Section 3.1 above, if at any time the Company grants,
issues or sells any Common Stock Equivalents or rights to purchase stock, warrants, securities or other property pro rata to all (or
substantially all) of the record holders of any class of shares of Common Stock (the &ldquo;<B><U>Purchase Rights</U></B>&rdquo;), then
the Holder will be entitled to acquire, upon the terms applicable to such Purchase Rights, the aggregate Purchase Rights which the Holder
could have acquired if the Holder had held the number of shares of Common Stock acquirable upon complete exercise of this Warrant (without
regard to any limitations on exercise hereof, including without limitation, the Beneficial Ownership Limitation) immediately before the
date on which a record is taken for the grant, issuance or sale of such Purchase Rights, or, if no such record is taken, the date as
of which the record holders of shares of Common Stock are to be determined for the grant, issue or sale of such Purchase Rights (provided,
however, that, to the extent that the Holder&rsquo;s right to participate in any such Purchase Right would result in the Holder exceeding
the Beneficial Ownership Limitation, then the Holder shall not be entitled to participate in such Purchase Right to such extent (or beneficial
ownership of such shares of Common Stock as a result of such Purchase Right to such extent) and such Purchase Right to such extent shall
be held in abeyance for the Holder until such time, if ever, as its right thereto would not result in the Holder exceeding the Beneficial
Ownership Limitation).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 9; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.3
<B><U>Pro Rata Distributions</U></B>. During such time as this Warrant is outstanding, if the Company shall declare or make any dividend
or other distribution of its assets (or rights to acquire its assets) to all (or substantially all) holders of shares of Common Stock,
by way of return of capital or otherwise (including, without limitation, any distribution of cash, stock or other securities, property
or options by way of a dividend, spin off, reclassification, corporate rearrangement, scheme of arrangement or other similar transaction)
(a &ldquo;<B><U>Distribution</U></B>&rdquo;), at any time after the issuance of this Warrant, then, in each such case, the Holder shall
be entitled to participate in such Distribution to the same extent that the Holder would have participated therein if the Holder had
held the number of shares of Common Stock acquirable upon complete exercise of this Warrant (without regard to any limitations on exercise
hereof, including without limitation, the Beneficial Ownership Limitation) immediately before the date of which a record is taken for
such Distribution, or, if no such record is taken, the date as of which the record holders of shares of Common Stock are to be determined
for the participation in such Distribution (provided, however, that, to the extent that the Holder&rsquo;s right to participate in any
such Distribution would result in the Holder exceeding the Beneficial Ownership Limitation, then the Holder shall not be entitled to
participate in such Distribution to such extent (or in the beneficial ownership of any shares of Common Stock as a result of such Distribution
to such extent) and the portion of such Distribution shall be held in abeyance for the benefit of the Holder until such time, if ever,
as its right thereto would not result in the Holder exceeding the Beneficial Ownership Limitation). To the extent that this Warrant has
not been partially or completely exercised at the time of such Distribution, such portion of the Distribution shall be held in abeyance
for the benefit of the Holder until the Holder has exercised this Warrant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.4
<B><U>Fundamental Transaction</U></B>. If, at any time while this Warrant is outstanding, (i) the Company, directly or indirectly, in
one or more related transactions effects any merger or consolidation of the Company with or into another Person, (ii) the Company (and
all of its subsidiaries taken as a whole), directly or indirectly, effects any sale, lease, license, assignment, transfer, conveyance
or other disposition of all or substantially all of its assets in one or a series of related transactions, (iii) any, direct or indirect,
purchase offer, tender offer or exchange offer (whether by the Company or another Person) is completed pursuant to which holders of Common
Stock are permitted to sell, tender or exchange their shares for other securities, cash or property and has been accepted by the holders
of 50% or more of the outstanding Common Stock or 50% or more of the voting power of the common equity of the Company, (iv) the Company,
directly or indirectly, in one or more related transactions effects any reclassification, reorganization or recapitalization of the Common
Stock or any compulsory share exchange pursuant to which the Common Stock is effectively converted into or exchanged for other securities,
cash or property, or (v) the Company, directly or indirectly, in one or more related transactions consummates a stock or share purchase
agreement or other business combination (including, without limitation, a reorganization, recapitalization, spin-off, merger or scheme
of arrangement) with another Person or group of Persons whereby such other Person or group acquires 50% or more of the outstanding shares
of Common Stock or 50% or more of the voting power of the common equity of the Company (each a &ldquo;<B><U>Fundamental Transaction</U></B>&rdquo;),
then, upon any subsequent exercise of this Warrant, the Holder shall have the right to receive, for each Warrant Share that would have
been issuable upon such exercise immediately prior to the occurrence of such Fundamental Transaction, at the option of the Holder (without
regard to any limitation in Section 2.5 on the exercise of this Warrant), the number of shares of Common Stock of the successor or acquiring
corporation or of the Company, if it is the surviving corporation, and any additional consideration (the &ldquo;<B><U>Alternate Consideration</U></B>&rdquo;)
receivable as a result of such Fundamental Transaction by a holder of the number of shares of Common Stock for which this Warrant is
exercisable immediately prior to such Fundamental Transaction (without regard to any limitation in Section 2.5 on the exercise of this
Warrant). For purposes of any such exercise, the determination of the Exercise Price shall be appropriately adjusted to apply to such
Alternate Consideration based on the amount of Alternate Consideration issuable in respect of one share of Common Stock in such Fundamental
Transaction, and the Company shall apportion the Exercise Price among the Alternate Consideration in a reasonable manner reflecting the
relative value of any different components of the Alternate Consideration.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 10; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
holders of Common Stock are given any choice as to the securities, cash or property to be received in a Fundamental Transaction, then
the Holder shall be given the same choice as to the Alternate Consideration it receives upon any exercise of this Warrant following such
Fundamental Transaction. Notwithstanding anything to the contrary, in the event of a Fundamental Transaction, the Company or any Successor
Entity (as defined below) shall, at the Holder&rsquo;s option, exercisable at any time concurrently with, or within 30 days after, the
consummation of the Fundamental Transaction (or, if later, the date of the public announcement of the applicable Fundamental Transaction),
purchase this Warrant from the Holder by paying to the Holder an amount of cash equal to the Black Scholes Value (as defined below) of
the remaining unexercised portion of this Warrant on the date of the consummation of such Fundamental Transaction; provided, however,
that, if the Fundamental Transaction is not within the Company&rsquo;s control, including not approved by the Company&rsquo;s Board of
Directors, the Holder shall only be entitled to receive from the Company or any Successor Entity the same type or form of consideration
(and in the same proportion), at the Black Scholes Value of the unexercised portion of this Warrant, that is being offered and paid to
the holders of Common Stock of the Company in connection with the Fundamental Transaction, whether that consideration be in the form
of cash, stock or any combination thereof, or whether the holders of Common Stock are given the choice to receive from among alternative
forms of consideration in connection with the Fundamental Transaction; provided, further, that if holders of Common Stock of the Company
are not offered or paid any consideration in such Fundamental Transaction, such holders of Common Stock will be deemed to have received
common stock/shares of the Successor Entity (which Entity may be the Company following such Fundamental Transaction) in such Fundamental
Transaction. &ldquo;<B><U>Black Scholes Value</U></B>&rdquo; means the value of this Warrant based on the Black-Scholes Option Pricing
Model obtained from the &ldquo;OV&rdquo; function on Bloomberg, L.P. (&ldquo;<B><U>Bloomberg</U></B>&rdquo;) determined as of the day
of consummation of the applicable contemplated Fundamental Transaction for pricing purposes and reflecting (A) a risk-free interest rate
corresponding to the U.S. Treasury rate for a period equal to the time between the date of the public announcement of the applicable
contemplated Fundamental Transaction and the Termination Date, (B) an expected volatility equal to the greater of (1) 100% and (2) the
100 day volatility as obtained from the HVT function on Bloomberg (determined utilizing a 365 day annualization factor) as of the Trading
Day immediately following the public announcement of the applicable contemplated Fundamental Transaction, (C) the underlying price per
share used in such calculation shall be the greater of (i) the sum of the price per share being offered in cash, if any, plus the value
of any non-cash consideration, if any, being offered in such Fundamental Transaction and (ii) the highest VWAP during the period beginning
on the Trading Day immediately preceding the public announcement of the applicable contemplated Fundamental Transaction (or the consummation
of the applicable Fundamental Transaction, if earlier) and ending on the Trading Day of the Holder&rsquo;s request pursuant to this Section
3.4 and (D) a remaining option time equal to the time between the date of the public announcement of the applicable contemplated Fundamental
Transaction and the Termination Date and (E) a zero cost of borrow. The payment of the Black Scholes Value will be made by wire transfer
of immediately available funds (or such other consideration) within the later of (i) five (5) Business Days after the Holder&rsquo;s
election and (ii) the date of consummation of the Fundamental Transaction. The Company shall cause any successor entity in a Fundamental
Transaction in which the Company is not the survivor (the &ldquo;<B><U>Successor Entity</U></B>&rdquo;) to assume in writing all of the
obligations of the Company under this Warrant in accordance with the provisions of this Section 3.4 pursuant to written agreements in
form and substance reasonably satisfactory to the Holder and approved by the Holder (without unreasonable delay) prior to such Fundamental
Transaction and shall, at the option of the Holder, deliver to the Holder in exchange for this Warrant a security of the Successor Entity
evidenced by a written instrument substantially similar in form and substance to this Warrant that is exercisable for a corresponding
number of shares of capital stock of such Successor Entity (or its parent entity) equivalent to the shares of Common Stock acquirable
and receivable upon exercise of this Warrant (without regard to any limitations on the exercise of this Warrant) prior to such Fundamental
Transaction, and with an exercise price which applies the exercise price hereunder to such shares of capital stock (but taking into account
the relative value of the shares of Common Stock prior to such Fundamental Transaction and the value of such shares of capital stock,
such number of shares of capital stock and such exercise price being for the purpose of protecting the economic value of this Warrant
immediately prior to the consummation of such Fundamental Transaction), and which is reasonably satisfactory in form and substance to
the Holder. Upon the occurrence of any such Fundamental Transaction, the Successor Entity shall be added to the term &ldquo;Company&rdquo;
under this Warrant (so that from and after the occurrence or consummation of such Fundamental Transaction, each and every provision of
this Warrant referring to the &ldquo;Company&rdquo; shall refer instead to each of the Company and the Successor Entity or Successor
Entities, jointly and severally), and the Successor Entity or Successor Entities, jointly and severally with the Company, may exercise
every right and power of the Company prior thereto and the Successor Entity or Successor Entities shall assume all of the obligations
of the Company prior thereto under this Warrant with the same effect as if the Company and such Successor Entity or Successor Entities,
jointly and severally, had been named as the Company herein. For the avoidance of doubt, the Holder shall be entitled to the benefits
of the provisions of this Section 3.4 regardless of (i) whether the Company has sufficient authorized shares of Common Stock for the
issuance of Warrant Shares and/or (ii) whether a Fundamental Transaction occurs prior to the Initial Exercise Date.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 11; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.5
<B><U>Calculations</U></B>. All calculations under this Section 3 shall be made to the nearest cent or the nearest 1/100th of a share,
as the case may be. For purposes of this Section 3, the number of shares of Common Stock deemed to be issued and outstanding as of a
given date shall be the sum of the number of shares of Common Stock (excluding treasury shares, if any) issued and outstanding.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.6
<B><U>Notice to Holder</U></B>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.6.1.
<B><U>Adjustment to Exercise Price</U></B>. Whenever the Exercise Price is adjusted pursuant to any provision of this Section 3, the
Company shall promptly deliver to the Holder by email a notice setting forth the Exercise Price after such adjustment and any resulting
adjustment to the number of Warrant Shares and setting forth a brief statement of the facts requiring such adjustment.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.6.2.
<B><U>Notice to Allow Exercise by Holder</U></B>. If (A) the Company shall declare a dividend (or any other distribution in whatever
form) on the Common Stock, (B) the Company shall declare a special nonrecurring cash dividend on or a redemption of the Common Stock,
(C) the Company shall authorize the granting to all holders of the Common Stock rights or warrants to subscribe for or purchase any shares
of capital stock of any class or of any rights, (D) the approval of any stockholders of the Company shall be required in connection with
any reclassification of the Common Stock, any consolidation or merger to which the Company (or any of its Subsidiaries) is a party, any
sale or transfer of all or substantially all of its assets, or any compulsory share exchange whereby the Common Stock is converted into
other securities, cash or property, or (E) the Company shall authorize the voluntary or involuntary dissolution, liquidation or winding
up of the affairs of the Company, then, in each case, the Company shall cause to be delivered by email to the Holder at its last email
address as it shall appear upon the Warrant Register of the Company, at least 20 calendar days prior to the applicable record or effective
date hereinafter specified, a notice stating (x) the date on which a record is to be taken for the purpose of such dividend, distribution,
redemption, rights or warrants, or if a record is not to be taken, the date as of which the holders of the Common Stock of record to
be entitled to such dividend, distributions, redemption, rights or warrants are to be determined or (y) the date on which such reclassification,
consolidation, merger, sale, transfer or share exchange is expected to become effective or close, and the date as of which it is expected
that holders of the Common Stock of record shall be entitled to exchange their shares of Common Stock for securities, cash or other property
deliverable upon such reclassification, consolidation, merger, sale, transfer or share exchange; provided that the failure to deliver
such notice or any defect therein or in the delivery thereof shall not affect the validity of the corporate action required to be specified
in such notice. To the extent that any notice provided in this Warrant constitutes, or contains, material, non-public information regarding
the Company or any of the Subsidiaries, the Company shall simultaneously file such notice with the Commission pursuant to a Current Report
on Form 8-K. The Holder shall remain entitled to exercise this Warrant during the period commencing on the date of such notice to the
effective date of the event triggering such notice except as may otherwise be expressly set forth herein.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 12; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.
<B><U>Transfer of Warrant</U></B>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.1
<B><U>Transferability</U></B>. Subject to compliance with any applicable securities laws, this Warrant and all rights hereunder are transferable,
in whole or in part, upon surrender of this Warrant at the principal office of the Company or its designated agent, together with a written
assignment of this Warrant substantially in the form attached hereto as Exhibit <U>2.4.6</U> duly executed by the Holder or its agent
or attorney and funds sufficient to pay any transfer taxes payable upon the making of such transfer. Upon such surrender and, if required,
such payment, the Company shall execute and deliver a new Warrant or Warrants in the name of the assignee or assignees, as applicable,
and in the denomination or denominations specified in such instrument of assignment, and shall issue to the assignor a new Warrant evidencing
the portion of this Warrant not so assigned, and this Warrant shall promptly be cancelled. Notwithstanding anything herein to the contrary,
the Holder shall not be required to physically surrender this Warrant to the Company unless the Holder has assigned this Warrant in full,
in which case, the Holder shall surrender this Warrant to the Company within three (3) Trading Days of the date on which the Holder delivers
an assignment form to the Company assigning this Warrant in full. The Warrant, if properly assigned in accordance herewith, may be exercised
by a new holder for the purchase of Warrant Shares without having a new Warrant issued.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.2
<B><U>New Warrants</U></B>. If this Warrant is not held in global form through DTC (or any successor depositary), this Warrant may be
divided or combined with other Warrants upon presentation hereof at the aforesaid office of the Company, together with a written notice
specifying the names and denominations in which new Warrants are to be issued, signed by the Holder or its agent or attorney. Subject
to compliance with Section 4.1, as to any transfer which may be involved in such division or combination, the Company shall execute and
deliver a new Warrant or Warrants in exchange for the Warrant or Warrants to be divided or combined in accordance with such notice. All
Warrants issued on transfers or exchanges shall be dated the initial issuance date of this Warrant and shall be identical with this Warrant
except as to the number of Warrant Shares issuable pursuant thereto.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.3
<B><U>Warrant Register</U></B>. The Warrant Agent shall register this Warrant, upon records to be maintained by the Warrant Agent for
that purpose (the &ldquo;<B><U>Warrant Register</U></B>&rdquo;), in the name of the record Holder hereof from time to time. The Company
and the Warrant Agent may deem and treat the registered Holder of this Warrant as the absolute owner hereof for the purpose of any exercise
hereof or any distribution to the Holder, and for all other purposes, absent actual notice to the contrary.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 13; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.
<B><U>Miscellaneous</U></B>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.1
<B><U>No Rights as Stockholder until Exercise; No Settlement in Cash</U></B>. This Warrant does not entitle the Holder to any voting
rights, dividends or other rights as a stockholder of the Company prior to the exercise hereof as set forth in Section 2.4.1, except
as expressly set forth in Section 3. Without limiting any rights of a Holder to receive Warrant Shares on a &ldquo;cashless exercise&rdquo;
pursuant to Section 2.3 or to receive cash payments pursuant to Section 2.4.1 and Section 2.4.4 herein, in no event shall the Company
be required to net cash settle an exercise of this Warrant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.2
<B><U>Loss, Theft, Destruction or Mutilation of Warrant</U></B>. The Company covenants that upon receipt by the Company of evidence reasonably
satisfactory to it of the loss, theft, destruction or mutilation of this Warrant or any stock certificate relating to the Warrant Shares,
and in case of loss, theft or destruction, of indemnity or security reasonably satisfactory to it (which, in the case of the Warrant,
shall not include the posting of any bond), and upon surrender and cancellation of such Warrant or stock certificate, if mutilated, the
Company will make and deliver a new Warrant or stock certificate of like tenor and dated as of such cancellation, in lieu of such Warrant
or stock certificate.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.3
<B><U>Saturdays, Sundays, Holidays, etc</U></B>. If the last or appointed day for the taking of any action or the expiration of any right
required or granted herein shall not be a Business Day, then such action may be taken or such right may be exercised on the next succeeding
Business Day.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.4
<B><U>Authorized Shares</U></B>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.4.1.
<B><U>Reservation of Authorized and Unissued Shares</U></B>. The Company covenants that, during the period the Warrant is outstanding,
it will reserve from its authorized and unissued Common Stock a sufficient number of shares of Common Stock to provide for the issuance
of the Warrant Shares upon the exercise of any purchase rights under this Warrant. The Company further covenants that its issuance of
this Warrant shall constitute full authority to its officers who are charged with the duty of issuing the necessary Warrant Shares upon
the exercise of the purchase rights under this Warrant. The Company will take all such reasonable action as may be necessary to assure
that such Warrant Shares may be issued as provided herein without violation of any applicable law or regulation, or of any requirements
of the Trading Market upon which the Common Stock may be listed. The Company covenants that all Warrant Shares which may be issued upon
the exercise of the purchase rights represented by this Warrant will, upon exercise of the purchase rights represented by this Warrant
and payment for such Warrant Shares in accordance herewith, be duly authorized, validly issued, fully paid and nonassessable (which means
that no further sums are required to be paid by the holders thereof in connection with the issue thereof) and free from all taxes, liens
and charges created by the Company in respect of the issue thereof (other than taxes in respect of any transfer occurring contemporaneously
with such issue).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 14; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.4.2.
<B><U>Noncircumvention</U></B>. Except and to the extent as waived or consented to by the Holder, the Company shall not by any action,
including, without limitation, amending its certificate of incorporation or through any reorganization, transfer of assets, consolidation,
merger, dissolution, issue or sale of securities or any other voluntary action, avoid or seek to avoid the observance or performance
of any of the terms of this Warrant, but will at all times in good faith assist in the carrying out of all such terms and in the taking
of all such actions as may be necessary or appropriate to protect the rights of Holder as set forth in this Warrant against impairment.
Without limiting the generality of the foregoing, the Company will (i) not increase the par value of any Warrant Shares above the amount
payable therefor upon such exercise immediately prior to such increase in par value, (ii) take all such action as may be necessary or
appropriate in order that the Company may validly and legally issue fully paid and nonassessable Warrant Shares upon the exercise of
this Warrant and (iii) use commercially reasonable efforts to obtain all such authorizations, exemptions or consents from any public
regulatory body having jurisdiction thereof, as may be, necessary to enable the Company to perform its obligations under this Warrant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.4.3.
<B><U>Authorizations, Exemptions and Consents</U></B>. Before taking any action that would result in an adjustment in the number of Warrant
Shares for which this Warrant is exercisable or in the Exercise Price, the Company shall obtain all such authorizations or exemptions
thereof, or consents thereto, as may be necessary from any public regulatory body or bodies having jurisdiction thereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.5
<B><U>Governing Law</U></B>. All questions concerning the construction, validity, enforcement and interpretation of this Warrant shall
be governed by and construed and enforced in accordance with the internal laws of the State of New York, without regard to the principles
of conflicts of law thereof. Each party agrees that all legal proceedings concerning the interpretations, enforcement and defense of
the transactions contemplated by this Warrant (whether brought against a party hereto or their respective affiliates, directors, officers,
shareholders, partners, members, employees or agents) shall be commenced exclusively in the state and federal courts sitting in the City
of New York. Each party hereby irrevocably submits to the exclusive jurisdiction of the state and federal courts sitting in the City
of New York, Borough of Manhattan for the adjudication of any dispute hereunder or in connection herewith or with any transaction contemplated
hereby or discussed herein, and hereby irrevocably waives, and agrees not to assert in any suit, action or proceeding, any claim that
it is not personally subject to the jurisdiction of any such court, that such suit, action or proceeding is improper or is an inconvenient
venue for such proceeding. Each party hereby irrevocably waives personal service of process and consents to process being served in any
such suit, action or proceeding by mailing a copy thereof via registered or certified mail or overnight delivery (with evidence of delivery)
to such party at the address in effect for notices to it under this Warrant and agrees that such service shall constitute good and sufficient
service of process and notice thereof. Nothing contained herein shall be deemed to limit in any way any right to serve process in any
other manner permitted by law. If either party shall commence an action, suit or proceeding to enforce any provisions of this Warrant,
the prevailing party in such action, suit or proceeding shall be reimbursed by the other party for their reasonable attorneys&rsquo;
fees and other costs and expenses incurred with the investigation, preparation and prosecution of such action or proceeding. Notwithstanding
the foregoing, nothing in this paragraph shall limit or restrict the federal district court in which a Holder may bring a claim under
the federal securities laws.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 15; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.6
<B><U>Restrictions</U></B>. The Holder acknowledges that the Warrant Shares acquired upon the exercise of this Warrant, if not registered,
and the Holder does not utilize cashless exercise, will have restrictions upon resale imposed by state and federal securities laws.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.7
<B><U>Nonwaiver and Expenses</U></B>. No course of dealing or any delay or failure to exercise any right hereunder on the part of Holder
shall operate as a waiver of such right or otherwise prejudice the Holder&rsquo;s rights, powers or remedies, notwithstanding the fact
that the right to exercise this Warrant terminates on the Termination Date. No provision of this Warrant shall be construed as a waiver
by the Holder of any rights which the Holder may have under the federal securities laws and the rules and regulations of the Commission
thereunder. Without limiting any other provision of this Warrant, if the Company willfully and knowingly fails to comply with any provision
of this Warrant, which results in any material damages to the Holder, the Company shall pay to the Holder such amounts as shall be sufficient
to cover any costs and expenses including, but not limited to, reasonable attorneys&rsquo; fees, including those of appellate proceedings,
incurred by the Holder in collecting any amounts due pursuant hereto or in otherwise enforcing any of its rights, powers or remedies
hereunder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.8
<B><U>Notices</U></B>. Any and all notices or other communications or deliveries to be provided by the Holders hereunder including, without
limitation, any Notice of Exercise, shall be in writing and delivered personally, by e-mail, or sent by a nationally recognized overnight
courier service, addressed to the Company, 8201 E. 34th Street N, Suite 1307, Wichita, Kansas 67226, Attention: Mark DiSiena, Chief Financial
Officer, email address: <U>mark.disiena@ageagle.com</U>, or such other email address or address as the Company may specify for such purposes
by notice to the Holders. Any and all notices or other communications or deliveries to be provided by the Company hereunder shall be
in writing and delivered personally, by e-mail, or sent by a nationally recognized overnight courier service addressed to each Holder
at the e-mail address or address of such Holder appearing on the books of the Company. Any notice or other communication or deliveries
hereunder shall be deemed given and effective on the earliest of (i) the time of transmission, if such notice or communication is delivered
via e-mail at the e-mail address set forth in this Section 5.8 prior to 5:30 p.m. (New York City time) on any date, (ii) the next Trading
Day after the time of transmission, if such notice or communication is delivered via e-mail at the e-mail address set forth in this Section
5.8 on a day that is not a Trading Day or later than 5:30 p.m. (New York City time) on any Trading Day, (iii) the second Trading Day
following the date of mailing, if sent by U.S. nationally recognized overnight courier service, or (iv) upon actual receipt by the party
to whom such notice is required to be given. To the extent that any notice provided hereunder constitutes, or contains, material, non-public
information regarding the Company or any Subsidiaries, the Company shall simultaneously file such notice with the Commission pursuant
to a Current Report on Form 8-K.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 16; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.9
<B><U>Limitation of Liability</U></B>. No provision hereof, in the absence of any affirmative action by the Holder to exercise this Warrant
to purchase Warrant Shares, and no enumeration herein of the rights or privileges of the Holder, shall give rise to any liability of
the Holder for the purchase price of any Common Stock or as a stockholder of the Company, whether such liability is asserted by the Company
or by creditors of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.10
<B><U>Remedies</U></B>. The Holder, in addition to being entitled to exercise all rights granted by law, including recovery of damages,
will be entitled to specific performance of its rights under this Warrant. The Company agrees that monetary damages would not be adequate
compensation for any loss incurred by reason of a breach by it of the provisions of this Warrant and hereby agrees to waive and not to
assert the defense in any action for specific performance that a remedy at law would be adequate.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.11
<B><U>Successors and Assigns</U></B>. Subject to applicable securities laws, this Warrant and the rights and obligations evidenced hereby
shall inure to the benefit of and be binding upon the successors and permitted assigns of the Company and the successors and permitted
assigns of Holder. The provisions of this Warrant are intended to be for the benefit of any Holder from time to time of this Warrant
and shall be enforceable by the Holder or holder of Warrant Shares.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.12
<B><U>Amendment</U></B>. This Warrant may be modified or amended or the provisions hereof waived with the written consent of the Company,
on the one hand, and the Holder, on the other hand.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.13
<B><U>Severability</U></B>. Wherever possible, each provision of this Warrant shall be interpreted in such manner as to be effective
and valid under applicable law, but if any provision of this Warrant shall be prohibited by or invalid under applicable law, such provision
shall be ineffective to the extent of such prohibition or invalidity, without invalidating the remainder of such provisions or the remaining
provisions of this Warrant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.14
<B><U>Headings</U></B>. The headings used in this Warrant are for the convenience of reference only and shall not, for any purpose, be
deemed a part of this Warrant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.15
<B><U>Warrant Agent Agreement</U></B>. If this Warrant is held in global form through DTC (or any successor depositary), this Warrant
is issued subject to the Warrant Agent Agreement. To the extent any provision of this Warrant conflicts with the express provisions of
the Warrant Agent Agreement, the provisions of this Warrant shall govern and be controlling.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">********************</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>[Investor
Pre-Funded Registered Warrant Signature Page Follows]</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 17; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>[Investor
Pre-Funded Registered Warrant Signature Page]</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">IN
WITNESS WHEREOF, the Company has caused this Pre-Funded Registered Warrant to be executed by its officer thereunto duly authorized as
of the date first above indicated.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>AgEagle
    Aerial Systems Inc.</B></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 5%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 45%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Its:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 18; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Exhibit
2.1</U></FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-transform: uppercase; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">NOTICE
OF EXERCISE</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: left">
  <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>TO:</B></FONT></TD>
  <TD STYLE="font: 10pt Times New Roman, Times, Serif"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-transform: uppercase; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>AgEagle
                                            Aerial Systems Inc.</B></FONT></P></TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; width: 0.5in; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1.)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                            undersigned hereby elects to purchase ________ Warrant Shares of the Company pursuant to
                                            the terms of the attached Warrant (only if exercised in full), and tenders herewith payment
                                            of the exercise price in full, together with all applicable transfer taxes, if any.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2.)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Payment
                                            shall take the form of (check applicable box):</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[
] in lawful money of the United States.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[
] if permitted the cancellation of such number of Warrant Shares as is necessary, in accordance with the formula set forth in subsection
2.3, to exercise this Warrant with respect to the maximum number of Warrant Shares purchasable pursuant to the cashless exercise procedure
set forth in subsection 2.3.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; width: 0.5in; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3.)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Please
                                            issue said Warrant Shares in the name of the undersigned or in such other name as is specified
                                            below:</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">_______________________________</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    Warrant Shares shall be delivered to the following DWAC Account Number:</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">_______________________________</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">_______________________________</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">_______________________________</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 19; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[SIGNATURE
OF HOLDER]</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name
    of Investing Entity:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 1pt solid; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Signature
    of Authorized Signatory of Investing Entity</I>:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name
    of Authorized Signatory:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title
    of Authorized Signatory:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 20; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Exhibit
2.4.6</U></FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-transform: uppercase; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ASSIGNMENT
FORM</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(To
assign the foregoing Warrant, execute this form and supply required information. Do not use this form to exercise the Warrant to purchase
shares of Common Stock.)</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">FOR
VALUE RECEIVED, the foregoing Warrant and all rights evidenced thereby are hereby assigned to</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 1pt solid; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Address:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Phone
    Number:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Email
    Address:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Holder&rsquo;s
    Signature</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Holder&rsquo;s
    Address</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 21; Options: Last -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->21<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-4.2
<SEQUENCE>4
<FILENAME>ex4-2.htm
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-transform: uppercase; text-align: center"></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-transform: uppercase; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: none">Exhibit
4.2</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-transform: uppercase; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-transform: uppercase; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">SERIES
A WARRANT TO PURCHASE COMMON STOCK</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-transform: uppercase; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">AGEAGLE
AERIAL SYSTEMS, INC.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Warrant
    Shares: [&#9679;]</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Initial
    Exercise Date: [&#9679;], 2024</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">CUSIP:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Issue
    Date: [&#9679;], 2024</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ISIN:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>THIS
WARRANT TO PURCHASE COMMON STOCK</B> (the &ldquo;<B><U>Warrant</U></B>&rdquo;) certifies that, for value received, [&#9679;] or its assigns
(the &ldquo;<B><U>Holder</U></B>&rdquo;) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter
set forth, at any time on or after the Initial Exercise Date and on or prior to 5:00 p.m. (New York City time) on [&#9679;], 2029 (the
&ldquo;<B><U>Termination Date</U></B>&rdquo;) but not thereafter, to subscribe for and purchase from AgEagle Aerial Systems, Inc., a
Nevada corporation (the &ldquo;<B><U>Company</U></B>&rdquo;), up to [&#9679;] shares (as subject to adjustment hereunder, the &ldquo;<B><U>Warrant
Shares</U></B>&rdquo;) of Common Stock. The purchase price of one (1) share of Common Stock under this Series A Warrant (this &ldquo;<B><U>Warrant</U></B>&rdquo;)
shall be equal to the Exercise Price, as defined in Section &lrm;2.2. This Warrant shall initially be issued and maintained in the form
of a security held in book-entry form and the Depository Trust Company or its nominee (&ldquo;<B><U>DTC</U></B>&rdquo;) shall initially
be the sole registered holder of this Warrant, subject to a Holder&rsquo;s right to elect to receive a Warrant in certificated form pursuant
to the terms of the Warrant Agent Agreement, in which case this sentence shall not apply.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.
<B><U>Definitions</U></B>. In addition to the terms defined elsewhere in this Warrant or in the Placement Agency Agreement dated [&#9679;],
2024, the following terms have the meanings indicated in this Section &lrm;1:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.1
&ldquo;<B><U>Affiliate</U></B>&rdquo; means any Person that, directly or indirectly through one or more intermediaries, controls or is
controlled by or is under common control with a Person, as such terms are used in and construed under Rule 405 under the Securities Act.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.2
&ldquo;<B><U>Bid Price</U></B>&rdquo; means, for any date, the price determined by the first of the following clauses that applies: (a)
if the Common Stock is then listed or quoted on a Trading Market, the bid price of the Common Stock for the time in question (or the
nearest preceding date) on the Trading Market on which the Common Stock is then listed or quoted as reported by Bloomberg L.P. (based
on a Trading Day from 9:30 a.m. (New York City time) to 4:02 p.m. (New York City time)), (b) if OTCQB or OTCQX is not a Trading Market,
the volume weighted average price of the Common Stock for such date (or the nearest preceding date) on OTCQB or OTCQX as applicable,
(c) if the Common Stock is not then listed or quoted for trading on OTCQB or OTCQX and if prices for the Common Stock are then reported
on the Pink Open Market (or a similar organization or agency succeeding to its functions of reporting prices), the most recent bid price
per share of Common Stock so reported, or (d) in all other cases, the fair market value of a share of Common Stock as determined by an
independent appraiser selected in good faith by the Holders of a majority in interest of the Warrants then outstanding and reasonably
acceptable to the Company, the fees and expenses of which shall be paid by the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.3
&ldquo;<B><U>Board of Directors</U></B>&rdquo; means the board of directors of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 1; Options: NewSection; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.4
&ldquo;<B><U>Business Day</U></B>&rdquo; means any day other than Saturday, Sunday or other day on which commercial banks in The City
of New York are authorized or required by law to remain closed; <U>provided</U>, <U>however</U>, for clarification, commercial banks
shall not be deemed to be authorized or required by law to remain closed due to &ldquo;stay at home&rdquo;, &ldquo;shelter-in-place&rdquo;,
&ldquo;non-essential employee&rdquo; or any other similar orders or restrictions or the closure of any physical branch locations at the
direction of any governmental authority so long as the electronic funds transfer systems (including for wire transfers) of commercial
banks in The City of New York generally are open for use by customers on such day.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.5
&ldquo;<B><U>Commission</U></B>&rdquo; means the United States Securities and Exchange Commission.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.6
&ldquo;<B><U>Common Stock</U></B>&rdquo; means the common stock of the Company, $0.001 par value per share, and any other class of securities
into which such securities may hereafter be reclassified or changed.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.7
&ldquo;<B><U>Common Stock Equivalents</U></B>&rdquo; means any securities of the Company or the Subsidiaries which would entitle the
holder thereof to acquire at any time Common Stock, including, without limitation, any debt, preferred stock, right, option, warrant
or other instrument that is at any time convertible into or exercisable or exchangeable for, or otherwise entitles the holder thereof
to receive, Common Stock.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.8
&ldquo;<B><U>Exchange Act</U></B>&rdquo; means the Securities Exchange Act of 1934, as amended, and the rules and regulations promulgated
thereunder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.9
&ldquo;<B><U>Person</U></B>&rdquo; means an individual or corporation, partnership, trust, incorporated or unincorporated association,
joint venture, limited liability company, joint stock company, government (or an agency or subdivision thereof) or other entity of any
kind.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.10
&ldquo;<B><U>Placement Agency Agreement</U></B>&rdquo; means the Placement Agency Agreement, dated as of [&#9679;], 2024, between the
Company and Spartan Capital Securities, LLC, as amended, modified or supplemented from time to time in accordance with its terms.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.11
&ldquo;<B><U>Registration Statement</U></B>&rdquo; means the Company&rsquo;s registration statement on Form S-1 (File No. 333-______).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.12
&ldquo;<B><U>Securities Act</U></B>&rdquo; means the Securities Act of 1933, as amended, and the rules and regulations promulgated thereunder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.13
&ldquo;<B><U>Stockholder Approval</U></B>&rdquo; means such approval as may be required by the applicable rules and regulations of the
NYSE American (or any successor entity) from the stockholders of the Company, or board of directors in lieu thereof, with respect to
issuance of all of the Warrants and the Warrant Shares upon the exercise thereof, including without limitation:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.13.1.
to give full effect to alternative cashless exercises pursuant to Section &lrm;2.3 hereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 2; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.13.2.
to consent to any adjustment to the exercise price or number of shares of Common Stock underlying the Warrants in the event of a Share
Combination Event pursuant to Section &lrm;3.10.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.13.3.
to consent to the voluntary adjustment, from time to time, of the exercise price of any and all currently outstanding warrants pursuant
to Section &lrm;3.11.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.14
&ldquo;<B><U>Subsidiary</U></B>&rdquo; means any subsidiary of the Company and shall, where applicable, also include any direct or indirect
subsidiary of the Company formed or acquired after the date hereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.15
&ldquo;<B><U>Trading Day</U></B>&rdquo; means a day on which the Common Stock is traded on a Trading Market.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.16
&ldquo;<B><U>Trading Market</U></B>&rdquo; means any of the following markets or exchanges on which the Common Stock is listed or quoted
for trading on the date in question: the NYSE American, the Nasdaq Capital Market, the Nasdaq Global Market, the Nasdaq Global Select
Market, the New York Stock Exchange, OTCQB or OTCQX (or any successors to any of the foregoing).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.17
&ldquo;<B><U>Transfer Agent</U></B>&rdquo; means Equiniti Trust Company, the current transfer agent of the Company, with a mailing address
of 1110 Centre Pointe Curve, Suite 101, Mendota Heights, Minnesota 55120 and an email address of issuerservices@equiniti.com, and any
successor transfer agent of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.18
&ldquo;<B><U>VWAP</U></B>&rdquo; means, for any date, the price determined by the first of the following clauses that applies: (a) if
the Common Stock is then listed or quoted on a Trading Market, the daily volume weighted average price of the Common Stock for such date
(or the nearest preceding date) on the Trading Market on which the Common Stock is then listed or quoted as reported by Bloomberg L.P.
(based on a Trading Day from 9:30 a.m. (New York City time) to 4:02 p.m. (New York City time)), (b) if OTCQB or OTCQX is not a Trading
Market, the volume weighted average price of the Common Stock for such date (or the nearest preceding date) on OTCQB or OTCQX as applicable,
(c) if the Common Stock is not then listed or quoted for trading on OTCQB or OTCQX and if prices for the Common Stock are then reported
on the Pink Open Market (or a similar organization or agency succeeding to its functions of reporting prices), the most recent bid price
per share of Common Stock so reported, or (d) in all other cases, the fair market value of a share of Common Stock as determined by an
independent appraiser selected in good faith by the holders of a majority in interest of the Warrants then outstanding and reasonably
acceptable to the Company, the fees and expenses of which shall be paid by the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.19
&ldquo;<B><U>Warrant Agent Agreement</U></B>&rdquo; means that certain Warrant Agent agreement, dated on or about the Initial Exercise
Date, between the Company and the Warrant Agent.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.20
&ldquo;<B><U>Warrant Agent</U></B>&rdquo; means the Transfer Agent and any successor warrant agent of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.21
&ldquo;<B><U>Warrants</U></B>&rdquo; means this Warrant and other Common Stock purchase warrants issued by the Company pursuant to the
Registration Statement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 3; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">2.
<B>Exercise.</B></FONT></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.1
<B><U>Exercise of Warrant</U></B>. Subject to the provisions of Section 2.5 herein, exercise of the purchase rights represented by this
Warrant may be made, in whole or in part, at any time or times on or after the Initial Exercise Date and on or before the Termination
Date by delivery to the Company of a duly executed PDF copy submitted by e-mail (or e-mail attachment) of the Notice of Exercise substantially
in the form attached hereto as Exhibit <U>&lrm;2.1</U> (the &ldquo;<B><U>Notice of Exercise</U></B>&rdquo;). Within the earlier of (i)
two (2) Trading Days and (ii) the number of Trading Days comprising the Standard Settlement Period (as defined in Section &lrm;2.4.1
herein) following the date of exercise as aforesaid, the Holder shall deliver the aggregate Exercise Price for the Warrant Shares specified
in the applicable Notice of Exercise by wire transfer or cashier&rsquo;s check drawn on a United States bank unless the cashless exercise
procedure specified in Section &lrm;2.3 below is specified in the applicable Notice of Exercise. For the avoidance of doubt, any reference
to cashless exercise herein shall include a reference to alternative cashless exercise. No ink-original Notice of Exercise shall be required,
nor shall any medallion guarantee (or other type of guarantee or notarization) of any Notice of Exercise be required. Notwithstanding
anything herein to the contrary, the Holder shall not be required to physically surrender this Warrant to the Company until the Holder
has purchased all of the Warrant Shares available hereunder and the Warrant has been exercised in full, in which case, the Holder shall
surrender this Warrant to the Company for cancellation within three (3) Trading Days of the date on which the final Notice of Exercise
is delivered to the Company. Partial exercises of this Warrant resulting in purchases of a portion of the total number of Warrant Shares
available hereunder shall have the effect of lowering the outstanding number of Warrant Shares purchasable hereunder in an amount equal
to the applicable number of Warrant Shares purchased. The Holder and the Company shall maintain records showing the number of Warrant
Shares purchased and the date of such purchases. The Company shall deliver any objection to any Notice of Exercise within one (1) Trading
Day of receipt of such notice. <B>The Holder and any assignee, by acceptance of this Warrant, acknowledge and agree that, by reason of
the provisions of this paragraph, following the purchase of a portion of the Warrant Shares hereunder, the number of Warrant Shares available
for purchase hereunder at any given time may be less than the amount stated on the face hereof.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Notwithstanding
the foregoing in this Section &lrm;2.1, a holder whose interest in this Warrant is a beneficial interest in certificate(s) representing
this Warrant held in book-entry form through DTC (or another established clearing corporation performing similar functions), shall effect
exercises made pursuant to this Section &lrm;2.1 by delivering to DTC (or such other clearing corporation, as applicable) the appropriate
instruction form for exercise, complying with the procedures to effect exercise that are required by DTC (or such other clearing corporation,
as applicable), subject to a Holder&rsquo;s right to elect to receive a Warrant in certificated form pursuant to the terms of the Warrant
Agent Agreement, in which case this sentence shall not apply.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.2
<B><U>Exercise Price</U></B>. The exercise price per Warrant Share shall be $[&#9679;], subject to adjustment hereunder (the &ldquo;<B><U>Exercise
Price</U></B>&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 4; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.3
<B><U>Cashless Exercise</U></B>. If at the time of exercise hereof there is no effective registration statement registering, or the prospectus
contained therein is not available for the issuance of the Warrant Shares to the Holder or the resale of the Warrant Shares by the Holder,
then this Warrant may also be exercised, in whole or in part, at such time by means of a &ldquo;cashless exercise&rdquo; in which the
Holder shall be entitled to receive a number of Warrant Shares equal to the quotient obtained by dividing [(A-B) (X)] by (A), where:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif; width: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: center; width: 0.25in; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">(A)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 0.25in; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">=</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">as
                                            applicable: (i) the VWAP on the Trading Day immediately preceding the date of the applicable
                                            Notice of Exercise if such Notice of Exercise is (1) both executed and delivered pursuant
                                            to Section 2.1 hereof on a day that is not a Trading Day or (2) both executed and delivered
                                            pursuant to Section 2.1 hereof on a Trading Day prior to the opening of &ldquo;regular trading
                                            hours&rdquo; (as defined in Rule 600(b) of Regulation NMS promulgated under the federal securities
                                            laws) on such Trading Day, (ii) at the option of the Holder, either (y) the VWAP on the Trading
                                            Day immediately preceding the date of the applicable Notice of Exercise or (z) the Bid Price
                                            of the Common Stock on the principal Trading Market as reported by Bloomberg L.P. as of the
                                            time of the Holder&rsquo;s execution of the applicable Notice of Exercise if such Notice
                                            of Exercise is executed during &ldquo;regular trading hours&rdquo; on a Trading Day and is
                                            delivered within two (2) hours thereafter (including until two (2) hours after the close
                                            of &ldquo;regular trading hours&rdquo; on a Trading Day) pursuant to Section 2.1 hereof or
                                            (iii) the VWAP on the date of the applicable Notice of Exercise if the date of such Notice
                                            of Exercise is a Trading Day and such Notice of Exercise is both executed and delivered pursuant
                                            to Section 2.1 hereof after the close of &ldquo;regular trading hours&rdquo; on such Trading
                                            Day;</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: center; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(B)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">=</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            Exercise Price of this Warrant, as adjusted hereunder; and</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: center; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(X)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">=</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    number of Warrant Shares that would be issuable upon exercise of this Warrant in accordance with the terms of this Warrant if such
    exercise were by means of a cash exercise rather than a cashless exercise.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
Warrant Shares are issued in such a cashless exercise, the parties acknowledge and agree that in accordance with Section 3(a)(9) of the
Securities Act, the Warrant Shares shall take on the registered characteristics of the Warrants being exercised, and the holding period
of the Warrant Shares being issued may be tacked on to the holding period of this Warrant. Assuming (i) the Holder is not an Affiliate
of the Company, and (ii) all of the applicable conditions of Rule 144 promulgated under the Securities Act with respect to Holder and
the Warrant Shares are met in the case of such a cashless exercise, the Company agrees that the Company will cause the removal of the
legend from such Warrant Shares (including by delivering an opinion of the Company&rsquo;s counsel to the Company&rsquo;s transfer agent
at its own expense to ensure the foregoing), and the Company agrees that the Holder is under no obligation to sell the Warrant Shares
issuable upon the exercise of the Warrant prior to removing the legend. The Company agrees not to take any position contrary to this
Section &lrm;2.3.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 5; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Holder may also effect an &ldquo;alternative cashless exercise&rdquo; following the Stockholder Approval Date. In such event, the aggregate
number of Warrant Shares issuable in such alternative cashless exercise pursuant to any given Notice of Exercise electing to effect an
alternative cashless exercise shall equal the product of (i) the aggregate number of Warrant Shares that would be issuable upon exercise
of this Warrant in accordance with the terms of this Warrant if such exercise were by means of a cash exercise rather than a cashless
exercise, multiplied by (ii) 2.0. Notwithstanding anything herein to the contrary, on the Termination Date, this Warrant shall be automatically
exercised via cashless exercise pursuant to this Section &lrm;2.3 (including an alternative cashless exercise pursuant to this paragraph).
Notwithstanding anything herein to the contrary, on the Termination Date, this Warrant shall be automatically exercised via cashless
exercise pursuant to this Section &lrm;2.3.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.4
<B><U>Mechanics of Exercise</U></B>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.4.1.
<B><U>Delivery of Warrant Shares upon Exercise</U></B>. The Company shall cause the Warrant Shares purchased hereunder to be transmitted
by the Transfer Agent to the Holder by crediting the account of the Holder&rsquo;s or its designee&rsquo;s balance account with The Depository
Trust Company through its Deposit or Withdrawal at Custodian system (&ldquo;<B><U>DWAC</U></B>&rdquo;) if the Company is then a participant
in such system and either (A) there is an effective registration statement permitting the issuance of the Warrant Shares to or resale
of the Warrant Shares by Holder or (B) the Warrant Shares are eligible for resale by the Holder without volume or manner-of-sale limitations
pursuant to Rule 144 (assuming cashless exercise of the Warrants), and otherwise by physical delivery of a certificate, for the number
of Warrant Shares to which the Holder is entitled pursuant to such exercise to the address specified by the Holder in the Notice of Exercise
by the date that is the earliest of (i) two (2) Trading Days after the delivery to the Company of the Notice of Exercise, (ii) one (1)
Trading Day after delivery of the aggregate Exercise Price to the Company and (iii) the number of Trading Days comprising the Standard
Settlement Period after the delivery to the Company of the Notice of Exercise (such date, the &ldquo;<B><U>Warrant Share Delivery Date</U></B>&rdquo;).
Upon delivery of the Notice of Exercise, the Holder shall be deemed for all corporate purposes to have become the holder of record of
the Warrant Shares with respect to which this Warrant has been exercised, irrespective of the date of delivery of the Warrant Shares,
provided that payment of the aggregate Exercise Price (other than in the case of a cashless exercise) is received within the earlier
of (i) two (2) Trading Days and (ii) the number of Trading Days comprising the Standard Settlement Period following delivery of the Notice
of Exercise. Notwithstanding anything herein to the contrary, upon delivery of the Notice of Exercise, the Holder shall be deemed for
purposes of Regulation SHO under the Exchange Act to have become the holder of the Warrant Shares irrespective of the date of delivery
of the Warrant Shares. If the Company fails for any reason (other than the failure of the Holder to timely deliver the aggregate Exercise
Price, unless the Warrant is validly exercised by means of a cashless exercise) to deliver to the Holder the Warrant Shares subject to
a Notice of Exercise by the Warrant Share Delivery Date, the Company shall pay to the Holder, in cash, as liquidated damages and not
as a penalty, for each $1,000 of Warrant Shares subject to such exercise (based on the VWAP of the Common Stock on the date of the applicable
Notice of Exercise), $10 per Trading Day (increasing to $20 per Trading Day on the third (3rd) Trading Day after the Warrant Share Delivery
Date) for each Trading Day after such Warrant Share Delivery Date until such Warrant Shares are delivered or Holder rescinds such exercise.
The Company agrees to maintain a Transfer Agent that is a participant in the FAST program so long as this Warrant remains outstanding
and exercisable. As used herein, &ldquo;<B><U>Standard Settlement Period</U></B>&rdquo; means the standard settlement period, expressed
in a number of Trading Days, on the Company&rsquo;s primary Trading Market with respect to the Common Stock as in effect on the date
of delivery of the Notice of Exercise. Notwithstanding the foregoing, with respect to any Notice(s) of Exercise delivered on or prior
to 12:00 p.m. (New York City time) on the Initial Exercise Date, which may be delivered at any time after the time of execution of the
Placement Agency Agreement, the Company agrees to deliver the Warrant Shares subject to such notice(s) by 4:00 p.m. (New York City time)
on the Initial Exercise Date and the Initial Exercise Date shall be the Warrant Share Delivery Date for purposes hereunder, provided
that payment of the aggregate Exercise Price (other than in the case of a cashless exercise) is received by such Warrant Share Delivery
Date.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 6; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.4.2.
<B><U>Delivery of New Warrants Upon Exercise</U></B>. If this Warrant shall have been exercised in part, the Company shall, at the request
of a Holder and upon surrender of this Warrant certificate, at the time of delivery of the Warrant Shares, deliver to the Holder a new
Warrant evidencing the rights of the Holder to purchase the unpurchased Warrant Shares called for by this Warrant, which new Warrant
shall in all other respects be identical with this Warrant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.4.3.
<B><U>Rescission Rights</U></B>. If the Company fails to cause the Transfer Agent to transmit to the Holder the Warrant Shares pursuant
to Section &lrm;2.4.1 by the Warrant Share Delivery Date, then the Holder will have the right to rescind such exercise; provided, however,
that the Holder shall be required to return any Warrant Shares subject to any such rescinded exercise notice concurrently with the return
to Holder of the aggregate Exercise Price paid to the Company for such Warrant Shares and the restoration of Holder&rsquo;s right to
acquire such Warrant Shares pursuant to this Warrant (including, issuance of a replacement warrant certificate evidencing such restored
right).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.4.4.
<B><U>Compensation for Buy-In on Failure to Timely Deliver Warrant Shares upon Exercise</U></B>. In addition to any other rights available
to the Holder, if the Company fails to cause the Transfer Agent to transmit to the Holder the Warrant Shares in accordance with the provisions
of Section &lrm;2.4.1 above pursuant to an exercise on or before the Warrant Share Delivery Date (other than the failure of the Holder
to timely deliver the aggregate Exercise Price, unless the Warrant is validly exercised by means of a cashless exercise), and if after
such date the Holder is required by its broker to purchase (in an open market transaction or otherwise) or the Holder&rsquo;s brokerage
firm otherwise purchases, shares of Common Stock to deliver in satisfaction of a sale by the Holder of the Warrant Shares which the Holder
anticipated receiving upon such exercise (a &ldquo;<B><U>Buy-In</U></B>&rdquo;), then the Company shall (A) pay in cash to the Holder
the amount, if any, by which (x) the Holder&rsquo;s total purchase price (including brokerage commissions, if any) for the shares of
Common Stock so purchased exceeds (y) the amount obtained by multiplying (1) the number of Warrant Shares that the Company was required
to deliver to the Holder in connection with the exercise at issue times (2) the price at which the sell order giving rise to such purchase
obligation was executed, and (B) at the option of the Holder, either reinstate the portion of the Warrant and equivalent number of Warrant
Shares for which such exercise was not honored and return any amount received by the Company in respect of the Exercise Price for those
Warrant Shares (in which case such exercise shall be deemed rescinded) or deliver to the Holder the number of shares of Common Stock
that would have been issued had the Company timely complied with its exercise and delivery obligations hereunder. For example, if the
Holder purchases Common Stock having a total purchase price of $11,000 to cover a Buy-In with respect to an attempted exercise of shares
of Common Stock with an aggregate sale price giving rise to such purchase obligation of $10,000, under clause (A) of the immediately
preceding sentence the Company shall be required to pay the Holder $1,000. The Holder shall provide the Company written notice indicating
the amounts payable to the Holder in respect of the Buy-In and, upon request of the Company, evidence of the amount of such loss. Nothing
herein shall limit a Holder&rsquo;s right to pursue any other remedies available to it hereunder, at law or in equity including, without
limitation, a decree of specific performance and/or injunctive relief with respect to the Company&rsquo;s failure to timely deliver shares
of Common Stock upon exercise of the Warrant as required pursuant to the terms hereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 7; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.4.5.
<B><U>No Fractional Shares or Scrip</U></B>. No fractional shares or scrip representing fractional shares shall be issued upon the exercise
of this Warrant. As to any fraction of a share which the Holder would otherwise be entitled to purchase upon such exercise, the Company
shall, at its election, either pay a cash adjustment in respect of such final fraction in an amount equal to such fraction multiplied
by the Exercise Price or round up to the next whole share.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.4.6.
<B><U>Charges, Taxes and Expenses</U></B>. Issuance of Warrant Shares shall be made without charge to the Holder for any issue or transfer
tax or other incidental expense in respect of the issuance of such Warrant Shares, all of which taxes and expenses shall be paid by the
Company, and such Warrant Shares shall be issued in the name of the Holder or in such name or names as may be directed by the Holder;
<U>provided</U>, <U>however</U>, that, in the event that Warrant Shares are to be issued in a name other than the name of the Holder,
this Warrant when surrendered for exercise shall be accompanied by the Assignment Form attached hereto as <U>Exhibit &lrm;2.4.6</U> duly
executed by the Holder and the Company may require, as a condition thereto, the payment of a sum sufficient to reimburse it for any transfer
tax incidental thereto. The Company shall pay all Transfer Agent fees required for same-day processing of any Notice of Exercise and
all fees to the Depository Trust Company (or another established clearing corporation performing similar functions) required for same-day
electronic delivery of the Warrant Shares.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.4.7.
<B><U>Closing of Books</U></B>. The Company will not close its stockholder books or records in any manner which prevents the timely exercise
of this Warrant, pursuant to the terms hereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 8; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.5
<B><U>Holder&rsquo;s Exercise Limitations</U></B>. The Company shall not effect any exercise of this Warrant, and a Holder shall not
have the right to exercise any portion of this Warrant, pursuant to Section &lrm;2 or otherwise, to the extent that after giving effect
to such issuance after exercise as set forth on the applicable Notice of Exercise, the Holder (together with the Holder&rsquo;s Affiliates,
and any other Persons acting as a group together with the Holder or any of the Holder&rsquo;s Affiliates (such Persons, &ldquo;<B><U>Attribution
Parties</U></B>&rdquo;)), would beneficially own in excess of the Beneficial Ownership Limitation (as defined below). For purposes of
the foregoing sentence, the number of shares of Common Stock beneficially owned by the Holder and its Affiliates and Attribution Parties
shall include the number of shares of Common Stock issuable upon exercise of this Warrant with respect to which such determination is
being made, but shall exclude the number of shares of Common Stock which would be issuable upon (i) exercise of the remaining, unexercised
portion of this Warrant beneficially owned by the Holder or any of its Affiliates or Attribution Parties and (ii) exercise or conversion
of the unexercised or unconverted portion of any other securities of the Company (including, without limitation, any other Common Stock
Equivalents) subject to a limitation on conversion or exercise analogous to the limitation contained herein beneficially owned by the
Holder or any of its Affiliates or Attribution Parties. Except as set forth in the preceding sentence, for purposes of this Section &lrm;2.5,
beneficial ownership shall be calculated in accordance with Section 13(d) of the Exchange Act and the rules and regulations promulgated
thereunder, it being acknowledged by the Holder that the Company is not representing to the Holder that such calculation is in compliance
with Section 13(d) of the Exchange Act and the Holder is solely responsible for any schedules required to be filed in accordance therewith.
To the extent that the limitation contained in this Section &lrm;2.5 applies, the determination of whether this Warrant is exercisable
(in relation to other securities owned by the Holder together with any Affiliates and Attribution Parties) and of which portion of this
Warrant is exercisable shall be in the sole discretion of the Holder, and the submission of a Notice of Exercise shall be deemed to be
the Holder&rsquo;s determination of whether this Warrant is exercisable (in relation to other securities owned by the Holder together
with any Affiliates and Attribution Parties) and of which portion of this Warrant is exercisable, in each case subject to the Beneficial
Ownership Limitation, and the Company shall have no obligation to verify or confirm the accuracy of such determination. In addition,
a determination as to any group status as contemplated above shall be determined in accordance with Section 13(d) of the Exchange Act
and the rules and regulations promulgated thereunder. For purposes of this Section &lrm;2.5, in determining the number of outstanding
shares of Common Stock, a Holder may rely on the number of outstanding shares of Common Stock as reflected in (A) the Company&rsquo;s
most recent periodic or annual report filed with the Commission, as the case may be, (B) a more recent public announcement by the Company
or (C) a more recent written notice by the Company or the Transfer Agent setting forth the number of shares of Common Stock outstanding.
Upon the written or oral request of a Holder, the Company shall within one (1) Trading Day confirm orally and in writing to the Holder
the number of shares of Common Stock then outstanding. In any case, the number of outstanding shares of Common Stock shall be determined
after giving effect to the conversion or exercise of securities of the Company, including this Warrant, by the Holder or its Affiliates
or Attribution Parties since the date as of which such number of outstanding shares of Common Stock was reported. The &ldquo;<B><U>Beneficial
Ownership Limitation</U></B>&rdquo; shall be 4.99% (or, upon election by a Holder prior to the issuance of any Warrants, 9.99%) of the
number of shares of Common Stock outstanding immediately after giving effect to the issuance of shares of Common Stock issuable upon
exercise of this Warrant. The Holder, upon notice to the Company, may increase or decrease the Beneficial Ownership Limitation provisions
of this Section &lrm;2.5, provided that the Beneficial Ownership Limitation in no event exceeds 9.99% of the number of shares of Common
Stock outstanding immediately after giving effect to the issuance of shares of Common Stock upon exercise of this Warrant held by the
Holder and the provisions of this Section &lrm;2.5 shall continue to apply. Any increase in the Beneficial Ownership Limitation will
not be effective until the 61st day after such notice is delivered to the Company. The provisions of this paragraph shall be construed
and implemented in a manner otherwise than in strict conformity with the terms of this Section &lrm;2.5 to correct this paragraph (or
any portion hereof) which may be defective or inconsistent with the intended Beneficial Ownership Limitation herein contained or to make
changes or supplements necessary or desirable to properly give effect to such limitation. The limitations contained in this paragraph
shall apply to a successor holder of this Warrant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 9; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>3.
Certain Adjustments.</B></FONT></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.1
<B><U>Stock Dividends and Splits</U></B>. If the Company, at any time while this Warrant is outstanding: (i) pays a stock dividend or
otherwise makes a distribution or distributions on shares of Common Stock or any other equity or equity equivalent securities payable
in shares of Common Stock (which, for avoidance of doubt, shall not include any shares of Common Stock issued by the Company upon exercise
of this Warrant), (ii) subdivides outstanding shares of Common Stock into a larger number of shares, (iii) combines (including by way
of reverse stock split) outstanding shares of Common Stock into a smaller number of shares, or (iv) issues by reclassification of shares
of Common Stock any shares of capital stock of the Company, then in each case the Exercise Price shall be multiplied by a fraction of
which the numerator shall be the number of shares of Common Stock (excluding treasury shares, if any) outstanding immediately before
such event and of which the denominator shall be the number of shares of Common Stock outstanding immediately after such event, and the
number of Shares issuable upon exercise of this Warrant shall be proportionately adjusted such that the aggregate Exercise Price of this
Warrant shall remain unchanged. Any adjustment made pursuant to this Section &lrm;3.1 shall become effective immediately after the record
date for the determination of stockholders entitled to receive such dividend or distribution and shall become effective immediately after
the effective date in the case of a subdivision, combination or re-classification.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.2
<B><U>Subsequent Rights Offerings</U></B>. In addition to any adjustments pursuant to Section &lrm;3.1 above, if at any time the Company
grants, issues or sells any Common Stock Equivalents or rights to purchase stock, warrants, securities or other property pro rata to
all (or substantially all) of the record holders of any class of shares of Common Stock (the &ldquo;<B><U>Purchase Rights</U></B>&rdquo;),
then the Holder will be entitled to acquire, upon the terms applicable to such Purchase Rights, the aggregate Purchase Rights which the
Holder could have acquired if the Holder had held the number of shares of Common Stock acquirable upon complete exercise of this Warrant
(without regard to any limitations on exercise hereof, including without limitation, the Beneficial Ownership Limitation) immediately
before the date on which a record is taken for the grant, issuance or sale of such Purchase Rights, or, if no such record is taken, the
date as of which the record holders of shares of Common Stock are to be determined for the grant, issue or sale of such Purchase Rights
(provided, however, that, to the extent that the Holder&rsquo;s right to participate in any such Purchase Right would result in the Holder
exceeding the Beneficial Ownership Limitation, then the Holder shall not be entitled to participate in such Purchase Right to such extent
(or beneficial ownership of such shares of Common Stock as a result of such Purchase Right to such extent) and such Purchase Right to
such extent shall be held in abeyance for the Holder until such time, if ever, as its right thereto would not result in the Holder exceeding
the Beneficial Ownership Limitation).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.3
<B><U>Pro Rata Distributions</U></B>. During such time as this Warrant is outstanding, if the Company shall declare or make any dividend
or other distribution of its assets (or rights to acquire its assets) to all (or substantially all) holders of shares of Common Stock,
by way of return of capital or otherwise (including, without limitation, any distribution of cash, stock or other securities, property
or options by way of a dividend, spin off, reclassification, corporate rearrangement, scheme of arrangement or other similar transaction)
(a &ldquo;<B><U>Distribution</U></B>&rdquo;), at any time after the issuance of this Warrant, then, in each such case, the Holder shall
be entitled to participate in such Distribution to the same extent that the Holder would have participated therein if the Holder had
held the number of shares of Common Stock acquirable upon complete exercise of this Warrant (without regard to any limitations on exercise
hereof, including without limitation, the Beneficial Ownership Limitation) immediately before the date of which a record is taken for
such Distribution, or, if no such record is taken, the date as of which the record holders of shares of Common Stock are to be determined
for the participation in such Distribution (provided, however, that, to the extent that the Holder&rsquo;s right to participate in any
such Distribution would result in the Holder exceeding the Beneficial Ownership Limitation, then the Holder shall not be entitled to
participate in such Distribution to such extent (or in the beneficial ownership of any shares of Common Stock as a result of such Distribution
to such extent) and the portion of such Distribution shall be held in abeyance for the benefit of the Holder until such time, if ever,
as its right thereto would not result in the Holder exceeding the Beneficial Ownership Limitation). To the extent that this Warrant has
not been partially or completely exercised at the time of such Distribution, such portion of the Distribution shall be held in abeyance
for the benefit of the Holder until the Holder has exercised this Warrant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 10; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.4
<B><U>Fundamental Transaction</U></B>. If, at any time while this Warrant is outstanding, (i) the Company, directly or indirectly, in
one or more related transactions effects any merger or consolidation of the Company with or into another Person, (ii) the Company or
any Subsidiary, directly or indirectly, effects any sale, lease, license, assignment, transfer, conveyance or other disposition of all
or substantially all of its assets in one or a series of related transactions, (iii) any, direct or indirect, purchase offer, tender
offer or exchange offer (whether by the Company or another Person) is completed pursuant to which holders of Common Stock are permitted
to sell, tender or exchange their shares for other securities, cash or property and has been accepted by the holders of 50% or more of
the outstanding Common Stock or 50% or more of the voting power of the common equity of the Company, (iv) the Company, directly or indirectly,
in one or more related transactions effects any reclassification, reorganization or recapitalization of the Common Stock or any compulsory
share exchange pursuant to which the Common Stock is effectively converted into or exchanged for other securities, cash or property,
or (v) the Company, directly or indirectly, in one or more related transactions consummates a stock or share purchase agreement or other
business combination (including, without limitation, a reorganization, recapitalization, spin-off, merger or scheme of arrangement) with
another Person or group of Persons whereby such other Person or group acquires 50% or more of the outstanding shares of Common Stock
or 50% or more of the voting power of the common equity of the Company (each a &ldquo;<B><U>Fundamental Transaction</U></B>&rdquo;),
then, upon any subsequent exercise of this Warrant, the Holder shall have the right to receive, for each Warrant Share that would have
been issuable upon such exercise immediately prior to the occurrence of such Fundamental Transaction, at the option of the Holder (without
regard to any limitation in Section &lrm;2.5 on the exercise of this Warrant), the number of shares of Common Stock of the successor
or acquiring corporation or of the Company, if it is the surviving corporation, and any additional consideration (the &ldquo;<B><U>Alternate
Consideration</U></B>&rdquo;) receivable as a result of such Fundamental Transaction by a holder of the number of shares of Common Stock
for which this Warrant is exercisable immediately prior to such Fundamental Transaction (without regard to any limitation in Section
&lrm;2.5 on the exercise of this Warrant). For purposes of any such exercise, the determination of the Exercise Price shall be appropriately
adjusted to apply to such Alternate Consideration based on the amount of Alternate Consideration issuable in respect of one share of
Common Stock in such Fundamental Transaction, and the Company shall apportion the Exercise Price among the Alternate Consideration in
a reasonable manner reflecting the relative value of any different components of the Alternate Consideration. If holders of Common Stock
are given any choice as to the securities, cash or property to be received in a Fundamental Transaction, then the Holder shall be given
the same choice as to the Alternate Consideration it receives upon any exercise of this Warrant following such Fundamental Transaction.
Notwithstanding anything to the contrary, in the event of a Fundamental Transaction, the Company or any Successor Entity (as defined
below) shall, at the Holder&rsquo;s option, exercisable at any time concurrently with, or within 30 days after, the consummation of the
Fundamental Transaction (or, if later, the date of the public announcement of the applicable Fundamental Transaction), purchase this
Warrant from the Holder by paying to the Holder an amount of cash equal to the Black Scholes Value (as defined below) of the remaining
unexercised portion of this Warrant on the date of the consummation of such Fundamental Transaction; provided, however, that, if the
Fundamental Transaction is not within the Company&rsquo;s control, including not approved by the Company&rsquo;s Board of Directors,
the Holder shall only be entitled to receive from the Company or any Successor Entity the same type or form of consideration (and in
the same proportion), at the Black Scholes Value of the unexercised portion of this Warrant, that is being offered and paid to the holders
of Common Stock of the Company in connection with the Fundamental Transaction, whether that consideration be in the form of cash, stock
or any combination thereof, or whether the holders of Common Stock are given the choice to receive from among alternative forms of consideration
in connection with the Fundamental Transaction; provided, further, that if holders of Common Stock of the Company are not offered or
paid any consideration in such Fundamental Transaction, such holders of Common Stock will be deemed to have received common stock/shares
of the Successor Entity (which Entity may be the Company following such Fundamental Transaction) in such Fundamental Transaction. &ldquo;<B><U>Black
Scholes Value</U></B>&rdquo; means the value of this Warrant based on the Black-Scholes Option Pricing Model obtained from the &ldquo;OV&rdquo;
function on Bloomberg, L.P. (&ldquo;<B><U>Bloomberg</U></B>&rdquo;) determined as of the day of consummation of the applicable contemplated
Fundamental Transaction for pricing purposes and reflecting (A) a risk-free interest rate corresponding to the U.S. Treasury rate for
a period equal to the time between the date of the public announcement of the applicable contemplated Fundamental Transaction and the
Termination Date, (B) an expected volatility equal to the greater of (1) 100% and (2) the 100 day volatility as obtained from the HVT
function on Bloomberg (determined utilizing a 365 day annualization factor) as of the Trading Day immediately following the public announcement
of the applicable contemplated Fundamental Transaction, (C) the underlying price per share used in such calculation shall be the greater
of (i) the sum of the price per share being offered in cash, if any, plus the value of any non-cash consideration, if any, being offered
in such Fundamental Transaction and (ii) the highest VWAP during the period beginning on the Trading Day immediately preceding the public
announcement of the applicable contemplated Fundamental Transaction (or the consummation of the applicable Fundamental Transaction, if
earlier) and ending on the Trading Day of the Holder&rsquo;s request pursuant to this Section &lrm;3.7 and (D) a remaining option time
equal to the time between the date of the public announcement of the applicable contemplated Fundamental Transaction and the Termination
Date and (E) a zero cost of borrow.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 11; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
payment of the Black Scholes Value will be made by wire transfer of immediately available funds (or such other consideration) within
the later of (i) five (5) Business Days after the Holder&rsquo;s election and (ii) the date of consummation of the Fundamental Transaction.
The Company shall cause any successor entity in a Fundamental Transaction in which the Company is not the survivor (the &ldquo;<B><U>Successor
Entity</U></B>&rdquo;) to assume in writing all of the obligations of the Company under this Warrant in accordance with the provisions
of this Section &lrm;3.7 pursuant to written agreements in form and substance reasonably satisfactory to the Holder and approved by the
Holder (without unreasonable delay) prior to such Fundamental Transaction and shall, at the option of the Holder, deliver to the Holder
in exchange for this Warrant a security of the Successor Entity evidenced by a written instrument substantially similar in form and substance
to this Warrant that is exercisable for a corresponding number of shares of capital stock of such Successor Entity (or its parent entity)
equivalent to the shares of Common Stock acquirable and receivable upon exercise of this Warrant (without regard to any limitations on
the exercise of this Warrant) prior to such Fundamental Transaction, and with an exercise price which applies the exercise price hereunder
to such shares of capital stock (but taking into account the relative value of the shares of Common Stock prior to such Fundamental Transaction
and the value of such shares of capital stock, such number of shares of capital stock and such exercise price being for the purpose of
protecting the economic value of this Warrant immediately prior to the consummation of such Fundamental Transaction), and which is reasonably
satisfactory in form and substance to the Holder. Upon the occurrence of any such Fundamental Transaction, the Successor Entity shall
be added to the term &ldquo;Company&rdquo; under this Warrant (so that from and after the occurrence or consummation of such Fundamental
Transaction, each and every provision of this Warrant referring to the &ldquo;Company&rdquo; shall refer instead to each of the Company
and the Successor Entity or Successor Entities, jointly and severally), and the Successor Entity or Successor Entities, jointly and severally
with the Company, may exercise every right and power of the Company prior thereto and the Successor Entity or Successor Entities shall
assume all of the obligations of the Company prior thereto under this Warrant with the same effect as if the Company and such Successor
Entity or Successor Entities, jointly and severally, had been named as the Company herein. For the avoidance of doubt, the Holder shall
be entitled to the benefits of the provisions of this Section &lrm;3.7 regardless of (i) whether the Company has sufficient authorized
shares of Common Stock for the issuance of Warrant Shares and/or (ii) whether a Fundamental Transaction occurs prior to the Initial Exercise
Date.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 12; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.5
<B><U>Calculations</U></B>. All calculations under this Section &lrm;3 shall be made to the nearest cent or the nearest 1/100th of a
share, as the case may be. For purposes of this Section &lrm;3, the number of shares of Common Stock deemed to be issued and outstanding
as of a given date shall be the sum of the number of shares of Common Stock (excluding treasury shares, if any) issued and outstanding.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.6
<B><U>Notice to Holder</U></B>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.6.1.
<B><U>Adjustment to Exercise Price</U></B>. Whenever the Exercise Price is adjusted pursuant to any provision of this Section &lrm;3,
the Company shall promptly deliver to the Holder by email a notice setting forth the Exercise Price after such adjustment and any resulting
adjustment to the number of Warrant Shares and setting forth a brief statement of the facts requiring such adjustment.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.6.2.
<B><U>Notice to Allow Exercise by Holder</U></B>. If (A) the Company shall declare a dividend (or any other distribution in whatever
form) on the Common Stock, (B) the Company shall declare a special nonrecurring cash dividend on or a redemption of the Common Stock,
(C) the Company shall authorize the granting to all holders of the Common Stock rights or warrants to subscribe for or purchase any shares
of capital stock of any class or of any rights, (D) the approval of any stockholders of the Company shall be required in connection with
any reclassification of the Common Stock, any consolidation or merger to which the Company (or any of its Subsidiaries) is a party, any
sale or transfer of all or substantially all of its assets, or any compulsory share exchange whereby the Common Stock is converted into
other securities, cash or property, or (E) the Company shall authorize the voluntary or involuntary dissolution, liquidation or winding
up of the affairs of the Company, then, in each case, the Company shall cause to be delivered by email to the Holder at its last email
address as it shall appear upon the Warrant Register of the Company, at least 20 calendar days prior to the applicable record or effective
date hereinafter specified, a notice stating (x) the date on which a record is to be taken for the purpose of such dividend, distribution,
redemption, rights or warrants, or if a record is not to be taken, the date as of which the holders of the Common Stock of record to
be entitled to such dividend, distributions, redemption, rights or warrants are to be determined or (y) the date on which such reclassification,
consolidation, merger, sale, transfer or share exchange is expected to become effective or close, and the date as of which it is expected
that holders of the Common Stock of record shall be entitled to exchange their shares of Common Stock for securities, cash or other property
deliverable upon such reclassification, consolidation, merger, sale, transfer or share exchange; provided that the failure to deliver
such notice or any defect therein or in the delivery thereof shall not affect the validity of the corporate action required to be specified
in such notice. To the extent that any notice provided in this Warrant constitutes, or contains, material, non-public information regarding
the Company or any of the Subsidiaries, the Company shall simultaneously file such notice with the Commission pursuant to a Current Report
on Form 8-K. The Holder shall remain entitled to exercise this Warrant during the period commencing on the date of such notice to the
effective date of the event triggering such notice except as may otherwise be expressly set forth herein.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 13; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.7
<B><U>Share Combination Event Adjustment</U></B>. In addition to the adjustments set forth in Section &lrm;3.1 above, if at any time
and from time to time on or after the Issuance Date there occurs any share split, share dividend, share combination recapitalization
or other similar transaction involving the Common Stock (each, a &ldquo;<B><U>Share Combination Event</U></B>&rdquo;, and such date thereof,
the &ldquo;<B><U>Share Combination Event Date</U></B>&rdquo;) and the lowest VWAP during the period commencing Five (5) consecutive Trading
Days immediately preceding and the Five (5) consecutive Trading Days immediately following the Share Combination Event Date (the &ldquo;<B><U>Event
Market Price</U></B>&rdquo;) (provided if the Share Combination Event is effective after close of Trading on the primary Trading Market,
then commencing on the next Trading Day which period shall be the &ldquo;<B><U>Share Combination Adjustment Period</U></B>&rdquo;) is
less than the Exercise Price then in effect (after giving effect to the adjustment in clause &lrm;3.1 above), then at the close of trading
on the primary Trading Market on the last day of the Share Combination Adjustment Period, the Exercise Price then in effect on such Fifth
(5th) Trading Day shall be reduced (but in no event increased) to the Event Market Price and the number of Warrant Shares issuable hereunder
shall be increased such that the aggregate Exercise Price of this Warrant on the Issuance Date for the Warrant Shares then outstanding
shall remain unchanged. For the avoidance of doubt, if the adjustment in the immediately preceding sentence would otherwise result in
an increase in the Exercise Price hereunder, no adjustment shall be made, and if this Warrant is exercised, on any given Exercise Date
during the Share Combination Adjustment Period, solely with respect to such portion of this Warrant exercised on such applicable Exercise
Date, such applicable Share Combination Adjustment Period shall be deemed to have ended on, and included, the Trading Day immediately
prior to such Exercise Date and the Event Market Price on such applicable Exercise Date will be the lowest VWAP of the Common Stock immediately
during such the Share Combination Adjustment Period prior to such Exercise Date and ending on, and including the Trading Day immediately
prior to such Exercise Date.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.8
<B><U>Voluntary Adjustment by Company</U></B>. Subject to the rules and regulations of the Trading Market and the consent of the Holders
of a majority in interest of the Warrants then outstanding, the Company may at any time during the term of this Warrant reduce the then
current Exercise Price to any amount and for any period of time deemed appropriate by the Board of Directors.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.9
<B><U>Stockholder Approval</U></B>. The Company shall seek Stockholder Approval in the time period and the manner provided in the Placement
Agency Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 14; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.
<B><U>Transfer of Warrant</U></B>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.1
<B><U>Transferability</U></B>. Subject to compliance with any applicable securities laws, this Warrant and all rights hereunder (including,
without limitation, any registration rights) are transferable, in whole or in part, upon surrender of this Warrant at the principal office
of the Company or its designated agent, together with a written assignment of this Warrant substantially in the form attached hereto
as Exhibit <U>&lrm;2.4.6</U> duly executed by the Holder or its agent or attorney and funds sufficient to pay any transfer taxes payable
upon the making of such transfer. Upon such surrender and, if required, such payment, the Company shall execute and deliver a new Warrant
or Warrants in the name of the assignee or assignees, as applicable, and in the denomination or denominations specified in such instrument
of assignment, and shall issue to the assignor a new Warrant evidencing the portion of this Warrant not so assigned, and this Warrant
shall promptly be cancelled. Notwithstanding anything herein to the contrary, the Holder shall not be required to physically surrender
this Warrant to the Company unless the Holder has assigned this Warrant in full, in which case, the Holder shall surrender this Warrant
to the Company within three (3) Trading Days of the date on which the Holder delivers an assignment form to the Company assigning this
Warrant in full. The Warrant, if properly assigned in accordance herewith, may be exercised by a new holder for the purchase of Warrant
Shares without having a new Warrant issued.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.2
<B><U>New Warrants</U></B>. If this Warrant is not held in global form through DTC (or any successor depositary), this Warrant may be
divided or combined with other Warrants upon presentation hereof at the aforesaid office of the Company, together with a written notice
specifying the names and denominations in which new Warrants are to be issued, signed by the Holder or its agent or attorney. Subject
to compliance with Section &lrm;4.1, as to any transfer which may be involved in such division or combination, the Company shall execute
and deliver a new Warrant or Warrants in exchange for the Warrant or Warrants to be divided or combined in accordance with such notice.
All Warrants issued on transfers or exchanges shall be dated the initial issuance date of this Warrant and shall be identical with this
Warrant except as to the number of Warrant Shares issuable pursuant thereto.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.3
<B><U>Warrant Register</U></B>. The Warrant Agent shall register this Warrant, upon records to be maintained by the Warrant Agent for
that purpose (the &ldquo;<B><U>Warrant Register</U></B>&rdquo;), in the name of the record Holder hereof from time to time. The Company
and the Warrant Agent may deem and treat the registered Holder of this Warrant as the absolute owner hereof for the purpose of any exercise
hereof or any distribution to the Holder, and for all other purposes, absent actual notice to the contrary.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.
<B><U>Miscellaneous</U></B>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.1
<B><U>No Rights as Stockholder until Exercise; No Settlement in Cash</U></B>. This Warrant does not entitle the Holder to any voting
rights, dividends or other rights as a stockholder of the Company prior to the exercise hereof as set forth in Section &lrm;2.4.1, except
as expressly set forth in Section &lrm;3. Without limiting any rights of a Holder to receive Warrant Shares on a &ldquo;cashless exercise&rdquo;
pursuant to Section <B>&lrm;</B>2.3 or to receive cash payments pursuant to Section <B>&lrm;</B>2.4.1 and Section <B>&lrm;</B>2.4.4 herein,
in no event shall the Company be required to net cash settle an exercise of this Warrant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 15; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.2
<B><U>Loss, Theft, Destruction or Mutilation of Warrant</U></B>. The Company covenants that upon receipt by the Company of evidence reasonably
satisfactory to it of the loss, theft, destruction or mutilation of this Warrant or any stock certificate relating to the Warrant Shares,
and in case of loss, theft or destruction, of indemnity or security reasonably satisfactory to it (which, in the case of the Warrant,
shall not include the posting of any bond), and upon surrender and cancellation of such Warrant or stock certificate, if mutilated, the
Company will make and deliver a new Warrant or stock certificate of like tenor and dated as of such cancellation, in lieu of such Warrant
or stock certificate.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.3
<B><U>Saturdays, Sundays, Holidays, etc</U></B>. If the last or appointed day for the taking of any action or the expiration of any right
required or granted herein shall not be a Business Day, then such action may be taken or such right may be exercised on the next succeeding
Business Day.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.4
<B><U>Authorized Shares</U></B>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.4.1.
<B><U>Reservation of Authorized and Unissued Shares</U></B>. The Company covenants that, during the period the Warrant is outstanding,
it will reserve from its authorized and unissued Common Stock a sufficient number of shares of Common Stock to provide for the issuance
of the Warrant Shares upon the exercise of any purchase rights under this Warrant. The Company further covenants that its issuance of
this Warrant shall constitute full authority to its officers who are charged with the duty of issuing the necessary Warrant Shares upon
the exercise of the purchase rights under this Warrant. The Company will take all such reasonable action as may be necessary to assure
that such Warrant Shares may be issued as provided herein without violation of any applicable law or regulation, or of any requirements
of the Trading Market upon which the Common Stock may be listed. The Company covenants that all Warrant Shares which may be issued upon
the exercise of the purchase rights represented by this Warrant will, upon exercise of the purchase rights represented by this Warrant
and payment for such Warrant Shares in accordance herewith, be duly authorized, validly issued, fully paid and nonassessable (which means
that no further sums are required to be paid by the holders thereof in connection with the issue thereof) and free from all taxes, liens
and charges created by the Company in respect of the issue thereof (other than taxes in respect of any transfer occurring contemporaneously
with such issue).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.4.2.
<B><U>Noncircumvention</U></B>. Except and to the extent as waived or consented to by the Holders of a majority in interest of the Warrants
then outstanding, the Company shall not by any action, including, without limitation, amending its certificate of incorporation or through
any reorganization, transfer of assets, consolidation, merger, dissolution, issue or sale of securities or any other voluntary action,
avoid or seek to avoid the observance or performance of any of the terms of this Warrant, but will at all times in good faith assist
in the carrying out of all such terms and in the taking of all such actions as may be necessary or appropriate to protect the rights
of Holder as set forth in this Warrant against impairment. Without limiting the generality of the foregoing, the Company will (i) not
increase the par value of any Warrant Shares above the amount payable therefor upon such exercise immediately prior to such increase
in par value, (ii) take all such action as may be necessary or appropriate in order that the Company may validly and legally issue fully
paid and nonassessable Warrant Shares upon the exercise of this Warrant and (iii) use commercially reasonable efforts to obtain all such
authorizations, exemptions or consents from any public regulatory body having jurisdiction thereof, as may be, necessary to enable the
Company to perform its obligations under this Warrant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 16; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.4.3.
<B><U>Authorizations, Exemptions and Consents</U></B>. Before taking any action that would result in an adjustment in the number of Warrant
Shares for which this Warrant is exercisable or in the Exercise Price, the Company shall obtain all such authorizations or exemptions
thereof, or consents thereto, as may be necessary from any public regulatory body or bodies having jurisdiction thereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.5
<B><U>Governing Law</U></B>. All questions concerning the construction, validity, enforcement and interpretation of this Warrant shall
be governed by and construed and enforced in accordance with the internal laws of the State of New York, without regard to the principles
of conflicts of law thereof. Each party agrees that all legal proceedings concerning the interpretations, enforcement and defense of
the transactions contemplated by this Warrant (whether brought against a party hereto or their respective affiliates, directors, officers,
shareholders, partners, members, employees or agents) shall be commenced exclusively in the state and federal courts sitting in the City
of New York. Each party hereby irrevocably submits to the exclusive jurisdiction of the state and federal courts sitting in the City
of New York, Borough of Manhattan for the adjudication of any dispute hereunder or in connection herewith or with any transaction contemplated
hereby or discussed herein, and hereby irrevocably waives, and agrees not to assert in any suit, action or proceeding, any claim that
it is not personally subject to the jurisdiction of any such court, that such suit, action or proceeding is improper or is an inconvenient
venue for such proceeding. Each party hereby irrevocably waives personal service of process and consents to process being served in any
such suit, action or proceeding by mailing a copy thereof via registered or certified mail or overnight delivery (with evidence of delivery)
to such party at the address in effect for notices to it under this Warrant and agrees that such service shall constitute good and sufficient
service of process and notice thereof. Nothing contained herein shall be deemed to limit in any way any right to serve process in any
other manner permitted by law. If either party shall commence an action, suit or proceeding to enforce any provisions of this Warrant,
the prevailing party in such action, suit or proceeding shall be reimbursed by the other party for their reasonable attorneys&rsquo;
fees and other costs and expenses incurred with the investigation, preparation and prosecution of such action or proceeding. Notwithstanding
the foregoing, nothing in this paragraph shall limit or restrict the federal district court in which a Holder may bring a claim under
the federal securities laws.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.6
<B><U>Restrictions</U></B>. The Holder acknowledges that the Warrant Shares acquired upon the exercise of this Warrant, if not registered,
and the Holder does not utilize cashless exercise, will have restrictions upon resale imposed by state and federal securities laws.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.7
<B><U>Nonwaiver and Expenses</U></B>. No course of dealing or any delay or failure to exercise any right hereunder on the part of Holder
shall operate as a waiver of such right or otherwise prejudice the Holder&rsquo;s rights, powers or remedies, notwithstanding the fact
that the right to exercise this Warrant terminates on the Termination Date. No provision of this Warrant shall be construed as a waiver
by the Holder of any rights which the Holder may have under the federal securities laws and the rules and regulations of the Commission
thereunder. Without limiting any other provision of this Warrant, if the Company willfully and knowingly fails to comply with any provision
of this Warrant, which results in any material damages to the Holder, the Company shall pay to the Holder such amounts as shall be sufficient
to cover any costs and expenses including, but not limited to, reasonable attorneys&rsquo; fees, including those of appellate proceedings,
incurred by the Holder in collecting any amounts due pursuant hereto or in otherwise enforcing any of its rights, powers or remedies
hereunder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 17; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.8
<B><U>Notices</U></B>. Any and all notices or other communications or deliveries to be provided by the Holders hereunder including, without
limitation, any Notice of Exercise, shall be in writing and delivered personally, by e-mail, or sent by a nationally recognized overnight
courier service, addressed to the Company, at 8201 E. 34th Cir N, Suite 1307, Wichita, Kansas 67226, <U>Attention</U>: Mark DiSiena,
Chief Financial Officer, email address: mark.disiena@ageagle.comor such other email address or address as the Company may specify for
such purposes by notice to the Holders. Any and all notices or other communications or deliveries to be provided by the Company hereunder
shall be in writing and delivered personally, by e-mail, or sent by a nationally recognized overnight courier service addressed to each
Holder at the e-mail address or address of such Holder appearing on the books of the Company. Any notice or other communication or deliveries
hereunder shall be deemed given and effective on the earliest of (i) the time of transmission, if such notice or communication is delivered
via e-mail at the e-mail address set forth in this Section &lrm;5.8 prior to 5:30 p.m. (New York City time) on any date, (ii) the next
Trading Day after the time of transmission, if such notice or communication is delivered via e-mail at the e-mail address set forth in
this Section &lrm;5.8 on a day that is not a Trading Day or later than 5:30 p.m. (New York City time) on any Trading Day, (iii) the second
Trading Day following the date of mailing, if sent by U.S. nationally recognized overnight courier service, or (iv) upon actual receipt
by the party to whom such notice is required to be given. To the extent that any notice provided hereunder constitutes, or contains,
material, non-public information regarding the Company or any Subsidiaries, the Company shall simultaneously file such notice with the
Commission pursuant to a Current Report on Form 8-K.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.9
<B><U>Limitation of Liability</U></B>. No provision hereof, in the absence of any affirmative action by the Holder to exercise this Warrant
to purchase Warrant Shares, and no enumeration herein of the rights or privileges of the Holder, shall give rise to any liability of
the Holder for the purchase price of any Common Stock or as a stockholder of the Company, whether such liability is asserted by the Company
or by creditors of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.10
<B><U>Remedies</U></B>. The Holder, in addition to being entitled to exercise all rights granted by law, including recovery of damages,
will be entitled to specific performance of its rights under this Warrant. The Company agrees that monetary damages would not be adequate
compensation for any loss incurred by reason of a breach by it of the provisions of this Warrant and hereby agrees to waive and not to
assert the defense in any action for specific performance that a remedy at law would be adequate.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.11
<B><U>Successors and Assigns</U></B>. Subject to applicable securities laws, this Warrant and the rights and obligations evidenced hereby
shall inure to the benefit of and be binding upon the successors and permitted assigns of the Company and the successors and permitted
assigns of Holder. The provisions of this Warrant are intended to be for the benefit of any Holder from time to time of this Warrant
and shall be enforceable by the Holder or holder of Warrant Shares.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 18; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.12
<B><U>Amendment</U></B>. This Warrant may be modified or amended or the provisions hereof waived with the written consent of the Company,
on the one hand, and the Holders of a majority in interest of the Warrants then outstanding, on the other hand.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.13
<B><U>Severability</U></B>. Wherever possible, each provision of this Warrant shall be interpreted in such manner as to be effective
and valid under applicable law, but if any provision of this Warrant shall be prohibited by or invalid under applicable law, such provision
shall be ineffective to the extent of such prohibition or invalidity, without invalidating the remainder of such provisions or the remaining
provisions of this Warrant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.14
<B><U>Headings</U></B>. The headings used in this Warrant are for the convenience of reference only and shall not, for any purpose, be
deemed a part of this Warrant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.15
<B><U>Warrant Agent Agreement</U></B>. If this Warrant is held in global form through DTC (or any successor depositary), this Warrant
is issued subject to the Warrant Agent Agreement. To the extent any provision of this Warrant conflicts with the express provisions of
the Warrant Agent Agreement, the provisions of this Warrant shall govern and be controlling.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">********************</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>[Investor
Registered Series A Warrant Signature Page Follows]</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 19; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>[Investor
Registered Series A Warrant Signature Page]</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">IN
WITNESS WHEREOF, the Company has caused this Registered Warrant to be executed by its officer thereunto duly authorized as of the date
first above indicated.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">AGEAGLE
    AERIAL SYSTEMS, INC.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 5%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 45%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">William
    Irby</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Its:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief
    Executive Officer</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 20; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Exhibit
2.1</U></FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-transform: uppercase; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">NOTICE
OF EXRCISE</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: top; text-align: left">
  <TD STYLE="font-family: Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">TO:</FONT></TD>
  <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">AGEAGLE AERIAL SYSTEMS,
  INC.</FONT></TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 0.5in; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                            undersigned hereby elects to purchase ________ Warrant Shares of the Company pursuant to
                                            the terms of the attached Warrant (only if exercised in full), and tenders herewith payment
                                            of the exercise price in full, together with all applicable transfer taxes, if any.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Payment
                                            shall take the form of (check applicable box):</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[
] in lawful money of the United States.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[
] if permitted the cancellation of such number of Warrant Shares as is necessary, in accordance with the formula set forth in subsection
2.3, to exercise this Warrant with respect to the maximum number of Warrant Shares purchasable pursuant to the cashless exercise procedure
set forth in subsection 2.3.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 0.5in; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Please
                                            issue said Warrant Shares in the name of the undersigned or in such other name as is specified
                                            below:</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">_______________________________</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                            Warrant Shares shall be delivered to the following DWAC Account Number:</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"></P></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">_______________________________</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">_______________________________</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">_______________________________</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 21; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->21<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[SIGNATURE
OF HOLDER]</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name
    of Investing Entity:</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Signature
    of Authorized Signatory of Investing Entity</I>:</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name
    of Authorized Signatory:</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title
    of Authorized Signatory:</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date:</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 22; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->22<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Exhibit
2.4.6</U></FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-transform: uppercase; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ASSIGNMENT
FORM</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(To
assign the foregoing Warrant, execute this form and supply required information. Do not use this form to exercise the Warrant to purchase
shares of Common Stock.)</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">FOR
VALUE RECEIVED, the foregoing Warrant and all rights evidenced thereby are hereby assigned to</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Address:</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Phone
    Number:</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Email
    Address:</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date:</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Holder&rsquo;s
    Signature</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Holder&rsquo;s
    Address</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 23; Options: Last -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->23<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-4.3
<SEQUENCE>5
<FILENAME>ex4-3.htm
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-transform: uppercase; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-transform: uppercase; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: none">Exhibit
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.3</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-transform: uppercase; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-transform: uppercase; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">SERIES
B WARRANT TO PURCHASE COMMON STOCK</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-transform: uppercase; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-transform: uppercase; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">AGEAGLE
AERIAL SYSTEMS, INC.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Warrant
    Shares: [&#9679;]</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Initial
    Exercise Date: [&#9679;], 2024</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">CUSIP:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Issue
    Date: [&#9679;], 2024</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ISIN:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>THIS
WARRANT TO PURCHASE COMMON STOCK</B> (the &ldquo;<B><U>Warrant</U></B>&rdquo;) certifies that, for value received, [&#9679;] or its assigns
(the &ldquo;<B><U>Holder</U></B>&rdquo;) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter
set forth, at any time on or after the Initial Exercise Date and on or prior to 5:00 p.m. (New York City time) on [&#9679;], 2029 (the
&ldquo;<B><U>Termination Date</U></B>&rdquo;) but not thereafter, to subscribe for and purchase from AgEagle Aerial Systems, Inc., a
Nevada corporation (the &ldquo;<B><U>Company</U></B>&rdquo;), up to [&#9679;] shares (as subject to adjustment hereunder, the &ldquo;<B><U>Warrant
Shares</U></B>&rdquo;) of Common Stock. The purchase price of one (1) share of Common Stock under this Series B Warrant (this &ldquo;<B><U>Warrant</U></B>&rdquo;)
shall be equal to the Exercise Price, as defined in Section &lrm;2.2. This Warrant shall initially be issued and maintained in the form
of a security held in book-entry form and the Depository Trust Company or its nominee (&ldquo;<B><U>DTC</U></B>&rdquo;) shall initially
be the sole registered holder of this Warrant, subject to a Holder&rsquo;s right to elect to receive a Warrant in certificated form pursuant
to the terms of the Warrant Agent Agreement, in which case this sentence shall not apply.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.
<B><U>Definitions</U></B>. In addition to the terms defined elsewhere in this Warrant or in the Placement Agency Agreement dated [&#9679;],
2024, the following terms have the meanings indicated in this Section &lrm;1:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.1
&ldquo;<B><U>Affiliate</U></B>&rdquo; means any Person that, directly or indirectly through one or more intermediaries, controls or is
controlled by or is under common control with a Person, as such terms are used in and construed under Rule 405 under the Securities Act.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.2
&ldquo;<B><U>Bid Price</U></B>&rdquo; means, for any date, the price determined by the first of the following clauses that applies: (a)
if the Common Stock is then listed or quoted on a Trading Market, the bid price of the Common Stock for the time in question (or the
nearest preceding date) on the Trading Market on which the Common Stock is then listed or quoted as reported by Bloomberg L.P. (based
on a Trading Day from 9:30 a.m. (New York City time) to 4:02 p.m. (New York City time)), (b) if OTCQB or OTCQX is not a Trading Market,
the volume weighted average price of the Common Stock for such date (or the nearest preceding date) on OTCQB or OTCQX as applicable,
(c) if the Common Stock is not then listed or quoted for trading on OTCQB or OTCQX and if prices for the Common Stock are then reported
on the Pink Open Market (or a similar organization or agency succeeding to its functions of reporting prices), the most recent bid price
per share of Common Stock so reported, or (d) in all other cases, the fair market value of a share of Common Stock as determined by an
independent appraiser selected in good faith by the Holders of a majority in interest of the Warrants then outstanding and reasonably
acceptable to the Company, the fees and expenses of which shall be paid by the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.3
&ldquo;<B><U>Board of Directors</U></B>&rdquo; means the board of directors of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 1; Options: NewSection; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.4
&ldquo;<B><U>Business Day</U></B>&rdquo; means any day other than Saturday, Sunday or other day on which commercial banks in The City
of New York are authorized or required by law to remain closed; <U>provided</U>, <U>however</U>, for clarification, commercial banks
shall not be deemed to be authorized or required by law to remain closed due to &ldquo;stay at home&rdquo;, &ldquo;shelter-in-place&rdquo;,
&ldquo;non-essential employee&rdquo; or any other similar orders or restrictions or the closure of any physical branch locations at the
direction of any governmental authority so long as the electronic funds transfer systems (including for wire transfers) of commercial
banks in The City of New York generally are open for use by customers on such day.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.5
&ldquo;<B><U>Commission</U></B>&rdquo; means the United States Securities and Exchange Commission.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.6
&ldquo;<B><U>Common Stock</U></B>&rdquo; means the common stock of the Company, $0.001 par value per share, and any other class of securities
into which such securities may hereafter be reclassified or changed.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.7
&ldquo;<B><U>Common Stock Equivalents</U></B>&rdquo; means any securities of the Company or the Subsidiaries which would entitle the
holder thereof to acquire at any time Common Stock, including, without limitation, any debt, preferred stock, right, option, warrant
or other instrument that is at any time convertible into or exercisable or exchangeable for, or otherwise entitles the holder thereof
to receive, Common Stock.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.8
&ldquo;<B><U>Exchange Act</U></B>&rdquo; means the Securities Exchange Act of 1934, as amended, and the rules and regulations promulgated
thereunder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.9
&ldquo;<B><U>Person</U></B>&rdquo; means an individual or corporation, partnership, trust, incorporated or unincorporated association,
joint venture, limited liability company, joint stock company, government (or an agency or subdivision thereof) or other entity of any
kind.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.10
<B><U>Placement Agency Agreement</U></B>&rdquo; means the placement agency agreement, dated as of [&#9679;], 2024, between the Company
and Spartan Capital Securities, LLC, as amended, modified or supplemented from time to time in accordance with its terms.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.11
&ldquo;<B><U>Registration Statement</U></B>&rdquo; means the Company&rsquo;s registration statement on Form S-1 (File No. 333-281897).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.12
&ldquo;<B><U>Securities Act</U></B>&rdquo; means the Securities Act of 1933, as amended, and the rules and regulations promulgated thereunder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.13
&ldquo;<B><U>Stockholder Approval</U></B>&rdquo; means such approval as may be required by the applicable rules and regulations of the
NYSE American (or any successor entity) from the stockholders of the Company, or board of directors in lieu thereof, with respect to
issuance of all of the Warrants and the Warrant Shares upon the exercise thereof, including without limitation:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.13.1.
to render inapplicable clause (i) of the definition of the Floor Price in Section &lrm;3.2 hereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.13.2.
to give full effect to the adjustment in the exercise price and number of Warrant Shares following a Dilutive Issuance pursuant to Section
&lrm;3.2.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 2; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.13.3.
to consent to any adjustment to the exercise price or number of shares of Common Stock underlying the Warrants in the event of a Share
Combination Event pursuant to Section &lrm;3.10.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.13.4.
to consent to the voluntary adjustment, from time to time, of the exercise price of any and all currently outstanding warrants pursuant
to Section &lrm;3.11.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.14
&ldquo;<B><U>Subsidiary</U></B>&rdquo; means any subsidiary of the Company and shall, where applicable, also include any direct or indirect
subsidiary of the Company formed or acquired after the date hereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.15
&ldquo;<B><U>Trading Day</U></B>&rdquo; means a day on which the Common Stock is traded on a Trading Market.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.16
&ldquo;<B><U>Trading Market</U></B>&rdquo; means any of the following markets or exchanges on which the Common Stock is listed or quoted
for trading on the date in question: the NYSE American, the Nasdaq Capital Market, the Nasdaq Global Market, the Nasdaq Global Select
Market, the New York Stock Exchange, OTCQB or OTCQX (or any successors to any of the foregoing).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.17
&ldquo;<B><U>Transfer Agent</U></B>&rdquo; means Equiniti Trust Company, the current transfer agent of the Company, with a mailing address
of 1110 Centre Pointe Curve, Suite 101, Mendota Heights, Minnesota 55120 and an email address of issuerservices@equiniti.com, and any
successor transfer agent of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.18
&ldquo;<B><U>Variable Rate Transaction</U></B>&rdquo; means a transaction in which the Company (i) issues or sells any debt or equity
securities that are convertible into, exchangeable or exercisable for, or include the right to receive, additional shares of Common Stock
either (A) at a conversion price, exercise price or exchange rate or other price that is based upon, and/or varies with, the trading
prices of or quotations for the shares of Common Stock at any time after the initial issuance of such debt or equity securities or (B)
with a conversion, exercise or exchange price that is subject to being reset at some future date after the initial issuance of such debt
or equity security or upon the occurrence of specified or contingent events directly or indirectly related to the business of the Company
or the market for the shares of Common Stock or (ii) enters into, or effects a transaction under, any agreement, including, but not limited
to, an equity line of credit, whereby the Company may issue securities at a future determined price.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.19
&ldquo;<B><U>VWAP</U></B>&rdquo; means, for any date, the price determined by the first of the following clauses that applies: (a) if
the Common Stock is then listed or quoted on a Trading Market, the daily volume weighted average price of the Common Stock for such date
(or the nearest preceding date) on the Trading Market on which the Common Stock is then listed or quoted as reported by Bloomberg L.P.
(based on a Trading Day from 9:30 a.m. (New York City time) to 4:02 p.m. (New York City time)), (b) if OTCQB or OTCQX is not a Trading
Market, the volume weighted average price of the Common Stock for such date (or the nearest preceding date) on OTCQB or OTCQX as applicable,
(c) if the Common Stock is not then listed or quoted for trading on OTCQB or OTCQX and if prices for the Common Stock are then reported
on the Pink Open Market (or a similar organization or agency succeeding to its functions of reporting prices), the most recent bid price
per share of Common Stock so reported, or (d) in all other cases, the fair market value of a share of Common Stock as determined by an
independent appraiser selected in good faith by the holders of a majority in interest of the Warrants then outstanding and reasonably
acceptable to the Company, the fees and expenses of which shall be paid by the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 3; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.20
&ldquo;<B><U>Warrant Agent Agreement</U></B>&rdquo; means that certain Warrant Agent agreement, dated on or about the Initial Exercise
Date, between the Company and the Warrant Agent.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.21
&ldquo;<B><U>Warrant Agent</U></B>&rdquo; means the Transfer Agent and any successor warrant agent of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.22
&ldquo;<B><U>Warrants</U></B>&rdquo; means this Warrant and other Common Stock purchase warrants issued by the Company pursuant to the
Registration Statement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.
<B><U>Exercise</U></B>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.1
<B><U>Exercise of Warrant</U></B>. Subject to the provisions of Section 2.5 herein, exercise of the purchase rights represented by this
Warrant may be made, in whole or in part, at any time or times on or after the Initial Exercise Date and on or before the Termination
Date by delivery to the Company of a duly executed PDF copy submitted by e-mail (or e-mail attachment) of the Notice of Exercise substantially
in the form attached hereto as Exhibit <U>&lrm;2.1</U> (the &ldquo;<B><U>Notice of Exercise</U></B>&rdquo;). Within the earlier of (i)
two (2) Trading Days and (ii) the number of Trading Days comprising the Standard Settlement Period (as defined in Section &lrm;2.4.1
herein) following the date of exercise as aforesaid, the Holder shall deliver the aggregate Exercise Price for the Warrant Shares specified
in the applicable Notice of Exercise by wire transfer or cashier&rsquo;s check drawn on a United States bank unless the cashless exercise
procedure specified in Section &lrm;2.3 below is specified in the applicable Notice of Exercise. No ink-original Notice of Exercise shall
be required, nor shall any medallion guarantee (or other type of guarantee or notarization) of any Notice of Exercise be required. Notwithstanding
anything herein to the contrary, the Holder shall not be required to physically surrender this Warrant to the Company until the Holder
has purchased all of the Warrant Shares available hereunder and the Warrant has been exercised in full, in which case, the Holder shall
surrender this Warrant to the Company for cancellation within three (3) Trading Days of the date on which the final Notice of Exercise
is delivered to the Company. Partial exercises of this Warrant resulting in purchases of a portion of the total number of Warrant Shares
available hereunder shall have the effect of lowering the outstanding number of Warrant Shares purchasable hereunder in an amount equal
to the applicable number of Warrant Shares purchased. The Holder and the Company shall maintain records showing the number of Warrant
Shares purchased and the date of such purchases. The Company shall deliver any objection to any Notice of Exercise within one (1) Trading
Day of receipt of such notice. <B>The Holder and any assignee, by acceptance of this Warrant, acknowledge and agree that, by reason of
the provisions of this paragraph, following the purchase of a portion of the Warrant Shares hereunder, the number of Warrant Shares available
for purchase hereunder at any given time may be less than the amount stated on the face hereof.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Notwithstanding
the foregoing in this Section &lrm;2.1, a holder whose interest in this Warrant is a beneficial interest in certificate(s) representing
this Warrant held in book-entry form through DTC (or another established clearing corporation performing similar functions), shall effect
exercises made pursuant to this Section &lrm;2.1 by delivering to DTC (or such other clearing corporation, as applicable) the appropriate
instruction form for exercise, complying with the procedures to effect exercise that are required by DTC (or such other clearing corporation,
as applicable), subject to a Holder&rsquo;s right to elect to receive a Warrant in certificated form pursuant to the terms of the Warrant
Agent Agreement, in which case this sentence shall not apply.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 4; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.2
<B><U>Exercise Price</U></B>. The exercise price per Warrant Share shall be $[&#9679;], subject to adjustment hereunder (the &ldquo;<B><U>Exercise
Price</U></B>&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.3
<B><U>Cashless Exercise</U></B>. If at the time of exercise hereof there is no effective registration statement registering, or the prospectus
contained therein is not available for the issuance of the Warrant Shares to the Holder or the resale of the Warrant Shares by the Holder,
then this Warrant may also be exercised, in whole or in part, at such time by means of a &ldquo;cashless exercise&rdquo; in which the
Holder shall be entitled to receive a number of Warrant Shares equal to the quotient obtained by dividing [(A-B) (X)] by (A), where:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="width: 0.5in">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(A)
    =</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">as
    applicable: (i) the VWAP on the Trading Day immediately preceding the date of the applicable Notice of Exercise if such Notice of
    Exercise is (1) both executed and delivered pursuant to Section 2.1 hereof on a day that is not a Trading Day or (2) both executed
    and delivered pursuant to Section 2.1 hereof on a Trading Day prior to the opening of &ldquo;regular trading hours&rdquo; (as defined
    in Rule 600(b) of Regulation NMS promulgated under the federal securities laws) on such Trading Day, (ii) at the option of the Holder,
    either (y) the VWAP on the Trading Day immediately preceding the date of the applicable Notice of Exercise or (z) the Bid Price of
    the Common Stock on the principal Trading Market as reported by Bloomberg L.P. as of the time of the Holder&rsquo;s execution of
    the applicable Notice of Exercise if such Notice of Exercise is executed during &ldquo;regular trading hours&rdquo; on a Trading
    Day and is delivered within two (2) hours thereafter (including until two (2) hours after the close of &ldquo;regular trading hours&rdquo;
    on a Trading Day) pursuant to Section 2.1 hereof or (iii) the VWAP on the date of the applicable Notice of Exercise if the date of
    such Notice of Exercise is a Trading Day and such Notice of Exercise is both executed and delivered pursuant to Section 2.1 hereof
    after the close of &ldquo;regular trading hours&rdquo; on such Trading Day;</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(B)
    =</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    Exercise Price of this Warrant, as adjusted hereunder; and</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(X)
    =</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    number of Warrant Shares that would be issuable upon exercise of this Warrant in accordance with the terms of this Warrant if such
    exercise were by means of a cash exercise rather than a cashless exercise.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
Warrant Shares are issued in such a cashless exercise, the parties acknowledge and agree that in accordance with Section 3(a)(9) of the
Securities Act, the Warrant Shares shall take on the registered characteristics of the Warrants being exercised, and the holding period
of the Warrant Shares being issued may be tacked on to the holding period of this Warrant. Assuming (i) the Holder is not an Affiliate
of the Company, and (ii) all of the applicable conditions of Rule 144 promulgated under the Securities Act with respect to Holder and
the Warrant Shares are met in the case of such a cashless exercise, the Company agrees that the Company will cause the removal of the
legend from such Warrant Shares (including by delivering an opinion of the Company&rsquo;s counsel to the Company&rsquo;s transfer agent
at its own expense to ensure the foregoing), and the Company agrees that the Holder is under no obligation to sell the Warrant Shares
issuable upon the exercise of the Warrant prior to removing the legend. The Company agrees not to take any position contrary to this
Section &lrm;2.3.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 5; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Notwithstanding
anything herein to the contrary, on the Termination Date, this Warrant shall be automatically exercised via cashless exercise pursuant
to this Section &lrm;2.3.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.4
<B><U>Mechanics of Exercise</U></B>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.4.1.
<B><U>Delivery of Warrant Shares upon Exercise</U></B>. The Company shall cause the Warrant Shares purchased hereunder to be transmitted
by the Transfer Agent to the Holder by crediting the account of the Holder&rsquo;s or its designee&rsquo;s balance account with The Depository
Trust Company through its Deposit or Withdrawal at Custodian system (&ldquo;<B><U>DWAC</U></B>&rdquo;) if the Company is then a participant
in such system and either (A) there is an effective registration statement permitting the issuance of the Warrant Shares to or resale
of the Warrant Shares by Holder or (B) the Warrant Shares are eligible for resale by the Holder without volume or manner-of-sale limitations
pursuant to Rule 144 (assuming cashless exercise of the Warrants), and otherwise by physical delivery of a certificate, for the number
of Warrant Shares to which the Holder is entitled pursuant to such exercise to the address specified by the Holder in the Notice of Exercise
by the date that is the earliest of (i) two (2) Trading Days after the delivery to the Company of the Notice of Exercise, (ii) one (1)
Trading Day after delivery of the aggregate Exercise Price to the Company and (iii) the number of Trading Days comprising the Standard
Settlement Period after the delivery to the Company of the Notice of Exercise (such date, the &ldquo;<B><U>Warrant Share Delivery Date</U></B>&rdquo;).
Upon delivery of the Notice of Exercise, the Holder shall be deemed for all corporate purposes to have become the holder of record of
the Warrant Shares with respect to which this Warrant has been exercised, irrespective of the date of delivery of the Warrant Shares,
provided that payment of the aggregate Exercise Price (other than in the case of a cashless exercise) is received within the earlier
of (i) two (2) Trading Days and (ii) the number of Trading Days comprising the Standard Settlement Period following delivery of the Notice
of Exercise. Notwithstanding anything herein to the contrary, upon delivery of the Notice of Exercise, the Holder shall be deemed for
purposes of Regulation SHO under the Exchange Act to have become the holder of the Warrant Shares irrespective of the date of delivery
of the Warrant Shares. If the Company fails for any reason (other than the failure of the Holder to timely deliver the aggregate Exercise
Price, unless the Warrant is validly exercised by means of a cashless exercise) to deliver to the Holder the Warrant Shares subject to
a Notice of Exercise by the Warrant Share Delivery Date, the Company shall pay to the Holder, in cash, as liquidated damages and not
as a penalty, for each $1,000 of Warrant Shares subject to such exercise (based on the VWAP of the Common Stock on the date of the applicable
Notice of Exercise), $10 per Trading Day (increasing to $20 per Trading Day on the third (3rd) Trading Day after the Warrant Share Delivery
Date) for each Trading Day after such Warrant Share Delivery Date until such Warrant Shares are delivered or Holder rescinds such exercise.
The Company agrees to maintain a Transfer Agent that is a participant in the FAST program so long as this Warrant remains outstanding
and exercisable. As used herein, &ldquo;<B><U>Standard Settlement Period</U></B>&rdquo; means the standard settlement period, expressed
in a number of Trading Days, on the Company&rsquo;s primary Trading Market with respect to the Common Stock as in effect on the date
of delivery of the Notice of Exercise. Notwithstanding the foregoing, with respect to any Notice(s) of Exercise delivered on or prior
to 12:00 p.m. (New York City time) on the Initial Exercise Date, which may be delivered at any time after the time of execution of the
Placement Agency Agreement, the Company agrees to deliver the Warrant Shares subject to such notice(s) by 4:00 p.m. (New York City time)
on the Initial Exercise Date and the Initial Exercise Date shall be the Warrant Share Delivery Date for purposes hereunder, provided
that payment of the aggregate Exercise Price (other than in the case of a cashless exercise) is received by such Warrant Share Delivery
Date.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 6; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.4.2.
<B><U>Delivery of New Warrants Upon Exercise</U></B>. If this Warrant shall have been exercised in part, the Company shall, at the request
of a Holder and upon surrender of this Warrant certificate, at the time of delivery of the Warrant Shares, deliver to the Holder a new
Warrant evidencing the rights of the Holder to purchase the unpurchased Warrant Shares called for by this Warrant, which new Warrant
shall in all other respects be identical with this Warrant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.4.3.
<B><U>Rescission Rights</U></B>. If the Company fails to cause the Transfer Agent to transmit to the Holder the Warrant Shares pursuant
to Section &lrm;2.4.1 by the Warrant Share Delivery Date, then the Holder will have the right to rescind such exercise; provided, however,
that the Holder shall be required to return any Warrant Shares subject to any such rescinded exercise notice concurrently with the return
to Holder of the aggregate Exercise Price paid to the Company for such Warrant Shares and the restoration of Holder&rsquo;s right to
acquire such Warrant Shares pursuant to this Warrant (including, issuance of a replacement warrant certificate evidencing such restored
right).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.4.4.
<B><U>Compensation for Buy-In on Failure to Timely Deliver Warrant Shares upon Exercise</U></B>. In addition to any other rights available
to the Holder, if the Company fails to cause the Transfer Agent to transmit to the Holder the Warrant Shares in accordance with the provisions
of Section &lrm;2.4.1 above pursuant to an exercise on or before the Warrant Share Delivery Date (other than the failure of the Holder
to timely deliver the aggregate Exercise Price, unless the Warrant is validly exercised by means of a cashless exercise), and if after
such date the Holder is required by its broker to purchase (in an open market transaction or otherwise) or the Holder&rsquo;s brokerage
firm otherwise purchases, shares of Common Stock to deliver in satisfaction of a sale by the Holder of the Warrant Shares which the Holder
anticipated receiving upon such exercise (a &ldquo;<B><U>Buy-In</U></B>&rdquo;), then the Company shall (A) pay in cash to the Holder
the amount, if any, by which (x) the Holder&rsquo;s total purchase price (including brokerage commissions, if any) for the shares of
Common Stock so purchased exceeds (y) the amount obtained by multiplying (1) the number of Warrant Shares that the Company was required
to deliver to the Holder in connection with the exercise at issue times (2) the price at which the sell order giving rise to such purchase
obligation was executed, and (B) at the option of the Holder, either reinstate the portion of the Warrant and equivalent number of Warrant
Shares for which such exercise was not honored and return any amount received by the Company in respect of the Exercise Price for those
Warrant Shares (in which case such exercise shall be deemed rescinded) or deliver to the Holder the number of shares of Common Stock
that would have been issued had the Company timely complied with its exercise and delivery obligations hereunder. For example, if the
Holder purchases Common Stock having a total purchase price of $11,000 to cover a Buy-In with respect to an attempted exercise of shares
of Common Stock with an aggregate sale price giving rise to such purchase obligation of $10,000, under clause (A) of the immediately
preceding sentence the Company shall be required to pay the Holder $1,000. The Holder shall provide the Company written notice indicating
the amounts payable to the Holder in respect of the Buy-In and, upon request of the Company, evidence of the amount of such loss. Nothing
herein shall limit a Holder&rsquo;s right to pursue any other remedies available to it hereunder, at law or in equity including, without
limitation, a decree of specific performance and/or injunctive relief with respect to the Company&rsquo;s failure to timely deliver shares
of Common Stock upon exercise of the Warrant as required pursuant to the terms hereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 7; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.4.5.
<B><U>No Fractional Shares or Scrip</U></B>. No fractional shares or scrip representing fractional shares shall be issued upon the exercise
of this Warrant. As to any fraction of a share which the Holder would otherwise be entitled to purchase upon such exercise, the Company
shall, at its election, either pay a cash adjustment in respect of such final fraction in an amount equal to such fraction multiplied
by the Exercise Price or round up to the next whole share.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.4.6.
<B><U>Charges, Taxes and Expenses</U></B>. Issuance of Warrant Shares shall be made without charge to the Holder for any issue or transfer
tax or other incidental expense in respect of the issuance of such Warrant Shares, all of which taxes and expenses shall be paid by the
Company, and such Warrant Shares shall be issued in the name of the Holder or in such name or names as may be directed by the Holder;
<U>provided</U>, <U>however</U>, that, in the event that Warrant Shares are to be issued in a name other than the name of the Holder,
this Warrant when surrendered for exercise shall be accompanied by the Assignment Form attached hereto as <U>Exhibit &lrm;2.4.6</U> duly
executed by the Holder and the Company may require, as a condition thereto, the payment of a sum sufficient to reimburse it for any transfer
tax incidental thereto. The Company shall pay all Transfer Agent fees required for same-day processing of any Notice of Exercise and
all fees to the Depository Trust Company (or another established clearing corporation performing similar functions) required for same-day
electronic delivery of the Warrant Shares.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.4.7.
<B><U>Closing of Books</U></B>. The Company will not close its stockholder books or records in any manner which prevents the timely exercise
of this Warrant, pursuant to the terms hereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 8; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.5
<B><U>Holder&rsquo;s Exercise Limitations</U></B>. The Company shall not effect any exercise of this Warrant, and a Holder shall not
have the right to exercise any portion of this Warrant, pursuant to Section &lrm;2 or otherwise, to the extent that after giving effect
to such issuance after exercise as set forth on the applicable Notice of Exercise, the Holder (together with the Holder&rsquo;s Affiliates,
and any other Persons acting as a group together with the Holder or any of the Holder&rsquo;s Affiliates (such Persons, &ldquo;<B><U>Attribution
Parties</U></B>&rdquo;)), would beneficially own in excess of the Beneficial Ownership Limitation (as defined below). For purposes of
the foregoing sentence, the number of shares of Common Stock beneficially owned by the Holder and its Affiliates and Attribution Parties
shall include the number of shares of Common Stock issuable upon exercise of this Warrant with respect to which such determination is
being made, but shall exclude the number of shares of Common Stock which would be issuable upon (i) exercise of the remaining, unexercised
portion of this Warrant beneficially owned by the Holder or any of its Affiliates or Attribution Parties and (ii) exercise or conversion
of the unexercised or unconverted portion of any other securities of the Company (including, without limitation, any other Common Stock
Equivalents) subject to a limitation on conversion or exercise analogous to the limitation contained herein beneficially owned by the
Holder or any of its Affiliates or Attribution Parties. Except as set forth in the preceding sentence, for purposes of this Section &lrm;2.5,
beneficial ownership shall be calculated in accordance with Section 13(d) of the Exchange Act and the rules and regulations promulgated
thereunder, it being acknowledged by the Holder that the Company is not representing to the Holder that such calculation is in compliance
with Section 13(d) of the Exchange Act and the Holder is solely responsible for any schedules required to be filed in accordance therewith.
To the extent that the limitation contained in this Section &lrm;2.5 applies, the determination of whether this Warrant is exercisable
(in relation to other securities owned by the Holder together with any Affiliates and Attribution Parties) and of which portion of this
Warrant is exercisable shall be in the sole discretion of the Holder, and the submission of a Notice of Exercise shall be deemed to be
the Holder&rsquo;s determination of whether this Warrant is exercisable (in relation to other securities owned by the Holder together
with any Affiliates and Attribution Parties) and of which portion of this Warrant is exercisable, in each case subject to the Beneficial
Ownership Limitation, and the Company shall have no obligation to verify or confirm the accuracy of such determination. In addition,
a determination as to any group status as contemplated above shall be determined in accordance with Section 13(d) of the Exchange Act
and the rules and regulations promulgated thereunder. For purposes of this Section &lrm;2.5, in determining the number of outstanding
shares of Common Stock, a Holder may rely on the number of outstanding shares of Common Stock as reflected in (A) the Company&rsquo;s
most recent periodic or annual report filed with the Commission, as the case may be, (B) a more recent public announcement by the Company
or (C) a more recent written notice by the Company or the Transfer Agent setting forth the number of shares of Common Stock outstanding.
Upon the written or oral request of a Holder, the Company shall within one (1) Trading Day confirm orally and in writing to the Holder
the number of shares of Common Stock then outstanding. In any case, the number of outstanding shares of Common Stock shall be determined
after giving effect to the conversion or exercise of securities of the Company, including this Warrant, by the Holder or its Affiliates
or Attribution Parties since the date as of which such number of outstanding shares of Common Stock was reported. The &ldquo;<B><U>Beneficial
Ownership Limitation</U></B>&rdquo; shall be 4.99% (or, upon election by a Holder prior to the issuance of any Warrants, 9.99%) of the
number of shares of Common Stock outstanding immediately after giving effect to the issuance of shares of Common Stock issuable upon
exercise of this Warrant. The Holder, upon notice to the Company, may increase or decrease the Beneficial Ownership Limitation provisions
of this Section &lrm;2.5, provided that the Beneficial Ownership Limitation in no event exceeds 9.99% of the number of shares of Common
Stock outstanding immediately after giving effect to the issuance of shares of Common Stock upon exercise of this Warrant held by the
Holder and the provisions of this Section &lrm;2.5 shall continue to apply. Any increase in the Beneficial Ownership Limitation will
not be effective until the 61<SUP>st</SUP> day after such notice is delivered to the Company. The provisions of this paragraph shall
be construed and implemented in a manner otherwise than in strict conformity with the terms of this Section &lrm;2.5 to correct this
paragraph (or any portion hereof) which may be defective or inconsistent with the intended Beneficial Ownership Limitation herein contained
or to make changes or supplements necessary or desirable to properly give effect to such limitation. The limitations contained in this
paragraph shall apply to a successor holder of this Warrant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 9; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.
<B><U>Certain Adjustments</U></B>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.1
<B><U>Stock Dividends and Splits</U></B>. If the Company, at any time while this Warrant is outstanding: (i) pays a stock dividend or
otherwise makes a distribution or distributions on shares of Common Stock or any other equity or equity equivalent securities payable
in shares of Common Stock (which, for avoidance of doubt, shall not include any shares of Common Stock issued by the Company upon exercise
of this Warrant), (ii) subdivides outstanding shares of Common Stock into a larger number of shares, (iii) combines (including by way
of reverse stock split) outstanding shares of Common Stock into a smaller number of shares, or (iv) issues by reclassification of shares
of Common Stock any shares of capital stock of the Company, then in each case the Exercise Price shall be multiplied by a fraction of
which the numerator shall be the number of shares of Common Stock (excluding treasury shares, if any) outstanding immediately before
such event and of which the denominator shall be the number of shares of Common Stock outstanding immediately after such event, and the
number of Shares issuable upon exercise of this Warrant shall be proportionately adjusted such that the aggregate Exercise Price of this
Warrant shall remain unchanged. Any adjustment made pursuant to this Section &lrm;3.1 shall become effective immediately after the record
date for the determination of stockholders entitled to receive such dividend or distribution and shall become effective immediately after
the effective date in the case of a subdivision, combination or re-classification.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.2
<B><U>Subsequent Equity Sales</U></B>. If the Company or any Subsidiary thereof, as applicable, at any time while this Warrant is outstanding,
shall sell, enter into an agreement to sell, or grant any option to purchase, or sell, enter into an agreement to sell, or grant any
right to reprice, or otherwise dispose of or issue (or announce any offer, sale, grant or any option to purchase or other disposition)
any shares of Common Stock or Common Stock Equivalents, at an effective price per share less than the Exercise Price then in effect (such
lower price, the &ldquo;<B><U>Base Share Price</U></B>&rdquo; and such issuances collectively, a &ldquo;<B><U>Dilutive Issuance</U></B>&rdquo;)
(it being understood and agreed that if the holder of the shares of Common Stock or share of Common Stock Equivalents or such other securities
so issued shall at any time, whether by operation of purchase price adjustments, reset provisions, floating conversion, exercise or exchange
prices or otherwise, or due to warrants, options or rights per share which are issued in connection with such issuance, be entitled to
receive shares of Common Stock at an effective price per share that is less than the Exercise Price, such issuance shall be deemed to
have occurred for less than the Exercise Price on such date of the Dilutive Issuance at such effective price), then simultaneously with
the consummation (or, if earlier, the announcement (provided such Dilutive Issuance occurs)) of each Dilutive Issuance the Exercise Price
shall be reduced and only reduced to equal the Base Share Price <B>and the number of Warrant Shares issuable hereunder shall be increased
such that the aggregate Exercise Price payable hereunder, after taking into account the decrease in the Exercise Price, shall be equal
to the aggregate Exercise Price on the Issuance Date</B>, provided that the Base Share Price shall not be less than (i) $[&#9679;] or
(ii) in the event of Stockholder Approval, the price of the Dilutive Issuance (the &ldquo;<B><U>Floor Price</U></B>&rdquo;) (subject
to adjustment for reverse and forward stock splits, recapitalizations and similar transactions following the date of the Placement Agency
Agreement). Notwithstanding the foregoing, (i) no adjustments shall be made, paid or issued under this Section 3.2 in respect of an Exempt
Issuance and (ii) if one or more Dilutive Issuances occurred prior to the Stockholder Approval being obtained and the reduction of the
Exercise Price was limited by clause (i) of the definition of Floor Price, once the Stockholder Approval is obtained, the Exercise Price
will automatically be reduced to equal the greater of (x) the lowest Base Share Price with respect to any Dilutive Issuance that occurred
prior to the Stockholder Approval being obtained, and (y) the price determined by reference to clause (ii) of the definition of Floor
Price. The Company shall notify the Holder, in writing, no later than the Trading Day following the issuance or deemed issuance of any
shares of Common Stock or share of Common Stock Equivalents subject to this Section 3(b), indicating therein the applicable issuance
price, or applicable reset price, exchange price, conversion price and other pricing terms (such notice, the &ldquo;<B><U>Dilutive Issuance
Notice</U></B>&rdquo;). For purposes of clarification, whether or not the Company provides a Dilutive Issuance Notice pursuant to this
Section 3(b), upon the occurrence of any Dilutive Issuance, the Holder is entitled to receive a number of Warrant Shares based upon the
Base Share Price regardless of whether the Holder accurately refers to the Base Share Price in the Notice of Exercise. If the Company
enters into a Variable Rate Transaction, the Company shall be deemed to have issued shares of Common Stock or share of Common Stock Equivalents
at the lowest possible price, conversion price or exercise price at which such securities may be issued, converted or exercised.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 10; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.3
<B><U>Subsequent Rights Offerings</U></B>. In addition to any adjustments pursuant to Section &lrm;3.1 above, if at any time the Company
grants, issues or sells any Common Stock Equivalents or rights to purchase stock, warrants, securities or other property pro rata to
all (or substantially all) of the record holders of any class of shares of Common Stock (the &ldquo;<B><U>Purchase Rights</U></B>&rdquo;),
then the Holder will be entitled to acquire, upon the terms applicable to such Purchase Rights, the aggregate Purchase Rights which the
Holder could have acquired if the Holder had held the number of shares of Common Stock acquirable upon complete exercise of this Warrant
(without regard to any limitations on exercise hereof, including without limitation, the Beneficial Ownership Limitation) immediately
before the date on which a record is taken for the grant, issuance or sale of such Purchase Rights, or, if no such record is taken, the
date as of which the record holders of shares of Common Stock are to be determined for the grant, issue or sale of such Purchase Rights
(provided, however, that, to the extent that the Holder&rsquo;s right to participate in any such Purchase Right would result in the Holder
exceeding the Beneficial Ownership Limitation, then the Holder shall not be entitled to participate in such Purchase Right to such extent
(or beneficial ownership of such shares of Common Stock as a result of such Purchase Right to such extent) and such Purchase Right to
such extent shall be held in abeyance for the Holder until such time, if ever, as its right thereto would not result in the Holder exceeding
the Beneficial Ownership Limitation).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.4
<B><U>Pro Rata Distributions</U></B>. During such time as this Warrant is outstanding, if the Company shall declare or make any dividend
or other distribution of its assets (or rights to acquire its assets) to all (or substantially all) holders of shares of Common Stock,
by way of return of capital or otherwise (including, without limitation, any distribution of cash, stock or other securities, property
or options by way of a dividend, spin off, reclassification, corporate rearrangement, scheme of arrangement or other similar transaction)
(a &ldquo;<B><U>Distribution</U></B>&rdquo;), at any time after the issuance of this Warrant, then, in each such case, the Holder shall
be entitled to participate in such Distribution to the same extent that the Holder would have participated therein if the Holder had
held the number of shares of Common Stock acquirable upon complete exercise of this Warrant (without regard to any limitations on exercise
hereof, including without limitation, the Beneficial Ownership Limitation) immediately before the date of which a record is taken for
such Distribution, or, if no such record is taken, the date as of which the record holders of shares of Common Stock are to be determined
for the participation in such Distribution (provided, however, that, to the extent that the Holder&rsquo;s right to participate in any
such Distribution would result in the Holder exceeding the Beneficial Ownership Limitation, then the Holder shall not be entitled to
participate in such Distribution to such extent (or in the beneficial ownership of any shares of Common Stock as a result of such Distribution
to such extent) and the portion of such Distribution shall be held in abeyance for the benefit of the Holder until such time, if ever,
as its right thereto would not result in the Holder exceeding the Beneficial Ownership Limitation). To the extent that this Warrant has
not been partially or completely exercised at the time of such Distribution, such portion of the Distribution shall be held in abeyance
for the benefit of the Holder until the Holder has exercised this Warrant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 11; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.5
<B><U>Fundamental Transaction</U></B>. If, at any time while this Warrant is outstanding, (i) the Company, directly or indirectly, in
one or more related transactions effects any merger or consolidation of the Company with or into another Person, (ii) the Company or
any Subsidiary, directly or indirectly, effects any sale, lease, license, assignment, transfer, conveyance or other disposition of all
or substantially all of its assets in one or a series of related transactions, (iii) any, direct or indirect, purchase offer, tender
offer or exchange offer (whether by the Company or another Person) is completed pursuant to which holders of Common Stock are permitted
to sell, tender or exchange their shares for other securities, cash or property and has been accepted by the holders of 50% or more of
the outstanding Common Stock or 50% or more of the voting power of the common equity of the Company, (iv) the Company, directly or indirectly,
in one or more related transactions effects any reclassification, reorganization or recapitalization of the Common Stock or any compulsory
share exchange pursuant to which the Common Stock is effectively converted into or exchanged for other securities, cash or property,
or (v) the Company, directly or indirectly, in one or more related transactions consummates a stock or share purchase agreement or other
business combination (including, without limitation, a reorganization, recapitalization, spin-off, merger or scheme of arrangement) with
another Person or group of Persons whereby such other Person or group acquires 50% or more of the outstanding shares of Common Stock
or 50% or more of the voting power of the common equity of the Company (each a &ldquo;<B><U>Fundamental Transaction</U></B>&rdquo;),
then, upon any subsequent exercise of this Warrant, the Holder shall have the right to receive, for each Warrant Share that would have
been issuable upon such exercise immediately prior to the occurrence of such Fundamental Transaction, at the option of the Holder (without
regard to any limitation in Section &lrm;2.5 on the exercise of this Warrant), the number of shares of Common Stock of the successor
or acquiring corporation or of the Company, if it is the surviving corporation, and any additional consideration (the &ldquo;<B><U>Alternate
Consideration</U></B>&rdquo;) receivable as a result of such Fundamental Transaction by a holder of the number of shares of Common Stock
for which this Warrant is exercisable immediately prior to such Fundamental Transaction (without regard to any limitation in Section
&lrm;2.5 on the exercise of this Warrant). For purposes of any such exercise, the determination of the Exercise Price shall be appropriately
adjusted to apply to such Alternate Consideration based on the amount of Alternate Consideration issuable in respect of one share of
Common Stock in such Fundamental Transaction, and the Company shall apportion the Exercise Price among the Alternate Consideration in
a reasonable manner reflecting the relative value of any different components of the Alternate Consideration. If holders of Common Stock
are given any choice as to the securities, cash or property to be received in a Fundamental Transaction, then the Holder shall be given
the same choice as to the Alternate Consideration it receives upon any exercise of this Warrant following such Fundamental Transaction.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 12; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Notwithstanding
anything to the contrary, in the event of a Fundamental Transaction, the Company or any Successor Entity (as defined below) shall, at
the Holder&rsquo;s option, exercisable at any time concurrently with, or within 30 days after, the consummation of the Fundamental Transaction
(or, if later, the date of the public announcement of the applicable Fundamental Transaction), purchase this Warrant from the Holder
by paying to the Holder an amount of cash equal to the Black Scholes Value (as defined below) of the remaining unexercised portion of
this Warrant on the date of the consummation of such Fundamental Transaction; provided, however, that, if the Fundamental Transaction
is not within the Company&rsquo;s control, including not approved by the Company&rsquo;s Board of Directors, the Holder shall only be
entitled to receive from the Company or any Successor Entity the same type or form of consideration (and in the same proportion), at
the Black Scholes Value of the unexercised portion of this Warrant, that is being offered and paid to the holders of Common Stock of
the Company in connection with the Fundamental Transaction, whether that consideration be in the form of cash, stock or any combination
thereof, or whether the holders of Common Stock are given the choice to receive from among alternative forms of consideration in connection
with the Fundamental Transaction; provided, further, that if holders of Common Stock of the Company are not offered or paid any consideration
in such Fundamental Transaction, such holders of Common Stock will be deemed to have received common stock/shares of the Successor Entity
(which Entity may be the Company following such Fundamental Transaction) in such Fundamental Transaction. &ldquo;<B><U>Black Scholes
Value</U></B>&rdquo; means the value of this Warrant based on the Black-Scholes Option Pricing Model obtained from the &ldquo;OV&rdquo;
function on Bloomberg, L.P. (&ldquo;<B><U>Bloomberg</U></B>&rdquo;) determined as of the day of consummation of the applicable contemplated
Fundamental Transaction for pricing purposes and reflecting (A) a risk-free interest rate corresponding to the U.S. Treasury rate for
a period equal to the time between the date of the public announcement of the applicable contemplated Fundamental Transaction and the
Termination Date, (B) an expected volatility equal to the greater of (1) 100% and (2) the 100 day volatility as obtained from the HVT
function on Bloomberg (determined utilizing a 365 day annualization factor) as of the Trading Day immediately following the public announcement
of the applicable contemplated Fundamental Transaction, (C) the underlying price per share used in such calculation shall be the greater
of (i) the sum of the price per share being offered in cash, if any, plus the value of any non-cash consideration, if any, being offered
in such Fundamental Transaction and (ii) the highest VWAP during the period beginning on the Trading Day immediately preceding the public
announcement of the applicable contemplated Fundamental Transaction (or the consummation of the applicable Fundamental Transaction, if
earlier) and ending on the Trading Day of the Holder&rsquo;s request pursuant to this Section &lrm;3.7 and (D) a remaining option time
equal to the time between the date of the public announcement of the applicable contemplated Fundamental Transaction and the Termination
Date and (E) a zero cost of borrow. The payment of the Black Scholes Value will be made by wire transfer of immediately available funds
(or such other consideration) within the later of (i) five (5) Business Days after the Holder&rsquo;s election and (ii) the date of consummation
of the Fundamental Transaction. The Company shall cause any successor entity in a Fundamental Transaction in which the Company is not
the survivor (the &ldquo;<B><U>Successor Entity</U></B>&rdquo;) to assume in writing all of the obligations of the Company under this
Warrant in accordance with the provisions of this Section &lrm;3.7 pursuant to written agreements in form and substance reasonably satisfactory
to the Holder and approved by the Holder (without unreasonable delay) prior to such Fundamental Transaction and shall, at the option
of the Holder, deliver to the Holder in exchange for this Warrant a security of the Successor Entity evidenced by a written instrument
substantially similar in form and substance to this Warrant that is exercisable for a corresponding number of shares of capital stock
of such Successor Entity (or its parent entity) equivalent to the shares of Common Stock acquirable and receivable upon exercise of this
Warrant (without regard to any limitations on the exercise of this Warrant) prior to such Fundamental Transaction, and with an exercise
price which applies the exercise price hereunder to such shares of capital stock (but taking into account the relative value of the shares
of Common Stock prior to such Fundamental Transaction and the value of such shares of capital stock, such number of shares of capital
stock and such exercise price being for the purpose of protecting the economic value of this Warrant immediately prior to the consummation
of such Fundamental Transaction), and which is reasonably satisfactory in form and substance to the Holder. Upon the occurrence of any
such Fundamental Transaction, the Successor Entity shall be added to the term &ldquo;Company&rdquo; under this Warrant (so that from
and after the occurrence or consummation of such Fundamental Transaction, each and every provision of this Warrant referring to the &ldquo;Company&rdquo;
shall refer instead to each of the Company and the Successor Entity or Successor Entities, jointly and severally), and the Successor
Entity or Successor Entities, jointly and severally with the Company, may exercise every right and power of the Company prior thereto
and the Successor Entity or Successor Entities shall assume all of the obligations of the Company prior thereto under this Warrant with
the same effect as if the Company and such Successor Entity or Successor Entities, jointly and severally, had been named as the Company
herein. For the avoidance of doubt, the Holder shall be entitled to the benefits of the provisions of this Section &lrm;3.7 regardless
of (i) whether the Company has sufficient authorized shares of Common Stock for the issuance of Warrant Shares and/or (ii) whether a
Fundamental Transaction occurs prior to the Initial Exercise Date.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 13; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.6
<B><U>Calculations</U></B>. All calculations under this Section &lrm;3 shall be made to the nearest cent or the nearest 1/100th of a
share, as the case may be. For purposes of this Section &lrm;3, the number of shares of Common Stock deemed to be issued and outstanding
as of a given date shall be the sum of the number of shares of Common Stock (excluding treasury shares, if any) issued and outstanding.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.7
<B><U>Notice to Holder</U></B>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.7.1.
<B><U>Adjustment to Exercise Price</U></B>. Whenever the Exercise Price is adjusted pursuant to any provision of this Section &lrm;3,
the Company shall promptly deliver to the Holder by email a notice setting forth the Exercise Price after such adjustment and any resulting
adjustment to the number of Warrant Shares and setting forth a brief statement of the facts requiring such adjustment.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.7.2.
<B><U>Notice to Allow Exercise by Holder</U></B>. If (A) the Company shall declare a dividend (or any other distribution in whatever
form) on the Common Stock, (B) the Company shall declare a special nonrecurring cash dividend on or a redemption of the Common Stock,
(C) the Company shall authorize the granting to all holders of the Common Stock rights or warrants to subscribe for or purchase any shares
of capital stock of any class or of any rights, (D) the approval of any stockholders of the Company shall be required in connection with
any reclassification of the Common Stock, any consolidation or merger to which the Company (or any of its Subsidiaries) is a party, any
sale or transfer of all or substantially all of its assets, or any compulsory share exchange whereby the Common Stock is converted into
other securities, cash or property, or (E) the Company shall authorize the voluntary or involuntary dissolution, liquidation or winding
up of the affairs of the Company, then, in each case, the Company shall cause to be delivered by email to the Holder at its last email
address as it shall appear upon the Warrant Register of the Company, at least 20 calendar days prior to the applicable record or effective
date hereinafter specified, a notice stating (x) the date on which a record is to be taken for the purpose of such dividend, distribution,
redemption, rights or warrants, or if a record is not to be taken, the date as of which the holders of the Common Stock of record to
be entitled to such dividend, distributions, redemption, rights or warrants are to be determined or (y) the date on which such reclassification,
consolidation, merger, sale, transfer or share exchange is expected to become effective or close, and the date as of which it is expected
that holders of the Common Stock of record shall be entitled to exchange their shares of Common Stock for securities, cash or other property
deliverable upon such reclassification, consolidation, merger, sale, transfer or share exchange; provided that the failure to deliver
such notice or any defect therein or in the delivery thereof shall not affect the validity of the corporate action required to be specified
in such notice. To the extent that any notice provided in this Warrant constitutes, or contains, material, non-public information regarding
the Company or any of the Subsidiaries, the Company shall simultaneously file such notice with the Commission pursuant to a Current Report
on Form 8-K. The Holder shall remain entitled to exercise this Warrant during the period commencing on the date of such notice to the
effective date of the event triggering such notice except as may otherwise be expressly set forth herein.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 14; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.8
<B><U>Share Combination Event Adjustment</U></B>. In addition to the adjustments set forth in Section &lrm;3.1 above, if at any time
and from time to time on or after the Issuance Date there occurs any share split, share dividend, share combination recapitalization
or other similar transaction involving the Common Stock (each, a &ldquo;<B><U>Share Combination Event</U></B>&rdquo;, and such date thereof,
the &ldquo;<B><U>Share Combination Event Date</U></B>&rdquo;) and the lowest VWAP during the period commencing Five (5) consecutive Trading
Days immediately preceding and the Five (5) consecutive Trading Days immediately following the Share Combination Event Date (the &ldquo;<B><U>Event
Market Price</U></B>&rdquo;) (provided if the Share Combination Event is effective after close of Trading on the primary Trading Market,
then commencing on the next Trading Day which period shall be the &ldquo;<B><U>Share Combination Adjustment Period</U></B>&rdquo;) is
less than the Exercise Price then in effect (after giving effect to the adjustment in clause &lrm;3.1 above), then at the close of trading
on the primary Trading Market on the last day of the Share Combination Adjustment Period, the Exercise Price then in effect on such Fifth
(5th) Trading Day shall be reduced (but in no event increased) to the Event Market Price and the number of Warrant Shares issuable hereunder
shall be increased such that the aggregate Exercise Price of this Warrant on the Issuance Date for the Warrant Shares then outstanding
shall remain unchanged. For the avoidance of doubt, if the adjustment in the immediately preceding sentence would otherwise result in
an increase in the Exercise Price hereunder, no adjustment shall be made, and if this Warrant is exercised, on any given Exercise Date
during the Share Combination Adjustment Period, solely with respect to such portion of this Warrant exercised on such applicable Exercise
Date, such applicable Share Combination Adjustment Period shall be deemed to have ended on, and included, the Trading Day immediately
prior to such Exercise Date and the Event Market Price on such applicable Exercise Date will be the lowest VWAP of the Common Stock immediately
during such the Share Combination Adjustment Period prior to such Exercise Date and ending on, and including the Trading Day immediately
prior to such Exercise Date.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.9
<B><U>Voluntary Adjustment by Company</U></B>. Subject to the rules and regulations of the Trading Market and the consent of the Holders
of a majority in interest of the Warrants then outstanding, the Company may at any time during the term of this Warrant reduce the then
current Exercise Price to any amount and for any period of time deemed appropriate by the Board of Directors.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.10
<B><U>Stockholder Approval</U></B>. The Company shall seek Stockholder Approval (which may also be at the annual meeting of stockholders)
within the time period and the manner provided in the Placement Agency Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 15; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.
<B><U>Transfer of Warrant</U></B>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.1
<B><U>Transferability</U></B>. Subject to compliance with any applicable securities laws, this Warrant and all rights hereunder (including,
without limitation, any registration rights) are transferable, in whole or in part, upon surrender of this Warrant at the principal office
of the Company or its designated agent, together with a written assignment of this Warrant substantially in the form attached hereto
as Exhibit <U>&lrm;2.4.6</U> duly executed by the Holder or its agent or attorney and funds sufficient to pay any transfer taxes payable
upon the making of such transfer. Upon such surrender and, if required, such payment, the Company shall execute and deliver a new Warrant
or Warrants in the name of the assignee or assignees, as applicable, and in the denomination or denominations specified in such instrument
of assignment, and shall issue to the assignor a new Warrant evidencing the portion of this Warrant not so assigned, and this Warrant
shall promptly be cancelled. Notwithstanding anything herein to the contrary, the Holder shall not be required to physically surrender
this Warrant to the Company unless the Holder has assigned this Warrant in full, in which case, the Holder shall surrender this Warrant
to the Company within three (3) Trading Days of the date on which the Holder delivers an assignment form to the Company assigning this
Warrant in full. The Warrant, if properly assigned in accordance herewith, may be exercised by a new holder for the purchase of Warrant
Shares without having a new Warrant issued.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.2
<B><U>New Warrants</U></B>. If this Warrant is not held in global form through DTC (or any successor depositary), this Warrant may be
divided or combined with other Warrants upon presentation hereof at the aforesaid office of the Company, together with a written notice
specifying the names and denominations in which new Warrants are to be issued, signed by the Holder or its agent or attorney. Subject
to compliance with Section &lrm;4.1, as to any transfer which may be involved in such division or combination, the Company shall execute
and deliver a new Warrant or Warrants in exchange for the Warrant or Warrants to be divided or combined in accordance with such notice.
All Warrants issued on transfers or exchanges shall be dated the initial issuance date of this Warrant and shall be identical with this
Warrant except as to the number of Warrant Shares issuable pursuant thereto.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.3
<B><U>Warrant Register</U></B>. The Warrant Agent shall register this Warrant, upon records to be maintained by the Warrant Agent for
that purpose (the &ldquo;<B><U>Warrant Register</U></B>&rdquo;), in the name of the record Holder hereof from time to time. The Company
and the Warrant Agent may deem and treat the registered Holder of this Warrant as the absolute owner hereof for the purpose of any exercise
hereof or any distribution to the Holder, and for all other purposes, absent actual notice to the contrary.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.
<B><U>Miscellaneous</U></B>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.1
<B><U>No Rights as Stockholder until Exercise; No Settlement in Cash</U></B>. This Warrant does not entitle the Holder to any voting
rights, dividends or other rights as a stockholder of the Company prior to the exercise hereof as set forth in Section &lrm;2.4.1, except
as expressly set forth in Section &lrm;3. Without limiting any rights of a Holder to receive Warrant Shares on a &ldquo;cashless exercise&rdquo;
pursuant to Section <B>&lrm;</B>2.3 or to receive cash payments pursuant to Section <B>&lrm;</B>2.4.1 and Section <B>&lrm;</B>2.4.4 herein,
in no event shall the Company be required to net cash settle an exercise of this Warrant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 16; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.2
<B><U>Loss, Theft, Destruction or Mutilation of Warrant</U></B>. The Company covenants that upon receipt by the Company of evidence reasonably
satisfactory to it of the loss, theft, destruction or mutilation of this Warrant or any stock certificate relating to the Warrant Shares,
and in case of loss, theft or destruction, of indemnity or security reasonably satisfactory to it (which, in the case of the Warrant,
shall not include the posting of any bond), and upon surrender and cancellation of such Warrant or stock certificate, if mutilated, the
Company will make and deliver a new Warrant or stock certificate of like tenor and dated as of such cancellation, in lieu of such Warrant
or stock certificate.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.3
<B><U>Saturdays, Sundays, Holidays, etc</U></B>. If the last or appointed day for the taking of any action or the expiration of any right
required or granted herein shall not be a Business Day, then such action may be taken or such right may be exercised on the next succeeding
Business Day.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.4
<B><U>Authorized Shares</U></B>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.4.1.
<B><U>Reservation of Authorized and Unissued Shares</U></B>. The Company covenants that, during the period the Warrant is outstanding,
it will reserve from its authorized and unissued Common Stock a sufficient number of shares of Common Stock to provide for the issuance
of the Warrant Shares upon the exercise of any purchase rights under this Warrant. The Company further covenants that its issuance of
this Warrant shall constitute full authority to its officers who are charged with the duty of issuing the necessary Warrant Shares upon
the exercise of the purchase rights under this Warrant. The Company will take all such reasonable action as may be necessary to assure
that such Warrant Shares may be issued as provided herein without violation of any applicable law or regulation, or of any requirements
of the Trading Market upon which the Common Stock may be listed. The Company covenants that all Warrant Shares which may be issued upon
the exercise of the purchase rights represented by this Warrant will, upon exercise of the purchase rights represented by this Warrant
and payment for such Warrant Shares in accordance herewith, be duly authorized, validly issued, fully paid and nonassessable (which means
that no further sums are required to be paid by the holders thereof in connection with the issue thereof) and free from all taxes, liens
and charges created by the Company in respect of the issue thereof (other than taxes in respect of any transfer occurring contemporaneously
with such issue).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.4.2.
<B><U>Noncircumvention</U></B>. Except and to the extent as waived or consented to by the Holders of a majority in interest of the Warrants
then outstanding, the Company shall not by any action, including, without limitation, amending its certificate of incorporation or through
any reorganization, transfer of assets, consolidation, merger, dissolution, issue or sale of securities or any other voluntary action,
avoid or seek to avoid the observance or performance of any of the terms of this Warrant, but will at all times in good faith assist
in the carrying out of all such terms and in the taking of all such actions as may be necessary or appropriate to protect the rights
of Holder as set forth in this Warrant against impairment. Without limiting the generality of the foregoing, the Company will (i) not
increase the par value of any Warrant Shares above the amount payable therefor upon such exercise immediately prior to such increase
in par value, (ii) take all such action as may be necessary or appropriate in order that the Company may validly and legally issue fully
paid and nonassessable Warrant Shares upon the exercise of this Warrant and (iii) use commercially reasonable efforts to obtain all such
authorizations, exemptions or consents from any public regulatory body having jurisdiction thereof, as may be, necessary to enable the
Company to perform its obligations under this Warrant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 17; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.4.3.
<B><U>Authorizations, Exemptions and Consents</U></B>. Before taking any action that would result in an adjustment in the number of Warrant
Shares for which this Warrant is exercisable or in the Exercise Price, the Company shall obtain all such authorizations or exemptions
thereof, or consents thereto, as may be necessary from any public regulatory body or bodies having jurisdiction thereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.5
<B><U>Governing Law</U></B>. All questions concerning the construction, validity, enforcement and interpretation of this Warrant shall
be governed by and construed and enforced in accordance with the internal laws of the State of New York, without regard to the principles
of conflicts of law thereof. Each party agrees that all legal proceedings concerning the interpretations, enforcement and defense of
the transactions contemplated by this Warrant (whether brought against a party hereto or their respective affiliates, directors, officers,
shareholders, partners, members, employees or agents) shall be commenced exclusively in the state and federal courts sitting in the City
of New York. Each party hereby irrevocably submits to the exclusive jurisdiction of the state and federal courts sitting in the City
of New York, Borough of Manhattan for the adjudication of any dispute hereunder or in connection herewith or with any transaction contemplated
hereby or discussed herein, and hereby irrevocably waives, and agrees not to assert in any suit, action or proceeding, any claim that
it is not personally subject to the jurisdiction of any such court, that such suit, action or proceeding is improper or is an inconvenient
venue for such proceeding. Each party hereby irrevocably waives personal service of process and consents to process being served in any
such suit, action or proceeding by mailing a copy thereof via registered or certified mail or overnight delivery (with evidence of delivery)
to such party at the address in effect for notices to it under this Warrant and agrees that such service shall constitute good and sufficient
service of process and notice thereof. Nothing contained herein shall be deemed to limit in any way any right to serve process in any
other manner permitted by law. If either party shall commence an action, suit or proceeding to enforce any provisions of this Warrant,
the prevailing party in such action, suit or proceeding shall be reimbursed by the other party for their reasonable attorneys&rsquo;
fees and other costs and expenses incurred with the investigation, preparation and prosecution of such action or proceeding. Notwithstanding
the foregoing, nothing in this paragraph shall limit or restrict the federal district court in which a Holder may bring a claim under
the federal securities laws.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.6
<B><U>Restrictions</U></B>. The Holder acknowledges that the Warrant Shares acquired upon the exercise of this Warrant, if not registered,
and the Holder does not utilize cashless exercise, will have restrictions upon resale imposed by state and federal securities laws.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.7
<B><U>Nonwaiver and Expenses</U></B>. No course of dealing or any delay or failure to exercise any right hereunder on the part of Holder
shall operate as a waiver of such right or otherwise prejudice the Holder&rsquo;s rights, powers or remedies, notwithstanding the fact
that the right to exercise this Warrant terminates on the Termination Date. No provision of this Warrant shall be construed as a waiver
by the Holder of any rights which the Holder may have under the federal securities laws and the rules and regulations of the Commission
thereunder. Without limiting any other provision of this Warrant, if the Company willfully and knowingly fails to comply with any provision
of this Warrant, which results in any material damages to the Holder, the Company shall pay to the Holder such amounts as shall be sufficient
to cover any costs and expenses including, but not limited to, reasonable attorneys&rsquo; fees, including those of appellate proceedings,
incurred by the Holder in collecting any amounts due pursuant hereto or in otherwise enforcing any of its rights, powers or remedies
hereunder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 18; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.8
<B><U>Notices</U></B>. Any and all notices or other communications or deliveries to be provided by the Holders hereunder including, without
limitation, any Notice of Exercise, shall be in writing and delivered personally, by e-mail, or sent by a nationally recognized overnight
courier service, addressed to the Company, at 8201 E. 34<SUP>th</SUP> Street N, Suite 1307, Wichita, Kansas 67226, <U>Attention</U>:
Mark DiSiena, Chief Financial Officer, email address: mark.disiena@ageagle.com, or such other email address or address as the Company
may specify for such purposes by notice to the Holders. Any and all notices or other communications or deliveries to be provided by the
Company hereunder shall be in writing and delivered personally, by e-mail, or sent by a nationally recognized overnight courier service
addressed to each Holder at the e-mail address or address of such Holder appearing on the books of the Company. Any notice or other communication
or deliveries hereunder shall be deemed given and effective on the earliest of (i) the time of transmission, if such notice or communication
is delivered via e-mail at the e-mail address set forth in this Section &lrm;5.8 prior to 5:30 p.m. (New York City time) on any date,
(ii) the next Trading Day after the time of transmission, if such notice or communication is delivered via e-mail at the e-mail address
set forth in this Section &lrm;5.8 on a day that is not a Trading Day or later than 5:30 p.m. (New York City time) on any Trading Day,
(iii) the second Trading Day following the date of mailing, if sent by U.S. nationally recognized overnight courier service, or (iv)
upon actual receipt by the party to whom such notice is required to be given. To the extent that any notice provided hereunder constitutes,
or contains, material, non-public information regarding the Company or any Subsidiaries, the Company shall simultaneously file such notice
with the Commission pursuant to a Current Report on Form 8-K.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.9
<B><U>Limitation of Liability</U></B>. No provision hereof, in the absence of any affirmative action by the Holder to exercise this Warrant
to purchase Warrant Shares, and no enumeration herein of the rights or privileges of the Holder, shall give rise to any liability of
the Holder for the purchase price of any Common Stock or as a stockholder of the Company, whether such liability is asserted by the Company
or by creditors of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.10
<B><U>Remedies</U></B>. The Holder, in addition to being entitled to exercise all rights granted by law, including recovery of damages,
will be entitled to specific performance of its rights under this Warrant. The Company agrees that monetary damages would not be adequate
compensation for any loss incurred by reason of a breach by it of the provisions of this Warrant and hereby agrees to waive and not to
assert the defense in any action for specific performance that a remedy at law would be adequate.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.11
<B><U>Successors and Assigns</U></B>. Subject to applicable securities laws, this Warrant and the rights and obligations evidenced hereby
shall inure to the benefit of and be binding upon the successors and permitted assigns of the Company and the successors and permitted
assigns of Holder. The provisions of this Warrant are intended to be for the benefit of any Holder from time to time of this Warrant
and shall be enforceable by the Holder or holder of Warrant Shares.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.12
<B><U>Amendment</U></B>. This Warrant may be modified or amended or the provisions hereof waived with the written consent of the Company,
on the one hand, and the Holders of a majority in interest of the Warrants then outstanding, on the other hand.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.13
<B><U>Severability</U></B>. Wherever possible, each provision of this Warrant shall be interpreted in such manner as to be effective
and valid under applicable law, but if any provision of this Warrant shall be prohibited by or invalid under applicable law, such provision
shall be ineffective to the extent of such prohibition or invalidity, without invalidating the remainder of such provisions or the remaining
provisions of this Warrant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.14
<B><U>Headings</U></B>. The headings used in this Warrant are for the convenience of reference only and shall not, for any purpose, be
deemed a part of this Warrant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.15
<B><U>Warrant Agent Agreement</U></B>. If this Warrant is held in global form through DTC (or any successor depositary), this Warrant
is issued subject to the Warrant Agent Agreement. To the extent any provision of this Warrant conflicts with the express provisions of
the Warrant Agent Agreement, the provisions of this Warrant shall govern and be controlling.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">********************</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>[Investor
Registered Series B Warrant Signature Page Follows]</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>


<!-- Field: Page; Sequence: 19; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>[Investor
Registered Series B Warrant Signature Page]</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">IN
WITNESS WHEREOF, the Company has caused this Registered Warrant to be executed by its officer thereunto duly authorized as of the date
first above indicated.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">AGEAGLE
    AERIAL SYSTEMS, INC.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 5%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 45%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">William
    Irby</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Its:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief
    Executive Officer</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>


<!-- Field: Page; Sequence: 20; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Exhibit
2.1</U></FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-transform: uppercase; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">NOTICE
OF EXRCISE</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-transform: uppercase; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">To:
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">AGEAGLE AERIAL SYSTEMS, INC.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.
The undersigned hereby elects to purchase ________ Warrant Shares of the Company pursuant to the terms of the attached Warrant (only
if exercised in full), and tenders herewith payment of the exercise price in full, together with all applicable transfer taxes, if any.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.
Payment shall take the form of (check applicable box):</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[&nbsp;&nbsp;&nbsp;] in lawful money of the United States.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[&nbsp;&nbsp;&nbsp;] if permitted the cancellation of such number of Warrant Shares as is necessary, in accordance with the formula set forth in subsection
2.3, to exercise this Warrant with respect to the maximum number of Warrant Shares purchasable pursuant to the cashless exercise procedure
set forth in subsection 2.3.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.
Please issue said Warrant Shares in the name of the undersigned or in such other name as is specified below:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">_______________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Warrant Shares shall be delivered to the following DWAC Account Number:</FONT></P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">_______________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">_______________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">_______________________________</FONT></P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 21; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->21<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[SIGNATURE
OF HOLDER]</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 60%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name
    of Investing Entity:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 1pt solid; width: 40%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Signature
    of Authorized Signatory of Investing Entity</I>:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name
    of Authorized Signatory:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title
    of Authorized Signatory:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 22; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->22<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Exhibit
2.4.6</U></FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-transform: uppercase; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ASSIGNMENT
FORM</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-transform: uppercase; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(To
assign the foregoing Warrant, execute this form and supply required information. Do not use this form to exercise the Warrant to purchase
shares of Common Stock.)</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">FOR
VALUE RECEIVED, the foregoing Warrant and all rights evidenced thereby are hereby assigned to</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 60%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 1pt solid; width: 40%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Address:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Phone
    Number:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Email
    Address:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Holder&rsquo;s
    Signature</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Holder&rsquo;s
    Address</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 23; Options: Last -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->23<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.1
<SEQUENCE>6
<FILENAME>ex10-1.htm
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal; text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">Exhibit
10.1</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal; text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal"><U>OMNIBUS
AGREEMENT</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal; text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
OMNIBUS AGREEMENT dated as of September 30, 2024 (this &ldquo;Agreement&rdquo;), is entered into by and between AgEagle Aerial Systems,
Inc. (&ldquo;Company&rdquo;), and Alpha Capital Anstalt (the &ldquo;Holder&rdquo; and together with the Company each a &ldquo;Party&rdquo;
and collectively as the &ldquo;Parties&rdquo;). Capitalized words not otherwise defined herein shall have the meanings attributed to
them in the Note (as defined below)</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: center; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">W
I T N E SS E T H :</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">WHEREAS,
pursuant to that certain Securities Exchange Agreement, dated February 8, 2024 (the &ldquo;SEA&rdquo;), the Company issued to the Holder
a note dated February 8, 2024 and due December 31, 2024, in the original principal amount of $4,849,491.00 (the &ldquo;Note&rdquo;) and
pursuant to that certain Securities Purchase Agreement dated June 26, 2022 (the &ldquo;SPA&rdquo;), the Company issued to Holders shares
of Series F 5% Convertible Preferred Stock (&ldquo;Series F 5% Convertible Preferred Stock&rdquo;) described in the Certificate of Designation
of Preferences, Rights and Limitations of Series F 5% Convertible Preferred Stock (&ldquo;Series F CoD&rdquo;) and warrants to purchase
shares of the Company&rsquo;s Common Stock (the &ldquo;Warrants,&rdquo; and together with the SEA, Note, SPA, and Series F 5% Convertible
Preferred Stock being the &ldquo;Holder Securities&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">WHEREAS,
the Company desires to conduct an offering of its securities (the &ldquo;Offering&rdquo;) as described in the form S-1/A filed with the
Securities and Exchange Commission on September 17, 2024 (the &ldquo;Spartan Capital Raise&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">WHEREAS,
the Spartan Capital Raise in part constitutes a Variable Rate Transaction as defined in the Holder Securities that requires the consent
of the Holder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">NOW,
THEREFORE, in consideration of the agreements of the Parties set forth herein, and other good and valuable consideration the receipt
and legal adequacy of which are hereby acknowledged by the Company and the Holder, it is hereby agreed as follows:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.
Subject to the terms of this Agreement, the Holder will execute and deliver to the Company the consent annexed hereto as Exhibit A (the
&ldquo;Consent&rdquo;). In consideration of Holder&rsquo;s execution and delivery of the Consent, at the initial closing of the Spartan
Capital Raise, the Company will issue and deliver to Holder 1,500 shares of Series F 5% Convertible Preferred Stock with an aggregate
stated value of $1,500,000 and having all the rights and benefits of Series F 5% Convertible Preferred Stock issued pursuant to the Series
F CoD and SPA.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.
Subject to the terms of this Agreement, the Holder agrees to execute and deliver the lock-up agreement annexed hereto as Exhibit B (the
&ldquo;Lock-up&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.
The Company acknowledges that the securities issued in the Spartan Capital Raise (the &ldquo;Spartan Securities&rdquo;) are not an Exempt
Issuance under the Holder Securities and will trigger the ratchet and repricing terms of the Holder Securities (the &ldquo;Holder Ratchet
Rights&rdquo;). Every future pricing and repricing of the Spartan Securities will further trigger the Holder Ratchet Rights, as applicable.
In addition to any other triggers of the Holder Ratchet Rights as a result of the Offering and the issuance of the Spartan Securities,
it is acknowledged that effective immediately following the Shareholder Approval, as such term is defined in the Series A Warrant component
of the Spartan Securities, the effective issuance price of the Common Stock component of the Spartan Securities shall be deemed reduced
to one third (1/3) of the Unit price in the Offering (the &ldquo;New Offering Price&rdquo;). To the extent the New Offering Price is
lower than the then in effect conversion price or exercise price of any Holder Security, in order effect the Holder Ratchet Rights, the
conversion price and exercise price of any such Holder Security shall be reduced to the New Offering Price. In no event shall the New
Offering Price increase the then in effect conversion price or exercise price of any Holder Security.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 1; Options: NewSection -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.
As of the date of this Agreement, the Company and Holder agree that the outstanding principal and interest owed and payable on the Note
is $5,000,000. At the initial closing of the Spartan Capital Raise, the Company will apply $3,000,000 of the Note balance as a subscription
on Holder&rsquo;s behalf in the Offering. Upon such payment, $2,000,000.00 in principal will remain outstanding on the Note which will
be paid in six monthly installments consisting of $333,333.33 in principal plus all accrued commencing on October 15, 2024 and continuing
on the 15<SUP>th</SUP> day of each calendar month until the Note is paid in full.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.
In addition to its existing obligations under its other agreement with the Holder, the Company shall reserve 40,000,000 shares of its
common stock for issuance to the Holder for any convertible securities issued by the Company to the Holder. Within three (3) days after
the date of this Agreement, the Company shall provide Holder with a reservation letter signed by the Company&rsquo;s transfer agent binding
the Company&rsquo;s transfer agent to the 40,000,000 share reservation. The foregoing is not a waiver by Holder of any right to have
a greater amount of shares of common stock reserved as required by the Holder Securities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.
To the extent the issuance of any securities by the Company, including any shares of Common Stock, requires shareholder approval under
the listing requirement of the Company&rsquo;s Trading Market, including the NYSE American, the Company will seek such shareholder approval
together with any shareholder approval sought in connection with terms of and securities issuable in the Offering (the &ldquo;Offering
Shareholder Approval&rdquo;) and shall seek such shareholder approval on the same terms and conditions as the Offering Shareholder Approval.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">7.
The Company acknowledges that the Holder&rsquo;s holding period for the Holder Securities is not reset or modified for purposes of Rule
144 by this Agreement and the transaction described herein.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8.
Contemporaneously with the filing of the prospectus amendment filed prior to the closing of the Offering, the Company shall file a form
8-K with the Securities and Exchange Commission, disclosing this Agreement, which shall be an exhibit to such filing. The form 8-K shall
be provided to Holder for review and comment prior to filing.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">9.
Except as expressly amended hereby, each of the Holder Securities, shall remain in full force and effect in accordance with their respective
terms and provisions.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.
This Agreement shall be governed by the terms of Section 9 of the Note.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">11.
This Agreement shall be deemed to have been drafted jointly by the Parties and therefore any rule of law that stands for the proposition
that ambiguities contained within an agreement are to be construed against the drafter thereof is inapplicable.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[REST
OF THIS PAGE LEFT INTENTIONALLY BLANK]</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">IN
WITNESS WHEREOF, each of the undersigned Parties has duly executed this Omnibus Agreement as of the date first written above.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">COMPANY</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">HOLDER</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">AgEagle
    Aerial Systems, Inc.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Alpha
    Capital Anstalt</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 3%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 46%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 3%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 46%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>/s/
    Wiliam Irby</I></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>/s/
    Nicola Feurestein</I></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">William
    Irby</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:
    </FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Nicola
    Feurerstien</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Its:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief
    Executive Officer</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Its:
    </FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 3; Options: Last -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>7
<FILENAME>ex99-1.htm
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit
99.1</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>AgEagle
Aerial Systems Inc. Announces Closing of $6.5 Million Public Offering</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Wichita,
Kan</B>., October 01, 2024 &ndash; AgEagle Aerial Systems Inc. (NYSE American: UAVS) (&ldquo;AgEagle&rdquo; or the &ldquo;Company&rdquo;),
an industry-leading provider of full stack flight hardware, sensors and software for commercial and government use, today announced the
closing of a public offering with gross proceeds to the Company of approximately $6.5 million, before deducting placement agent fees
and other estimated offering expenses payable by the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
offering consisted of 26,899,996 Units, each consisting of one (1) share of our common stock, $0.001 par value per share (the
&ldquo;Common Stock&rdquo;) or one Pre-Funded Warrant to purchase one share of Common stock, one Series A warrant (&ldquo;Series A Warrant&rdquo;)
to purchase one share of Common Stock and one Series B warrant (&ldquo;Series B Warrant&rdquo;) to purchase one share of Common Stock.
The public offering price per Unit was $0.24 (or $0.239 for each Unit with a Pre-Funded Warrant, which was equal to the public offering
price per Unit with a share of Common Stock sold in the offering minus an exercise price of $0.001 per Pre-Funded Warrant). The Pre-Funded
Warrants are immediately exercisable and may be exercised at any time until exercised in full. The initial exercise price of each Series
A Warrant is $0.24 per share of Common Stock or pursuant to an alternative cashless exercise option. The Series A Warrants are exercisable
immediately and expire five years from the closing date of the public offering. The initial exercise price of each Series B Warrant is
$0.50 per share of common stock. The Series B Warrants are exercisable immediately and expire five years from the closing date of the
public offering.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Aggregate
gross proceeds to the Company are approximately $6.5 million. The Company expects to use the proceeds from the offering for the repayment
of an outstanding note and the remainder for general corporate and working capital purposes.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Spartan
Capital Securities, LLC acted as the sole placement agent for the offering. Duane Morris LLP. acted as counsel to the Company. Manatt,
Phelps &amp; Phillips LLP acted as counsel to Spartan Capital Securities, LLC.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
securities described above were offered pursuant to a registration statement on Form S-1 (File No. 333-281897) previously filed with
the U.S. Securities and Exchange Commission (&ldquo;SEC&rdquo;) on September 30, 2024, as amended, which became effective on September
30, 2024. The offering was made only by means of a prospectus forming part of the effective registration statement. Copies of the final
prospectus relating to the offering may be obtained on the SEC&rsquo;s website located at http://www.sec.gov. Electronic copies of the
final prospectus relating to the offering may be obtained from: Spartan Capital Securities, LLC, 45 Broadway, New York, NY 10006, at
(212) 293-0123.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
press release shall not constitute an offer to sell or a solicitation of an offer to buy, nor shall there be any sale of these securities
in any state or jurisdiction in which such an offer, solicitation or sale would be unlawful prior to registration or qualification under
the securities laws of any such state or jurisdiction.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>About
AgEagle Aerial Systems Inc.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Through
its three centers of excellence, AgEagle is actively engaged in designing and delivering best-in-class flight hardware, sensors and software
that solve important problems for its customers. Founded in 2010, AgEagle was originally formed to pioneer proprietary, professional-grade,
fixed-winged drones and aerial imagery-based data collection and analytics solutions for the agriculture industry. Today, AgEagle is
a leading provider of full stack drone solutions for customers worldwide in the energy, construction, agriculture, and government verticals.
For additional information, please visit our website at www.ageagle.com.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>AgEagle
Aerial Systems Contacts</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Investor
Relations Email: UAVS@ageagle.com</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Media
Email: media@ageagle.com</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 1; Options: Last -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>8
<FILENAME>uavs-20240930.xsd
<DESCRIPTION>XBRL SCHEMA FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" ?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.23b -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
    <!-- Field: Doc-Info; Name: Misc; Value: 96Mps7xRiXgen8uDanwsWaOG+bP9z5Z8iekhvWBybakazy4rLULcFipN8wm2YewL -->
<schema xmlns="http://www.w3.org/2001/XMLSchema" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:dei="http://xbrl.sec.gov/dei/2024" xmlns:us-gaap="http://fasb.org/us-gaap/2024" xmlns:srt="http://fasb.org/srt/2024" xmlns:srt-types="http://fasb.org/srt-types/2024" xmlns:UAVS="http://ageagle.com/20240930" elementFormDefault="qualified" targetNamespace="http://ageagle.com/20240930">
    <annotation>
      <appinfo>
        <link:roleType roleURI="http://ageagle.com/role/Cover" id="Cover">
          <link:definition>00000001 - Document - Cover</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:linkbaseRef xlink:type="simple" xlink:href="uavs-20240930_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Presentation Links" />
        <link:linkbaseRef xlink:type="simple" xlink:href="uavs-20240930_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Label Links" />
      </appinfo>
    </annotation>
    <import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" />
    <import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" />
    <import namespace="http://xbrl.sec.gov/dei/2024" schemaLocation="https://xbrl.sec.gov/dei/2024/dei-2024.xsd" />
    <import namespace="http://fasb.org/us-gaap/2024" schemaLocation="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd" />
    <import namespace="http://fasb.org/us-types/2024" schemaLocation="https://xbrl.fasb.org/us-gaap/2024/elts/us-types-2024.xsd" />
    <import namespace="http://www.xbrl.org/dtr/type/2022-03-31" schemaLocation="https://www.xbrl.org/dtr/type/2022-03-31/types.xsd" />
    <import namespace="http://xbrl.sec.gov/country/2024" schemaLocation="https://xbrl.sec.gov/country/2024/country-2024.xsd" />
    <import namespace="http://fasb.org/srt/2024" schemaLocation="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd" />
    <import namespace="http://fasb.org/srt-types/2024" schemaLocation="https://xbrl.fasb.org/srt/2024/elts/srt-types-2024.xsd" />
</schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>9
<FILENAME>uavs-20240930_lab.xml
<DESCRIPTION>XBRL LABEL FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.23b -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" roleURI="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" roleURI="http://www.xbrl.org/2009/role/netLabel" />
    <link:labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CoverAbstract" xlink:label="dei_CoverAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CoverAbstract" xlink:to="dei_CoverAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CoverAbstract_lbl" xml:lang="en-US">Cover [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentType" xlink:label="dei_DocumentType" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentType_lbl" xml:lang="en-US">Document Type</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentFlag_lbl" xml:lang="en-US">Amendment Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AmendmentDescription" xlink:label="dei_AmendmentDescription" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentDescription" xlink:to="dei_AmendmentDescription_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentDescription_lbl" xml:lang="en-US">Amendment Description</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentRegistrationStatement" xlink:label="dei_DocumentRegistrationStatement" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentRegistrationStatement" xlink:to="dei_DocumentRegistrationStatement_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentRegistrationStatement_lbl" xml:lang="en-US">Document Registration Statement</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentAnnualReport" xlink:label="dei_DocumentAnnualReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAnnualReport" xlink:to="dei_DocumentAnnualReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAnnualReport_lbl" xml:lang="en-US">Document Annual Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentQuarterlyReport" xlink:label="dei_DocumentQuarterlyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentQuarterlyReport" xlink:to="dei_DocumentQuarterlyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentQuarterlyReport_lbl" xml:lang="en-US">Document Quarterly Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentTransitionReport" xlink:label="dei_DocumentTransitionReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentTransitionReport" xlink:to="dei_DocumentTransitionReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentTransitionReport_lbl" xml:lang="en-US">Document Transition Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentShellCompanyReport" xlink:label="dei_DocumentShellCompanyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyReport" xlink:to="dei_DocumentShellCompanyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyReport_lbl" xml:lang="en-US">Document Shell Company Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentShellCompanyEventDate" xlink:label="dei_DocumentShellCompanyEventDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyEventDate" xlink:to="dei_DocumentShellCompanyEventDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyEventDate_lbl" xml:lang="en-US">Document Shell Company Event Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentPeriodStartDate" xlink:label="dei_DocumentPeriodStartDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodStartDate" xlink:to="dei_DocumentPeriodStartDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodStartDate_lbl" xml:lang="en-US">Document Period Start Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodEndDate_lbl" xml:lang="en-US">Document Period End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="dei_DocumentFiscalPeriodFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalPeriodFocus" xlink:to="dei_DocumentFiscalPeriodFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalPeriodFocus_lbl" xml:lang="en-US">Document Fiscal Period Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentFiscalYearFocus" xlink:label="dei_DocumentFiscalYearFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalYearFocus" xlink:to="dei_DocumentFiscalYearFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalYearFocus_lbl" xml:lang="en-US">Document Fiscal Year Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CurrentFiscalYearEndDate" xlink:label="dei_CurrentFiscalYearEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CurrentFiscalYearEndDate" xlink:to="dei_CurrentFiscalYearEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CurrentFiscalYearEndDate_lbl" xml:lang="en-US">Current Fiscal Year End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFileNumber_lbl" xml:lang="en-US">Entity File Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityRegistrantName_lbl" xml:lang="en-US">Entity Registrant Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCentralIndexKey_lbl" xml:lang="en-US">Entity Central Index Key</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityPrimarySicNumber" xlink:label="dei_EntityPrimarySicNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPrimarySicNumber" xlink:to="dei_EntityPrimarySicNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPrimarySicNumber_lbl" xml:lang="en-US">Entity Primary SIC Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xml:lang="en-US">Entity Tax Identification Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine1_lbl" xml:lang="en-US">Entity Address, Address Line One</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine2" xlink:label="dei_EntityAddressAddressLine2" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine2" xlink:to="dei_EntityAddressAddressLine2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine2_lbl" xml:lang="en-US">Entity Address, Address Line Two</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine3" xlink:label="dei_EntityAddressAddressLine3" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine3" xlink:to="dei_EntityAddressAddressLine3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine3_lbl" xml:lang="en-US">Entity Address, Address Line Three</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCityOrTown_lbl" xml:lang="en-US">Entity Address, City or Town</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressStateOrProvince_lbl" xml:lang="en-US">Entity Address, State or Province</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCountry" xlink:label="dei_EntityAddressCountry" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCountry" xlink:to="dei_EntityAddressCountry_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCountry_lbl" xml:lang="en-US">Entity Address, Country</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressPostalZipCode_lbl" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CountryRegion" xlink:label="dei_CountryRegion" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CountryRegion" xlink:to="dei_CountryRegion_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CountryRegion_lbl" xml:lang="en-US">Country Region</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CityAreaCode_lbl" xml:lang="en-US">City Area Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_LocalPhoneNumber_lbl" xml:lang="en-US">Local Phone Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Extension" xlink:label="dei_Extension" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Extension" xlink:to="dei_Extension_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Extension_lbl" xml:lang="en-US">Extension</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_WrittenCommunications" xlink:label="dei_WrittenCommunications" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_WrittenCommunications_lbl" xml:lang="en-US">Written Communications</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SolicitingMaterial" xlink:label="dei_SolicitingMaterial" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SolicitingMaterial_lbl" xml:lang="en-US">Soliciting Material</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementTenderOffer" xlink:label="dei_PreCommencementTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementTenderOffer_lbl" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="dei_PreCommencementIssuerTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12bTitle_lbl" xml:lang="en-US">Title of 12(b) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_NoTradingSymbolFlag" xlink:label="dei_NoTradingSymbolFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_NoTradingSymbolFlag" xlink:to="dei_NoTradingSymbolFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_NoTradingSymbolFlag_lbl" xml:lang="en-US">No Trading Symbol Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_TradingSymbol_lbl" xml:lang="en-US">Trading Symbol</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityExchangeName_lbl" xml:lang="en-US">Security Exchange Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Security12gTitle" xlink:label="dei_Security12gTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12gTitle" xlink:to="dei_Security12gTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12gTitle_lbl" xml:lang="en-US">Title of 12(g) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SecurityReportingObligation" xlink:label="dei_SecurityReportingObligation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityReportingObligation" xlink:to="dei_SecurityReportingObligation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityReportingObligation_lbl" xml:lang="en-US">Security Reporting Obligation</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AnnualInformationForm" xlink:label="dei_AnnualInformationForm" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AnnualInformationForm" xlink:to="dei_AnnualInformationForm_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AnnualInformationForm_lbl" xml:lang="en-US">Annual Information Form</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="dei_AuditedAnnualFinancialStatements" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AuditedAnnualFinancialStatements" xlink:to="dei_AuditedAnnualFinancialStatements_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AuditedAnnualFinancialStatements_lbl" xml:lang="en-US">Audited Annual Financial Statements</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="dei_EntityWellKnownSeasonedIssuer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityWellKnownSeasonedIssuer" xlink:to="dei_EntityWellKnownSeasonedIssuer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityWellKnownSeasonedIssuer_lbl" xml:lang="en-US">Entity Well-known Seasoned Issuer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityVoluntaryFilers" xlink:label="dei_EntityVoluntaryFilers" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityVoluntaryFilers" xlink:to="dei_EntityVoluntaryFilers_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityVoluntaryFilers_lbl" xml:lang="en-US">Entity Voluntary Filers</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCurrentReportingStatus" xlink:label="dei_EntityCurrentReportingStatus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCurrentReportingStatus" xlink:to="dei_EntityCurrentReportingStatus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCurrentReportingStatus_lbl" xml:lang="en-US">Entity Current Reporting Status</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityInteractiveDataCurrent" xlink:label="dei_EntityInteractiveDataCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityInteractiveDataCurrent" xlink:to="dei_EntityInteractiveDataCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityInteractiveDataCurrent_lbl" xml:lang="en-US">Entity Interactive Data Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFilerCategory" xlink:label="dei_EntityFilerCategory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFilerCategory" xlink:to="dei_EntityFilerCategory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFilerCategory_lbl" xml:lang="en-US">Entity Filer Category</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntitySmallBusiness" xlink:label="dei_EntitySmallBusiness" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntitySmallBusiness" xlink:to="dei_EntitySmallBusiness_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntitySmallBusiness_lbl" xml:lang="en-US">Entity Small Business</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xml:lang="en-US">Entity Emerging Growth Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityExTransitionPeriod" xlink:label="dei_EntityExTransitionPeriod" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityExTransitionPeriod" xlink:to="dei_EntityExTransitionPeriod_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityExTransitionPeriod_lbl" xml:lang="en-US">Elected Not To Use the Extended Transition Period</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentAccountingStandard" xlink:label="dei_DocumentAccountingStandard" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAccountingStandard" xlink:to="dei_DocumentAccountingStandard_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAccountingStandard_lbl" xml:lang="en-US">Document Accounting Standard</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_OtherReportingStandardItemNumber" xlink:label="dei_OtherReportingStandardItemNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_OtherReportingStandardItemNumber" xlink:to="dei_OtherReportingStandardItemNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_OtherReportingStandardItemNumber_lbl" xml:lang="en-US">Other Reporting Standard Item Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityShellCompany" xlink:label="dei_EntityShellCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityShellCompany" xlink:to="dei_EntityShellCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityShellCompany_lbl" xml:lang="en-US">Entity Shell Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityPublicFloat" xlink:label="dei_EntityPublicFloat" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPublicFloat" xlink:to="dei_EntityPublicFloat_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPublicFloat_lbl" xml:lang="en-US">Entity Public Float</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityBankruptcyProceedingsReportingCurrent" xlink:to="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xml:lang="en-US">Entity Bankruptcy Proceedings, Reporting Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="dei_EntityCommonStockSharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCommonStockSharesOutstanding" xlink:to="dei_EntityCommonStockSharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCommonStockSharesOutstanding_lbl" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentsIncorporatedByReferenceTextBlock" xlink:to="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xml:lang="en-US">Documents Incorporated by Reference [Text Block]</link:label>
    </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>10
<FILENAME>uavs-20240930_pre.xml
<DESCRIPTION>XBRL PRESENTATION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.23b -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef roleURI="http://ageagle.com/role/Cover" xlink:href="uavs-20240930.xsd#Cover" xlink:type="simple" />
    <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/PvpDisclosure" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#PvpDisclosure" xlink:type="simple" />
    <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ErrCompDisclosure" xlink:type="simple" />
    <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#AwardTimingDisclosure" xlink:type="simple" />
    <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#InsiderTradingArrangements" xlink:type="simple" />
    <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#InsiderTradingPoliciesProc" xlink:type="simple" />
    <link:presentationLink xlink:type="extended" xlink:role="http://ageagle.com/role/Cover" xlink:title="00000001 - Document - Cover">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CoverAbstract" xlink:label="loc_deiCoverAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentType" xlink:label="loc_deiDocumentType" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentType" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AmendmentFlag" xlink:label="loc_deiAmendmentFlag" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAmendmentFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AmendmentDescription" xlink:label="loc_deiAmendmentDescription" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAmendmentDescription" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentRegistrationStatement" xlink:label="loc_deiDocumentRegistrationStatement" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentRegistrationStatement" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentAnnualReport" xlink:label="loc_deiDocumentAnnualReport" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentAnnualReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentQuarterlyReport" xlink:label="loc_deiDocumentQuarterlyReport" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentQuarterlyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentTransitionReport" xlink:label="loc_deiDocumentTransitionReport" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentTransitionReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentShellCompanyReport" xlink:label="loc_deiDocumentShellCompanyReport" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentShellCompanyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentShellCompanyEventDate" xlink:label="loc_deiDocumentShellCompanyEventDate" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentShellCompanyEventDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentPeriodStartDate" xlink:label="loc_deiDocumentPeriodStartDate" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentPeriodStartDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_deiDocumentPeriodEndDate" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentPeriodEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="loc_deiDocumentFiscalPeriodFocus" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentFiscalPeriodFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentFiscalYearFocus" xlink:label="loc_deiDocumentFiscalYearFocus" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentFiscalYearFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CurrentFiscalYearEndDate" xlink:label="loc_deiCurrentFiscalYearEndDate" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCurrentFiscalYearEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFileNumber" xlink:label="loc_deiEntityFileNumber" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityFileNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityRegistrantName" xlink:label="loc_deiEntityRegistrantName" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityRegistrantName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCentralIndexKey" xlink:label="loc_deiEntityCentralIndexKey" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCentralIndexKey" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityPrimarySicNumber" xlink:label="loc_deiEntityPrimarySicNumber" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityPrimarySicNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityTaxIdentificationNumber" xlink:label="loc_deiEntityTaxIdentificationNumber" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityTaxIdentificationNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="loc_deiEntityIncorporationStateCountryCode" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityIncorporationStateCountryCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine1" xlink:label="loc_deiEntityAddressAddressLine1" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine2" xlink:label="loc_deiEntityAddressAddressLine2" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine2" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine3" xlink:label="loc_deiEntityAddressAddressLine3" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine3" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCityOrTown" xlink:label="loc_deiEntityAddressCityOrTown" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressCityOrTown" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressStateOrProvince" xlink:label="loc_deiEntityAddressStateOrProvince" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressStateOrProvince" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCountry" xlink:label="loc_deiEntityAddressCountry" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressCountry" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressPostalZipCode" xlink:label="loc_deiEntityAddressPostalZipCode" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressPostalZipCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CountryRegion" xlink:label="loc_deiCountryRegion" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCountryRegion" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CityAreaCode" xlink:label="loc_deiCityAreaCode" />
      <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCityAreaCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LocalPhoneNumber" xlink:label="loc_deiLocalPhoneNumber" />
      <link:presentationArc order="290" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiLocalPhoneNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Extension" xlink:label="loc_deiExtension" />
      <link:presentationArc order="300" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiExtension" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_WrittenCommunications" xlink:label="loc_deiWrittenCommunications" />
      <link:presentationArc order="310" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiWrittenCommunications" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SolicitingMaterial" xlink:label="loc_deiSolicitingMaterial" />
      <link:presentationArc order="320" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSolicitingMaterial" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementTenderOffer" xlink:label="loc_deiPreCommencementTenderOffer" />
      <link:presentationArc order="330" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiPreCommencementTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="loc_deiPreCommencementIssuerTenderOffer" />
      <link:presentationArc order="340" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiPreCommencementIssuerTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Security12bTitle" xlink:label="loc_deiSecurity12bTitle" />
      <link:presentationArc order="350" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurity12bTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_NoTradingSymbolFlag" xlink:label="loc_deiNoTradingSymbolFlag" />
      <link:presentationArc order="360" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiNoTradingSymbolFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_TradingSymbol" xlink:label="loc_deiTradingSymbol" />
      <link:presentationArc order="370" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiTradingSymbol" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SecurityExchangeName" xlink:label="loc_deiSecurityExchangeName" />
      <link:presentationArc order="380" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurityExchangeName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Security12gTitle" xlink:label="loc_deiSecurity12gTitle" />
      <link:presentationArc order="390" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurity12gTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SecurityReportingObligation" xlink:label="loc_deiSecurityReportingObligation" />
      <link:presentationArc order="400" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurityReportingObligation" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AnnualInformationForm" xlink:label="loc_deiAnnualInformationForm" />
      <link:presentationArc order="410" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAnnualInformationForm" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="loc_deiAuditedAnnualFinancialStatements" />
      <link:presentationArc order="420" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAuditedAnnualFinancialStatements" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="loc_deiEntityWellKnownSeasonedIssuer" />
      <link:presentationArc order="430" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityWellKnownSeasonedIssuer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityVoluntaryFilers" xlink:label="loc_deiEntityVoluntaryFilers" />
      <link:presentationArc order="440" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityVoluntaryFilers" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCurrentReportingStatus" xlink:label="loc_deiEntityCurrentReportingStatus" />
      <link:presentationArc order="450" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCurrentReportingStatus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityInteractiveDataCurrent" xlink:label="loc_deiEntityInteractiveDataCurrent" />
      <link:presentationArc order="460" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityInteractiveDataCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFilerCategory" xlink:label="loc_deiEntityFilerCategory" />
      <link:presentationArc order="470" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityFilerCategory" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntitySmallBusiness" xlink:label="loc_deiEntitySmallBusiness" />
      <link:presentationArc order="480" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntitySmallBusiness" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityEmergingGrowthCompany" xlink:label="loc_deiEntityEmergingGrowthCompany" />
      <link:presentationArc order="490" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityEmergingGrowthCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityExTransitionPeriod" xlink:label="loc_deiEntityExTransitionPeriod" />
      <link:presentationArc order="500" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityExTransitionPeriod" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentAccountingStandard" xlink:label="loc_deiDocumentAccountingStandard" />
      <link:presentationArc order="510" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentAccountingStandard" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_OtherReportingStandardItemNumber" xlink:label="loc_deiOtherReportingStandardItemNumber" />
      <link:presentationArc order="520" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiOtherReportingStandardItemNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityShellCompany" xlink:label="loc_deiEntityShellCompany" />
      <link:presentationArc order="530" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityShellCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityPublicFloat" xlink:label="loc_deiEntityPublicFloat" />
      <link:presentationArc order="540" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityPublicFloat" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="loc_deiEntityBankruptcyProceedingsReportingCurrent" />
      <link:presentationArc order="550" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityBankruptcyProceedingsReportingCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="loc_deiEntityCommonStockSharesOutstanding" />
      <link:presentationArc order="560" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCommonStockSharesOutstanding" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="loc_deiDocumentsIncorporatedByReferenceTextBlock" />
      <link:presentationArc order="570" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentsIncorporatedByReferenceTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://xbrl.sec.gov/ecd/role/PvpDisclosure" />
    <link:presentationLink xlink:type="extended" xlink:role="http://xbrl.sec.gov/ecd/role/PvpDisclosure" />
    <link:presentationLink xlink:type="extended" xlink:role="http://xbrl.sec.gov/ecd/role/PvpDisclosure" />
    <link:presentationLink xlink:type="extended" xlink:role="http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" />
    <link:presentationLink xlink:type="extended" xlink:role="http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" />
    <link:presentationLink xlink:type="extended" xlink:role="http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" />
    <link:presentationLink xlink:type="extended" xlink:role="http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" />
    <link:presentationLink xlink:type="extended" xlink:role="http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" />
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45111258238752">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Cover<br></strong></div></th>
<th class="th"><div>Sep. 30, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Sep. 30,  2024<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-36492<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">AGEAGLE
AERIAL SYSTEMS INC.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0000008504<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">88-0422242<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">NV<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">8201
    E. 34th Cir N<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine2', window );">Entity Address, Address Line Two</a></td>
<td class="text">Suite 1307<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Wichita<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">KS<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">67226<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">(620)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">325-6363<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common
    Stock<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">UAVS<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSEAMER<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 2 such as Street or Suite number</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14a<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>13
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M?!^2!F.,6_0T7X\48JVFL:W&VC$,>8!8\PRA9CC?AT6:&C/5BZPYC0IO0=5
MY3_;U UH]@TT')$%7C&9MC:CY$X*/-S^[PVPPL2.X>V+OP%02P,$%     @
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MPS ,0'_%T)XP!] AB#-E\18$^0%6H@_8$@6*19V_K]JE<9 +&7D]/!+<'FE
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MU\7!ZQ^4ZD2HN7/08&<B+EA0BJN$7/D=<.I[.T!*1D.QD8E>I6.5Z*U .EK
M>MKBRAE#VQH%.JB]XY8:8P*IL0,@9^O1=#%-)IXPC,^[V?S!9@K(RDT*$3FQ
M!'_'G2/)W55D(TADIJ]X(;+U[/M!3EN#OI'-X_T,:3?D@6)8YL_X>\87_QO.
M\1'"[K\_L;S63AI_YHOA/UY_ 5!+ 0(4 Q0    ( /$Q0ED'04UB@0   +$
M   0              "  0    !D;V-0<F]P<R]A<' N>&UL4$L! A0#%
M  @ \3%"6;9Z?ESM    *P(  !$              ( !KP   &1O8U!R;W!S
M+V-O<F4N>&UL4$L! A0#%     @ \3%"69E<G",0!@  G"<  !,
M     ( !RP$  'AL+W1H96UE+W1H96UE,2YX;6Q02P$"% ,4    " #Q,4)9
M2=N:B5H$   3$0  &               @($,"   >&PO=V]R:W-H965T<R]S
M:&5E=#$N>&UL4$L! A0#%     @ \3%"69^@&_"Q @  X@P   T
M     ( !G P  'AL+W-T>6QE<RYX;6Q02P$"% ,4    " #Q,4)9EXJ[',
M   3 @  "P              @ %X#P  7W)E;',O+G)E;'-02P$"% ,4
M" #Q,4)9JL0B%C,!   B @  #P              @ %A$   >&PO=V]R:V)O
M;VLN>&UL4$L! A0#%     @ \3%"620>FZ*M    ^ $  !H
M ( !P1$  'AL+U]R96QS+W=O<FMB;V]K+GAM;"YR96QS4$L! A0#%     @
M\3%"6660>9(9 0  SP,  !,              ( !IA(  %M#;VYT96YT7U1Y
><&5S72YX;6Q02P4&      D "0 ^ @  \!,

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>15
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>17
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.24.3</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>23</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>3</UnitCount>
  <MyReports>
    <Report instance="form8-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>00000001 - Document - Cover</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://ageagle.com/role/Cover</Role>
      <ShortName>Cover</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K" isOnlyDei="true" isUsgaap="true" original="form8-k.htm">form8-k.htm</File>
    <File>uavs-20240930.xsd</File>
    <File>uavs-20240930_lab.xml</File>
    <File>uavs-20240930_pre.xml</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="24">http://xbrl.sec.gov/dei/2024</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>19
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "form8-k.htm": {
   "nsprefix": "UAVS",
   "nsuri": "http://ageagle.com/20240930",
   "dts": {
    "inline": {
     "local": [
      "form8-k.htm"
     ]
    },
    "schema": {
     "local": [
      "uavs-20240930.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd",
      "https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd",
      "https://xbrl.fasb.org/srt/2024/elts/srt-roles-2024.xsd",
      "https://xbrl.fasb.org/srt/2024/elts/srt-types-2024.xsd",
      "https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd",
      "https://xbrl.fasb.org/us-gaap/2024/elts/us-roles-2024.xsd",
      "https://xbrl.fasb.org/us-gaap/2024/elts/us-types-2024.xsd",
      "https://xbrl.sec.gov/country/2024/country-2024.xsd",
      "https://xbrl.sec.gov/dei/2024/dei-2024.xsd",
      "https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd",
      "https://xbrl.sec.gov/stpr/2024/stpr-2024.xsd"
     ]
    },
    "labelLink": {
     "local": [
      "uavs-20240930_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "uavs-20240930_pre.xml"
     ]
    }
   },
   "keyStandard": 23,
   "keyCustom": 0,
   "axisStandard": 0,
   "axisCustom": 0,
   "memberStandard": 0,
   "memberCustom": 0,
   "hidden": {
    "total": 2,
    "http://xbrl.sec.gov/dei/2024": 2
   },
   "contextCount": 1,
   "entityCount": 1,
   "segmentCount": 0,
   "elementCount": 59,
   "unitCount": 3,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/dei/2024": 24
   },
   "report": {
    "R1": {
     "role": "http://ageagle.com/role/Cover",
     "longName": "00000001 - Document - Cover",
     "shortName": "Cover",
     "isDefault": "true",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "AsOf2024-09-30",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "b",
       "span",
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form8-k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2024-09-30",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "b",
       "span",
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form8-k.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "dei_AmendmentDescription": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AmendmentDescription",
     "presentation": [
      "http://ageagle.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Description",
        "documentation": "Description of changes contained within amended document."
       }
      }
     },
     "auth_ref": []
    },
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://ageagle.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Flag",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "dei_AnnualInformationForm": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AnnualInformationForm",
     "presentation": [
      "http://ageagle.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Annual Information Form",
        "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form."
       }
      }
     },
     "auth_ref": [
      "r14"
     ]
    },
    "dei_AuditedAnnualFinancialStatements": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AuditedAnnualFinancialStatements",
     "presentation": [
      "http://ageagle.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Audited Annual Financial Statements",
        "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements."
       }
      }
     },
     "auth_ref": [
      "r14"
     ]
    },
    "dei_CityAreaCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "CityAreaCode",
     "presentation": [
      "http://ageagle.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "City Area Code",
        "documentation": "Area code of city"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CountryRegion": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "CountryRegion",
     "presentation": [
      "http://ageagle.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Country Region",
        "documentation": "Region code of country"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CoverAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "CoverAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Cover [Abstract]",
        "documentation": "Cover page."
       }
      }
     },
     "auth_ref": []
    },
    "dei_CurrentFiscalYearEndDate": {
     "xbrltype": "gMonthDayItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "CurrentFiscalYearEndDate",
     "presentation": [
      "http://ageagle.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Current Fiscal Year End Date",
        "documentation": "End date of current fiscal year in the format --MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentAccountingStandard": {
     "xbrltype": "accountingStandardItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentAccountingStandard",
     "presentation": [
      "http://ageagle.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Accounting Standard",
        "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "dei_DocumentAnnualReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentAnnualReport",
     "presentation": [
      "http://ageagle.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Annual Report",
        "documentation": "Boolean flag that is true only for a form used as an annual report."
       }
      }
     },
     "auth_ref": [
      "r11",
      "r13",
      "r14"
     ]
    },
    "dei_DocumentFiscalPeriodFocus": {
     "xbrltype": "fiscalPeriodItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentFiscalPeriodFocus",
     "presentation": [
      "http://ageagle.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Fiscal Period Focus",
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentFiscalYearFocus": {
     "xbrltype": "gYearItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentFiscalYearFocus",
     "presentation": [
      "http://ageagle.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Fiscal Year Focus",
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodEndDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentPeriodEndDate",
     "presentation": [
      "http://ageagle.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period End Date",
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodStartDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentPeriodStartDate",
     "presentation": [
      "http://ageagle.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period Start Date",
        "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentQuarterlyReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentQuarterlyReport",
     "presentation": [
      "http://ageagle.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Quarterly Report",
        "documentation": "Boolean flag that is true only for a form used as an quarterly report."
       }
      }
     },
     "auth_ref": [
      "r12"
     ]
    },
    "dei_DocumentRegistrationStatement": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentRegistrationStatement",
     "presentation": [
      "http://ageagle.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Registration Statement",
        "documentation": "Boolean flag that is true only for a form used as a registration statement."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "dei_DocumentShellCompanyEventDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentShellCompanyEventDate",
     "presentation": [
      "http://ageagle.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Shell Company Event Date",
        "documentation": "Date of event requiring a shell company report."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "dei_DocumentShellCompanyReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentShellCompanyReport",
     "presentation": [
      "http://ageagle.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Shell Company Report",
        "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "dei_DocumentTransitionReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentTransitionReport",
     "presentation": [
      "http://ageagle.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Transition Report",
        "documentation": "Boolean flag that is true only for a form used as a transition report."
       }
      }
     },
     "auth_ref": [
      "r15"
     ]
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentType",
     "presentation": [
      "http://ageagle.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentsIncorporatedByReferenceTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentsIncorporatedByReferenceTextBlock",
     "presentation": [
      "http://ageagle.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Documents Incorporated by Reference [Text Block]",
        "documentation": "Documents incorporated by reference."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "dei_EntityAddressAddressLine1": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressAddressLine1",
     "presentation": [
      "http://ageagle.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line One",
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine2": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressAddressLine2",
     "presentation": [
      "http://ageagle.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line Two",
        "documentation": "Address Line 2 such as Street or Suite number"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine3": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressAddressLine3",
     "presentation": [
      "http://ageagle.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line Three",
        "documentation": "Address Line 3 such as an Office Park"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCityOrTown": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressCityOrTown",
     "presentation": [
      "http://ageagle.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, City or Town",
        "documentation": "Name of the City or Town"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCountry": {
     "xbrltype": "countryCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressCountry",
     "presentation": [
      "http://ageagle.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Country",
        "documentation": "ISO 3166-1 alpha-2 country code."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressPostalZipCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressPostalZipCode",
     "presentation": [
      "http://ageagle.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Postal Zip Code",
        "documentation": "Code for the postal or zip code"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressStateOrProvince": {
     "xbrltype": "stateOrProvinceItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressStateOrProvince",
     "presentation": [
      "http://ageagle.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, State or Province",
        "documentation": "Name of the state or province."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityBankruptcyProceedingsReportingCurrent": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityBankruptcyProceedingsReportingCurrent",
     "presentation": [
      "http://ageagle.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Bankruptcy Proceedings, Reporting Current",
        "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not. Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://ageagle.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityCommonStockSharesOutstanding",
     "presentation": [
      "http://ageagle.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Common Stock, Shares Outstanding",
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCurrentReportingStatus": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityCurrentReportingStatus",
     "presentation": [
      "http://ageagle.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Current Reporting Status",
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityEmergingGrowthCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityEmergingGrowthCompany",
     "presentation": [
      "http://ageagle.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Emerging Growth Company",
        "documentation": "Indicate if registrant meets the emerging growth company criteria."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityExTransitionPeriod": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityExTransitionPeriod",
     "presentation": [
      "http://ageagle.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Elected Not To Use the Extended Transition Period",
        "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards."
       }
      }
     },
     "auth_ref": [
      "r19"
     ]
    },
    "dei_EntityFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityFileNumber",
     "presentation": [
      "http://ageagle.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity File Number",
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityFilerCategory": {
     "xbrltype": "filerCategoryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityFilerCategory",
     "presentation": [
      "http://ageagle.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Filer Category",
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityIncorporationStateCountryCode": {
     "xbrltype": "edgarStateCountryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityIncorporationStateCountryCode",
     "presentation": [
      "http://ageagle.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Incorporation, State or Country Code",
        "documentation": "Two-character EDGAR code representing the state or country of incorporation."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityInteractiveDataCurrent": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityInteractiveDataCurrent",
     "presentation": [
      "http://ageagle.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Interactive Data Current",
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files)."
       }
      }
     },
     "auth_ref": [
      "r16"
     ]
    },
    "dei_EntityPrimarySicNumber": {
     "xbrltype": "sicNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityPrimarySicNumber",
     "presentation": [
      "http://ageagle.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Primary SIC Number",
        "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity."
       }
      }
     },
     "auth_ref": [
      "r14"
     ]
    },
    "dei_EntityPublicFloat": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityPublicFloat",
     "crdr": "credit",
     "presentation": [
      "http://ageagle.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Public Float",
        "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://ageagle.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityShellCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityShellCompany",
     "presentation": [
      "http://ageagle.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Shell Company",
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntitySmallBusiness": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntitySmallBusiness",
     "presentation": [
      "http://ageagle.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Small Business",
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC)."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityTaxIdentificationNumber": {
     "xbrltype": "employerIdItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityTaxIdentificationNumber",
     "presentation": [
      "http://ageagle.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Tax Identification Number",
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityVoluntaryFilers": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityVoluntaryFilers",
     "presentation": [
      "http://ageagle.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Voluntary Filers",
        "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityWellKnownSeasonedIssuer": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityWellKnownSeasonedIssuer",
     "presentation": [
      "http://ageagle.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Well-known Seasoned Issuer",
        "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A."
       }
      }
     },
     "auth_ref": [
      "r17"
     ]
    },
    "dei_Extension": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "Extension",
     "presentation": [
      "http://ageagle.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Extension",
        "documentation": "Extension number for local phone number."
       }
      }
     },
     "auth_ref": []
    },
    "dei_LocalPhoneNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "LocalPhoneNumber",
     "presentation": [
      "http://ageagle.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Local Phone Number",
        "documentation": "Local phone number for entity."
       }
      }
     },
     "auth_ref": []
    },
    "dei_NoTradingSymbolFlag": {
     "xbrltype": "trueItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "NoTradingSymbolFlag",
     "presentation": [
      "http://ageagle.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "No Trading Symbol Flag",
        "documentation": "Boolean flag that is true only for a security having no trading symbol."
       }
      }
     },
     "auth_ref": []
    },
    "dei_OtherReportingStandardItemNumber": {
     "xbrltype": "otherReportingStandardItemNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "OtherReportingStandardItemNumber",
     "presentation": [
      "http://ageagle.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Reporting Standard Item Number",
        "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "PreCommencementIssuerTenderOffer",
     "presentation": [
      "http://ageagle.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-commencement Issuer Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r7"
     ]
    },
    "dei_PreCommencementTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "PreCommencementTenderOffer",
     "presentation": [
      "http://ageagle.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-commencement Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r9"
     ]
    },
    "dei_Security12bTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "Security12bTitle",
     "presentation": [
      "http://ageagle.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of 12(b) Security",
        "documentation": "Title of a 12(b) registered security."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_Security12gTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "Security12gTitle",
     "presentation": [
      "http://ageagle.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of 12(g) Security",
        "documentation": "Title of a 12(g) registered security."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "dei_SecurityExchangeName": {
     "xbrltype": "edgarExchangeCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "SecurityExchangeName",
     "presentation": [
      "http://ageagle.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Exchange Name",
        "documentation": "Name of the Exchange on which a security is registered."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "dei_SecurityReportingObligation": {
     "xbrltype": "securityReportingObligationItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "SecurityReportingObligation",
     "presentation": [
      "http://ageagle.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Reporting Obligation",
        "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r10"
     ]
    },
    "dei_SolicitingMaterial": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "SolicitingMaterial",
     "presentation": [
      "http://ageagle.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Soliciting Material",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r8"
     ]
    },
    "dei_TradingSymbol": {
     "xbrltype": "tradingSymbolItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "TradingSymbol",
     "presentation": [
      "http://ageagle.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Symbol",
        "documentation": "Trading symbol of an instrument as listed on an exchange."
       }
      }
     },
     "auth_ref": []
    },
    "dei_WrittenCommunications": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "WrittenCommunications",
     "presentation": [
      "http://ageagle.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Written Communications",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act."
       }
      }
     },
     "auth_ref": [
      "r18"
     ]
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12"
  },
  "r1": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b"
  },
  "r2": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r3": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-23"
  },
  "r4": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r5": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "g"
  },
  "r6": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12, 13, 15d"
  },
  "r7": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r8": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14a",
   "Subsection": "12"
  },
  "r9": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r10": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "15",
   "Subsection": "d"
  },
  "r11": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 10-K",
   "Number": "249",
   "Section": "310"
  },
  "r12": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 10-Q",
   "Number": "240",
   "Section": "308",
   "Subsection": "a"
  },
  "r13": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Number": "249",
   "Section": "220",
   "Subsection": "f"
  },
  "r14": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Number": "249",
   "Section": "240",
   "Subsection": "f"
  },
  "r15": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Section": "13",
   "Subsection": "a-1"
  },
  "r16": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-T",
   "Number": "232",
   "Section": "405"
  },
  "r17": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "405"
  },
  "r18": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "425"
  },
  "r19": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "7A",
   "Section": "B",
   "Subsection": "2"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>20
<FILENAME>0001493152-24-039093-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001493152-24-039093-xbrl.zip
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MM=73_)GGSD!7(WN,Y:JV ZR_U2(O77$=\2TF_S@DC1H>*?+A.$Q#]DYUC/3
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MZ7\RBLJ;B#M3U\H^JV.IJ-I-[ZHVW-+ 9F;JFQLFY,ESH87#.5"(@3[Y*R^
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MY1'[AJC2C.JFT,%2<C:\>TB;;U\3^+V?4^\+"-PT4IIA_%TC&S I"1C(!R#
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M)O*%.@J+<ETCMKI&[#NLXFH.U#UY<WKX$2GYR?OSXZ/7_Q]02P,$%     @
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M,1.GH-CJC/5OKG^JS\MB,3VG&PG^,BM('E%LDCB-RA0'!09&719915^MR.#
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M(6\A#KJ45)G#,FGC7'",J@1)@$[/!X2TP0>N+'W$&!EE2WDX[;2,%&2#);@
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MQ:@F73&8COG*RS$5Q&3K_1XK0&TPO]"@N)!+(*7LBD/8(7%.1/!L:AW(SUZ
M)(WQL058%%SPYF&HD*OBA?\]%X:BX[W6=^HFT!2K("GA1W?O6O:<M:1#KK;
MKZFWHW=4TG(T2R3:BHM7=$96)P>?EPE#>TXO:KL+5XU<H3MJC,$[XW_%X373
M3/Q:HM-VR-J]/[:3.LPP''&7:6@W57.]TX:-NYYQ6Z5D%-#U2=6*E=&CG&VY
MS@I<6FT&V'=WX:NKE:KG[BFO!Q;TP?#QX__$\+M@H%02EUI>:RR<W1G#SFCA
MEJJ"H#!XC,_2RNTZ\@U7LP4LZ]Y9-YWV9[PS&W(F4U?GV<4XA:1!I$P]88BC
M_'L=;[BEV[>CG-TB4_>)_5[K(].<VJ!1,DV0O+ST7[+RP=4+SS*\QLJO=H>I
M&VY[;FSU(O'IY[YM:;Z@3"%W00V.<FMKQ(J[:D=T8@!A#YH(2;I%P/<?[</U
M$[OD  IQ2 :;JJIVY80%:E5S=\L]*J@KKD!Z4X2?XNVC\IZ2@S  #55+#%]*
M84M07V/^JUY:F&F7&-A>/@*BEB5MICN@';=OI:0J!GX9N5HCRA13@\^*G KU
M;LPTU@GU%;UJ\<7%-:X'ZY49DOZQ+<1(F<5<U@2<LP2C3UCO3V>O2DN%BL0V
MPTF9<:=ZW?=8046,I\-;8]%"M;@^_BZ1@+&'#T_#$<#;;8:26U)3=QM:W/^\
M3>YL,+GS\S:Y<RN3.]<\EYL]E:8L] 5(*3+%'&E$774[2#1O/W+A&VO6P^&^
MVD2VEXY3*BR(V=L_G6=I=Y%OZ)"XP 6=>:UF4X?AAWL1SHF2C'$/W+05V8R1
ML,O8%GCUXH=BY(%4/@S>M-;/%35$ZK E2RMH+L4(A?Z75?]D>5Y2H<&4E>V/
MW2$;A$/1T461QLKVC(O%J ZMC*5*W8BKV^42- ND''.U ><8"%=AM1CQRE7K
MN&E@"%%2 &&%9<,0#X6B<%S,1F!]^/S1EQ%3F"'J!(%=O&\5RL7@&B^O9L@F
MT/9V#&>D%P->#^+D!*LPBZJ*N1(DLM=5MNDN\#B:IX@LXT'ZOC0% )PH8 M"
MUV R-9B7W4X+Q8R-DA5\&2:$C>4+BX1N+7=GA]-HY-FCJ[ HEWI)5/EDETO$
M=ZBJ@2.?RXF(<G2<V]I??V2K'3'S3AU\[O?,,U55\GK92(,C!:N9[7UYE^H\
MQ,VGE1O:R6\D#S9<&/QD3B9B;H[,^)B=,POW3<!;%R)E.2J@'/40B1'0N&;-
MA>'D)098P1]3%$ZM>0H+\E6U-L+FZ+!1C:X>)'3MFJ-B-]E\@ ;6(( 2=<)Q
M2M8#D5*Y9;+KGL;OP+.XVU,Z'![H*WTQJLA6KX6N(W@'HH#8U6HELX$Y(54K
M#N90D0BPKK*, /LNFW((C@GZQ8=.LJRB3SLJQ\IDD\SQ6)TB4X[Z7^JXGATS
M5>!W]KUK @-C'Z&(YH.5\6A>@)2C7JLYAPW_3T<%A516'4F)(9+8K]+@M1_P
M?*]&ZW*CN(7[?"1M'A*OU"4:"Q!;5]EP&,4"!*EP@O?"T%.2WI\;13<8OM*5
MS?+:V"LY/H]BCI*M=7?P0XSFITPTZ+_N*V!'$ ^8PYDB-:.(H!T9L:\0#@?9
M@?$VR,0:,;=!RY7*MQG3+ZIR\TB)!])1@UV::\4^Y5"\"4*67.&L\GN-W2F8
M#227W?.>*UEM#LN3I6/VJRFA71N@BQ:LK$3+@*\<;;"CHL!P@*5\0I5.M,#>
M6I!@IIY8D83RW4,F6_.- A*"28'AI>XH$4*.*%-,?IUL+5MZUO>-8>Z7E;E#
M:QN68:.EV>X0-XJ)AAN@B5K([DQCI&;7ON;>JP:FCF;UD"04/4KXH.(2CY(E
MB:3:>5D'BS,6M35)(V\LTI#6>L^DMH1WA($HJW9EK13!X#LP'%:')!]O0Y(;
M#$D^WH8DM]9OF_5[J*S?]V %?D K\-@.&QG#]Y@[QFMUV&"I=L-7#28OOE5B
MC%:4TO-#VD0IWPVN!V6;NJ$L!DF"?9G@3>N8O&*'61\86&9LT&+%7FD5A(0'
MN8P(>B1D/5:TQ,:TKP5&]>?";/"5"KWYR*]0&^:\'G.VZLR0(KU@\)0Y D(F
M8.'Y8:#0:A8!YQ:W:"K\SPA(Y!),Z]?64*0@S^(3&_1[/MN6+25-T[V=KMIM
M0F,#-- $,9@S 6JVM2V@B_LJF\0>FS*_L(RPPP:S&8NLQPE("Q[:L/'!QOL*
M1GZPEHV/8[EA(U]3K*^P\26^9B_]M4SX8',6?+^G##FSFX*Z:(J',=R#3=OM
M+4NREMF^%L9R;:L=V92N/B*^T2Y#:\6(B\=_#<O=?IM)[]N&.^V6@:8VQZB#
MGYU6.X_5:Q+6;<3W>YNTXMO/TS!HQ7"[#7;Z/=ZTA,F4I6B@U(K"JEB-?2;D
MEC/'Y& NG]UZ*VG.S:JE=#1A90WM.P-4W.TI'9JNCB\7>1S-F&3@S-SY=AKS
MFJG+4/>IU=DDYI]@P4;6-_X)[RRP<G*V!QF@R\ALR_BH)"+/D=!90GDY1HN3
M5Q?9DFYJQ[$VL)2$6FY7[X6FO9.N*:*.M<+C077F8#>F<!&6&#'E.X[T&C'/
M#+JG8X\4XT4AN'=DQV3I&,E ,'2@&"I"S?40<M&1'$+;"-8=5%'G$CUFTZ3U
M[&-!"&/2%:S*4F"R;>NJ<IG6!MGS":DIE' ,3FB8M>)JG_ 6) K]SK_9494/
M33RUNP74,D/I-Y<@CFT Z^)W8<EXWTMK0[;_,$9N!F8-"5Z7:O*Z2:NA3;Q&
MA14)QYM(MSR+QEAQ99+.,B:*-3[<^T\MLB)Y=B+03Z^W?/RB(&CV'&P.S8T[
MYJ^I%+R7D*6\K_V;?J_[5 77.E1-YP$LRG(:Y>D?5FI+/"#].[NIE-H?P1+@
MWBZRJE!I6K,MS;TV#]&Y?I.#(X)052E(A]G:X[A]7_L]?V,Y;WZQMDZZ>O50
M^2QF,RYI,LX<3U8=&^D/Y;I7HT6%P('*21U>Z4=Z&Q(VMH-]P5WR!8V.9%>/
M*PN,KS=0!43VF<2/<[$,?%C5.5^B5:1:VK1_6CSPZJHST85)V,SQ"';(<_2<
MU"NN-NVO4J \EQP21]QU*K"[AKYA?+=1Y%..VC1T\^C!/<)<]&Z%,=<XC"YW
MKTO?:H'Z"RR8*A.;J*IC^KJ?1AM!\AHI)CP@-CJY:&LC[L!PUD-2\# ,5A=U
M"0D7I3)L^J"B;&C'%"]!U02U6I07#(&WOB6D!Y2PY01NE-$Y!N]/GMM,4AYE
MX%4BS +>9'W2ER!<+-QIVK4V#ZAC*Q@LX[9-O'*A#-NT9X/U>W:)8:NDK!S,
ME8&'-7=> TN:O $FG^42$C9@'ZO 1M$<%7N9>N@7552@YMGO=>Q>X'1(-%S
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MDH^N^6Z-L\9*F9U#IU.O5<%C.]76FT0,J:&WM=U\6KTW\9_]?K=J0NQ Z&K
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M.GLAG#9I6287Q9C3VXO1+*TKX]C(JUU5)8+RQ:,(@^<%^R/PRS=1?HZE@X9
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M/,2JR&16N[HO5;S^?MXQ=(M!E!1XL*!'(0JM5@6%5@4Z*  VU1B+-"4"T<'
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M"]V28M/;T%3^IVV>:(-YHI^^T3S1;4\ .2/]A$?Z$N7N#&6:O//"@OJQ#8G
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MXK5$\R*Q?$>$CE*Q_;U&)R,"(DH-Y,$N%O5(R_E0S8P-)W.Z^[U.722A;C3
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M;#4E&MU(Z<4EGHS?_SA\&\0,PJ*!L]2/DHLT)Q(7435=>V4XOLQ>863MT\_
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M\[SN2),L6=2UYF6(*/4CEPTO]'GLNJ:A"YV\E6!720.X.7Y R2HXWK65$4I
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M"NL@UW$8N?C$H=(B4K*)C8!U2.\,HY?,#<:!-:0<[4C(J.!?X,(4([*GI"$
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MV/M[_+?3X[^].1T.CF&CC]]$9W\_.S_]Z2R.7K]]N7?#I#?B^NG>GO/C%V]
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M-6A#33)0:4W.BK<P/S675;FXN*1+#/XR*TD246#229;@?16C8=-495[35\'
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M8SA/.1+4R87$:&NC5-%Z:H&DAX.?4;.&:]*UKLZ^&ZMK@M503(!*RE>JM\C
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M\+<Q> VUO[IPX71$QV'>AOPA:=G>8CUXMJBJV5?'9^>8D+FHDAGR4><E:J6
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M;TE)*/PRYS!K,RAWI+0N>98NPB%3[JWU^*U]MN%3>F*#86=)LZB0,P0^C;S
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M0K?5!O%0COE8LNGLM-WJL&8?T/7RX.[+NZ0]O]FF/=>9]OQFF_:\]VG/!\2
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MCYWU%OWXFDZM$>C^%ZV0NY]07?#N$Y*TVWV#&*)H;>_U]G9H[V"_W>WM[;\
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M$N.G;% $O #Y= "])0CFD9ZT!ED2VT!OD)?N3TIW:6;W_'L2D:\>D5HX1I=
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M1";7B^HG(I.H(%BB_,<) LP!>42-I.G!HX5 >>GBR6WC$2%><L2]Q!&=I*/
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M6?X%\OZBM^0]OR[IV>#.72*MJ;%WH[V%M\)%:/8UKOU?T>^3Z%>X]HM\XU=
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MI5!YH#9N@FRU"$!NA<:N-4+O^J6;8?$0\)""&<D(5*I5S6)1F !3+2XFMS#
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M_4SV8+M:.K=, #:;4!BB@*BP.P.P*,4H5R,I]P+&G4@V6.P72=0S5;2%;M&
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MB-"D5)MU;8[LO+P4-  X:RB!HE%>[W^EG'\0<BX&E&@I:)0_ZOO>\#N+0*.
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MFR/_ %!+ 0(4 Q0    ( /$Q0ED@'JXR-CX  &5] 0 )              "
M 0    !E>#$M,2YH=&U02P$"% ,4    " #Q,4)96\,'."4.  "86P  "@
M            @ %=/@  97@Q,"TQ+FAT;5!+ 0(4 Q0    ( /$Q0ED5^AW_
M,5,  ,(: @ )              "  :I,  !E>#0M,2YH=&U02P$"% ,4
M" #Q,4)9$*_Q:/98  !A1P( "0              @ $"H   97@T+3(N:'1M
M4$L! A0#%     @ \3%"66C%LFOF7@  5H4"  D              ( !'_D
M &5X-"TS+FAT;5!+ 0(4 Q0    ( /$Q0EF.:<%5SP@  +TE   *
M      "  2Q8 0!E>#DY+3$N:'1M4$L! A0#%     @ \3%"6?"#[TX3'P
M2O    L              ( !(V$! &9O<FTX+6LN:'1M4$L! A0#%     @
M\3%"684TBK4G P  X L  !$              ( !7X ! '5A=G,M,C R-# Y
M,S N>'-D4$L! A0#%     @ \3%"6=A]B'3^"@  @(8  !4
M ( !M8,! '5A=G,M,C R-# Y,S!?;&%B+GAM;%!+ 0(4 Q0    ( /$Q0EEE
M?OLKV@<  .Y>   5              "  >:. 0!U879S+3(P,C0P.3,P7W!R
;92YX;6Q02P4&      H "@!* @  \Y8!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>21
<FILENAME>form8-k_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2024"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="uavs-20240930.xsd" xlink:type="simple"/>
    <context id="AsOf2024-09-30">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000008504</identifier>
        </entity>
        <period>
            <startDate>2024-09-30</startDate>
            <endDate>2024-09-30</endDate>
        </period>
    </context>
    <unit id="USD">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="Shares">
        <measure>shares</measure>
    </unit>
    <unit id="USDPShares">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <dei:AmendmentFlag contextRef="AsOf2024-09-30" id="Fact000003">false</dei:AmendmentFlag>
    <dei:EntityCentralIndexKey contextRef="AsOf2024-09-30" id="Fact000004">0000008504</dei:EntityCentralIndexKey>
    <dei:DocumentType contextRef="AsOf2024-09-30" id="Fact000009">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="AsOf2024-09-30" id="Fact000010">2024-09-30</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName contextRef="AsOf2024-09-30" id="Fact000011">AGEAGLE AERIAL SYSTEMS INC.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="AsOf2024-09-30" id="Fact000012">NV</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber contextRef="AsOf2024-09-30" id="Fact000013">001-36492</dei:EntityFileNumber>
    <dei:EntityFileNumber contextRef="AsOf2024-09-30" id="Fact000014">001-36492</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber contextRef="AsOf2024-09-30" id="Fact000015">88-0422242</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="AsOf2024-09-30" id="Fact000016">8201     E. 34th Cir N</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2 contextRef="AsOf2024-09-30" id="Fact000017">Suite 1307</dei:EntityAddressAddressLine2>
    <dei:EntityAddressCityOrTown contextRef="AsOf2024-09-30" id="Fact000018">Wichita</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="AsOf2024-09-30" id="Fact000019">KS</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="AsOf2024-09-30" id="Fact000020">67226</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="AsOf2024-09-30" id="Fact000021">(620)</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="AsOf2024-09-30" id="Fact000022">325-6363</dei:LocalPhoneNumber>
    <dei:WrittenCommunications contextRef="AsOf2024-09-30" id="Fact000023">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial contextRef="AsOf2024-09-30" id="Fact000024">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer contextRef="AsOf2024-09-30" id="Fact000025">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer contextRef="AsOf2024-09-30" id="Fact000026">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle contextRef="AsOf2024-09-30" id="Fact000027">Common     Stock</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="AsOf2024-09-30" id="Fact000028">UAVS</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="AsOf2024-09-30" id="Fact000029">NYSEAMER</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany contextRef="AsOf2024-09-30" id="Fact000030">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
